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List of Abbreviations Used.
ALV avian leukosis virus
ATP adenosine 3’-triphosphate
BPV bovine papillomavirus
CRPV cottontail rabbit papillomavirus
dATP deoxyadenosine 3’-triphosphate
dCTP deoxycytidine 3’-triphosphate
dGTP deoxyguanosine 3’-triphosphate
DMEM Dulbecco’s modified Eagle’s medium
DMSO dimethyl sulphoxide
DNA deoxyribonucleic acid
DNase I deoxyribonuclease I
dsDNA double stranded DNA
DTT dithiothreitol
dTTP deoxythymidine 3’-triphosphate
EDTA sodium ethylene diamine tetraacetate
FBS foetal bovine serum
FITC fluorescein isothiocyanate
HPV human papillomavirus
MMTV mouse mammary tumour virus
PBS phosphate buffered saline
PCR polymerase chain reaction
Rb retinoblastoma
RNA ribonucleic acid
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RNase A  
SDS
TEMED
ribonuclease A  
sodium dodecyl sulphate 
N,N,N’,N’-tetramethylethylene diamine
4
Contents.
Acknowledgements 2
Abbreviations 3
Contents 5
List of Figures 11
List of Tables 13
Summary 14
1. Oral Squamous Cell Carcinoma 16
1.1. Epidemiology of Oral Squamous Cell Carcinoma 16
1.1.1. Incidence 16
1.1.2. Age and Sex Incidence 16
1.1.3. Site Incidence 17
1.2. Pathology of Oral Cancer 18
1.3. Prognosis 19
1.4. Aetiological Factors in Oral Cancer 20
1.4.1. Tobacco 20
1.4.2. Alcohol 22
1.4.3. Liver Cirrhosis 23
1.4.4. Industrial Factors 24
1.5. Precancerous Conditions 24
1.5.1. Syphilis 24
1.5.2. Iron Deficiency Anaemia 25
1.5.3. Oral Submucous Fibrosis 26
5
1.6. Oral Precancerous Lesions 26
1.6.1. Leukoplakia 26
1.6.2. Erythroplakia 27
1.7. Oncogene Activation in Oral Squamous Cell
Carcinoma 28
1.8 Field of Growth Theory.
2. Viral Oncogenesis 30
2.1. RNA Tumour Viruses 30
2.2. DNA Tumour Viruses 33
2.2.1. Simian Virus 40 (SV40) and Polyomavirus 33
2.2.2. Adenoviruses 35
2.2.3. Hepatitis B Virus 36
2.2.4. Herpesviruses 37
2.2.5. Papillomaviruses 40
2.2.5.1. Physical and Biological Features 40
2.2.5.2. Oncogenic Activity of Papillomaviruses 43
2.2.5.3. Papillomaviruses in Human Cancers 44
2.2.5.4. Human Papillomaviruses in Oral Disease 54
2.2.6. Objectives of the Current Study 59
6
3. Materials and Methods 61
3.1. Materials 61
3.1.1. Chemicals 61
3.1.2. Enzymes and Markers 62
3.1.3. Stock Solutions 62
3.1.4. Growth Media 63
3.1.5. Cloning Vectors and Host Strains 64
3.1.6. Recombinant HPV Clones 64
3.1.7. Other Materials 65
3.2. Methods 65
3.2.1. General Methods 65
3.2.1.1. Sterilisation of Materials and Solutions 65
3.2.1.2. Handling of Bacteria 66
3.2.1.3. Handling of Radioactive Isotopes 66
3.2.1.4. Phenol/Chloroform Extraction 66
3.2.1.5. Ethanol Precipitation 66
3.2.1.6. Spectrophotometric Quantitation of
Nucleic Acids 67
3.2.1.7. Collection and Sampling of Human
Tissue Specimens 67
3.2.2. Manipulation of Nucleic Acids 69
3.2.2.1. Preparation of DNA and RNA from
Stored Tissue 69
3.2.2.2. Transformation of Host Bacteria with
Plasmid DNA 71
3.2.2.3. Small Scale Plasmid DNA Preparation 72
3.2.2.4. Large Scale Plasmid DNA Preparation 73
7
3.2.2.5. Restriction Enzyme Digestion of DNA 74
32.2.6. Agarose Gel Electrophoresis 74
32.2.1. Polyacrylamide Gel Electrophoresis 75
3.2.2.8. Purification of DNA by Electroelution 75
3.2.2.9. DNA Purification on a Silica Matrix 77
3.2.2.10. Southern Transfer 78
3.2.2.11. Preparation of^a^iolabelled DNA Probes 78
3.2.2.12. Purification of Radiolabelled Probes 79
3.2.2.13. Prehybridisation of Southern Blots 80
3.2.2.14. Hybridisation of Southern Filters 81
3.2.2.15. Washing of Southern Blots 81
3.2.2.16. Removal of Probe from Southern Blots 82
3.2.3. Molecular Cloning 82
3.2.3.1. Construction of Genomic DNA Libraries 82
3.2.3.2. Subcloning of DNA into Plasmid Vectors 85
3.2.4. Sequencing of Double-stranded DNA Templates 86
3.2.5. Polymerase Chain Reaction 88
3.2.5.1. Precautions 88
3.2.5.2. Reaction Conditions 89
3.2.5.3. Analysis of PCR Products 90
3.2.5.4. Sequencing of PCR Products 91
3.2.6. Culture of Keratinocytes from Oral
Squamous Cell Carcinomas 92
3.2.6.1. Preparation of Feeder Cells 92
3.2.6.2. Preparation of Cells from Carcinoma
Biopsies 92
3.2.6.3. Subculture of Keratinocytes 93
8
3.2.6.4. Immunocytochemistry 94
3.2.6.5. Preparation of Nucleic Acids from
Keratinocyte Cultures 95
32.6.6. In Vivo Tumorigenicity Studies 95
3.2.7. Computer Analysis of DNA Sequence Data 96
4. Results 97
4.1. Southern Blot Analysis of Human DNA Samples 97
4.2. Molecular Cloning of HPV-4 DNA from Cancer C4 104
4.2.1. Isolation of HPV-4 DNA 104
4.2.2. Comparative Restriction Analysis of HPV-4 DNA 109
4.2.3. Restriction Analysis of the 6kb Fragment 111
4.3. Nucleotide Sequencing of HPV-4 Isolates 114
4.3.1. The Partial Nucleotide Sequence of HPV-4 114
4.3.2. Sequence Analysis of the 6kb Clone 116
4.4. PCR Screening of Genomic DNA Samples for HPV DNA 119
4.4.1. PCR Screening for HPV-4 Sequences 122
4.4.2. Screening for HPV-16 Sequences by PCR 124
4.4.3. PCR-mediated Detection of HPV-18 DNA 130
4.4.4. Use of Anticontamination Primers 133
4.5. Late Region Alterations in HPV-16 from Oral Samples 139
4.5.1. PCR Amplification of HPV-16 Late Region
Sequences 139
4.5.2. DNA Sequence Analysis of HPV-16 Late Region
PCR Products 145
9
4.5.3. Hybridisation of C3 and C5 DNAs to
Genomic Sequences 148
4.5.4. Hybridisation of C3 and C5 PCR Products
to Prototype HPV-16 DNA 150
4.6. Culture of Keratinocytes from Oral Tumour Biopsies 152
4.6.1. Establishment of Cells in Culture 152
4.6.2. Tumorigenicity of T45 Cells 152
4.6.3. HPV Status of T45 Cells 153
5. Discussion 159
5.1. Detection of Viral DNA in Oral Biopsies 159
5.2. Frequency of HPV Sequences in Oral Tissues 166
5.3. HPV-18 DNA in Oral Samples 174
5.4. HPV-4 DNA in Oral Lesions 178
5.5. HPV-16 Sequences in Oral Tissue Biopsies 181
5.6. Oral Keratinocyte Cultures Harbour HPV Sequences 188
5.7. Conclusions 192
6. References 194
10
List of Figures.
4.1. Southern blot detection of HPV DNA 101
4.2. Alteration of the HPV-16 late region 102
4.3. Physical state of HPV DNA in carcinomas 103
4.4. Map of EMBL3 106
4.5. Restriction analysis of HPV-4 clones 107
4.6. Subcloning of HPV-4 DNAs 108
4.7. Restriction analysis of oral and prototype
HPV-4 clones 110
4.8. Restriction analysis of the 6kb band 112
4.9. Partial nucleotide sequence of HPV-4 and
homology comparison 117
4.10. PCR detection of HPV-4 DNA 123
4.11. PCR detection of HPV-16 DNA 126
4.12. HPV-16 DNA in samples D2 and N2 127
4.13. Nucleotide sequence comparison of HPV-16 E6
PCR products from D2 and HPV-16 128
4.14. Nucleotide sequence comparison of HPV-16 E7
sequences from N30 and HPV-16 129
4.15. PCR detection of HPV-18 DNA 131
4.16. Nucleotide sequence comparison of HPV-18
E6 region DNAs 132
4.17. Anticontamination PCR primer strategy 136
4.18. Sensitivity of anticontamination PCR primers 137
4.19. Detection of HPV-18 DNA using the
anticontamination primers 138
11
4.20. Hybridisation patterns of C2 DNA using a 
HPV-16 DNA probe
4.21. PCR amplification strategy for analysis of 
the late region of oral HPV-16 DNA
4.22. PCR amplification of HPV-16 late region DNAs 
from C3 and C5
4.23. Paraffin section PCR amplification of c-Ha-ras 
exon 1 from C2
4.24. Nucleotide sequences of DNA fragments amplified 
from C3 and C5
4.25. Regions of homology between C3 and C5 DNAs 
and the HPV-16 late region
4.26. Hybridisation of carcinoma and normal cellular 
DNAs to the C3 probe
4.27. Hybridisation of HPV-16 DNA to the C3 probe
4.28. Phase contrast micrograph of T45 cells
4.29. Keratin staining of T45 cells
4.30. Detection and sequence comparison of HPV-16 E6 
DNA in T45 cell DNA
List of Tables.
4.1. Sequence and location of PCR primers 120
4.2. Internal oligonucleotide probes 121
4.3. HPV-16 late region PCR primers 135
13
Summary.
The DNAs of human papillomavirus (HPV) types 4, 16 and 18 have 
been detected in biopsies of normal and malignant human oral 
mucosa by Southern blot hybridisation and polymerase chain reaction 
(PCR). By the former technique HPV-4, HPV-16 and HPV-18 DNAs 
were detected in three separate carcinomas, but only found in 
adjacent dysplastic and normal tissue by PCR. The PCR technique 
also allowed detection of HPV-16 and HPV-18 DNA in additional 
carcinomas and normal samples. The oral HPV-4 DNA has been 
molecularly cloned and extensive restriction analysis and nucleotide 
sequencing showed identity with the prototype HPV-4 DNA. The 
HPV-18 DNA detected by Southern blot hybridisation showed an 
altered restriction pattern in the E l region of the viral genome; 
however direct nucleotide sequencing of PCR products from the E6 
ORF showed no sequence alterations in either normal or malignant 
samples.
HPV-16 DNA detected in one carcinoma by Southern blot 
hybridisation revealed altered PstI and Hpall restriction patterns as 
compared with the prototype viral genome. The expected 2.6kb Hpall 
and 1.55kb PstI bands, which overlap, were absent, and an additional 
band of reduced molecular weight was visible in the Hpall digest, 
suggesting that the oral HPV-16 genome had undergone a deletion 
or rearrangement.
In a further two carcinoma samples positive for HPV-16 DNA by 
PCR, amplification of a late region fragment of the viral genome
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produced fragments of reduced molecular weight. When these PCR 
fragments were used as probes, hybridisation was observed to the 
1.78kb PstI and 1.81kb Hpall-BamHI bands of HPV-16 DNA, and 
also (as a smear) to human genomic DNA from both tumour and 
normal samples. This suggests that the viral DNA in these samples 
had undergone recombination events with repetitive cellular 
sequences, perhaps as a prelude to viral integration or as a means of 
activating cellular genes.
A keratinocyte culture (T45) derived from an oral squamous cell 
carcinoma was found to be non-tumorigenic in vivo. PCR analysis 
revealed that a proportion of cells in the culture contained HPV-16 
early sequences. The establishment of HPV-positive and 
HPV-negative clones from this culture will provide an excellent 
system for studying the role of viral and cellular factors in oral 
squamous cell carcinogenesis.
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1. Oral Squamous Cell Carcinoma.
1.1 Epidemiology of Oral Squamous Cell Carcinoma.
1.1.1. Incidence.
Squamous cell carcinoma is the most common form of intraoral 
malignant disease, accounting for 90-95% of cancers in this region and 
around 5% of all malignant tumours in the western world (Lucas, 
1984). Oral cancer is, however, relatively uncommon compared to the 
incidence of cancer at other sites such as breast, bronchus and colon 
(Cawson, 1984). The remainder of oral malignancy comprises tumours 
of glandular epithelium, connective tissue lesions such as fibrosarcoma 
and osteosarcoma, and metastatic deposits from primary cancers at 
distant sites.
1.1.2. Age and Sex Incidence.
Oral cancer is mainly a disease of the elderly, with the majority of 
sufferers older than forty years of age (Cawson, 1984). The sex 
incidence of intraoral squamous cell carcinoma is approximately equal 
at present, with males being marginally more likely to develop the 
disease. However the male to female ratio has decreased from 10:1 to 
the current level, principally due to a decrease of disease in males,
16
while the incidence in females has remained static (Binnie et al, 
1972).
1.1.3. Site Incidence.
Squamous cell carcinoma may develop in any region of the oral cavity, 
but frequency of lesions is different for different sites. According to 
Binnie et al (1972), lip is the most common site with 28.6% of oral 
cancers arising there, followed by tongue (24.7%), retromolar (13.4%) 
and floor of mouth (9.1%). Lesions of alveolar mucosa, buccal 
mucosa, hard palate and soft palate account for the remainder.
The high level of lip cancer (the vast proportion of which affects the 
lower lip) is thought to be a result of exposure to actinic radiation, as 
it is more common in rural populations than in city dwellers, and is 
frequently seen in outdoor workers in sunny climates (Miller, 1974). 
The lateral and ventral surfaces of the tongue together with the floor 
of mouth and lower alveolus form a U-shaped "sump" which extends 
backwards on both sides of the oral cavity, forming a region where any 
soluble carcinogen might pool. This may afford some explanation as to 
why approximately 70% of intraoral squamous cell carcinomas arise at 
these sites, although the area accounts for only 20% of the total 
mucosal surface of the oral cavity (Langdon, 1985).
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1.2. Pathology of Oral Cancer.
The pathological features of intraoral squamous cell carcinoma are 
described well by Lucas (1984). Macroscopically, well-established 
lesions may appear as papillary outgrowths or, more commonly, as 
chronic ulcers with raised edges and a necrotic floor which bleeds 
easily. Earlier lesions may present as hyperkeratotic areas, or as 
erythematous patches.
At the histological level changes can be seen in the structure of the 
epithelium from normal to the malignant state. Normal oral 
epithelium is well-ordered, with a single layer of basal cells below the 
stratum spinosum, and granular and cornified layers may be above, 
dependent on the site. Maturation is regular, with mitotic activity 
being confined to the basal layer and keratinisation only occurring at 
the surface.
As the epithelium progresses through various stages of dysplasia 
towards frank carcinoma an increasing number of characteristic 
features (atypia) can be seen, such as increased and aberrant mitoses, 
and mitoses in cells other than basal cells. The cells may become 
pleomorphic and the regularity of maturation may be lost. Later 
changes may include keratin pearls throughout the epithelium and 
nuclear hyperchromatism. Invasion of epithelial cells through the 
basement membrane into the underlying connective tissue is the 
hallmark of malignancy. A large number of intraoral carcinomas are 
well-differentiated, but a whole spectrum of histological types through 
moderate to poorly-differentiated lesions may be observed.
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Spread of these tumours is not uncommon. They are locally invasive at
first, but may metastasize via local lymphatic vessels to involve
regional lymph nodes. Perineural spread may occur, which clinically
can cause anaesthesia or paraesthesia of the a can cause anaes
involved nerve. Haematogenous spread is uncommon in head and
neck cancers.
1.3. Prognosis.
Several factors are probably of importance for the prognosis of 
intraoral carcinomas. The site of the lesion has a marked effect on the 
survival of the patient, and Langdon et al (1977) document a five year 
survival of 57% for lip lesions, compared to 38% for tongue and only 
17% where the tumour affects the maxillary alveolus. These authors 
also observed that early stage lesions had an improved outcome over 
those which presented later, and that prognosis was better for smaller 
tumours than for large primaries. Different studies have tried to relate 
histological appearance of tumours to prognosis, but conflicting 
reports are present in the literature (Johnson, 1977; Langdon et a l ,
1977). Some authors (Langdon et a l , 1977; Smith, 1973) quote a 
higher five year survival for females over males, but Binnie et al 
(1972) disagree. Langdon et al (1977) found that tumours in patients 
below sixty years of age had a better prognosis than those in the "over 
sixty" age group.
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1.4. Aetiological Factors in Oral Cancer.
The aetiology of oral cancer is poorly understood. A number of 
different predisposing factors are generally believed to be of 
importance, although Langdon et al. (1977) report a lack of any 
obvious risk factor in 55.7% of cases in southern England.
1.4.1. Tobacco.
The majority of oral cancer patients are heavy smokers, with 96% of 
subjects in Wynder and Stellman’s (1977) series being either smokers 
or ex-smokers. These authors note that the method of smoking is 
important, as cigar and pipe smokers are considerably more likely to 
develop oral cancer than non-smokers, the relative risk being four to 
six fold for low usage (one to five cigars or pipes daily). Smith (1979) 
points out that the incidence of oral cavity cancer has not increased in 
parallel with other smoking-associated diseases. Perhaps this reflects 
the relative importance of the method of smoking to development of 
oral cancer. As mentioned previously, the incidence of oral cancer in 
males has declined steadily since the 1930s while cigarette 
consumption has risen considerably in the same period. Lucas (1984) 
and Cawson (1984) suggest that the decrease in male cancer cases 
might be explained by a reduction in pipe smoking, whereas the 
disease in women, who never had this habit, does not show a similar 
trend. Moore (1965) has shown that, of patients who have been 
successfully treated for oral, pharyngeal or laryngeal cancer, 
approximately one third will develop new primary tumours if smoking
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does not cease. There is only a small risk of developing a second 
tumour if the patient stops smoking after removal of the original 
malignancy.
A recent study carried out in northern Italy (Franceschi et a l , 1990) 
investigated the effects of tobacco and alcohol intake on development 
of carcinomas of the upper aerodigestive tract, including cancer of the 
oral cavity. These authors reported that smokers of cigars and pipes 
were at greater risk of intraoral malignancy than cigarette smokers, 
and that heavy drinkers were also at significantly greater risk, the 
figures relating mainly to wine consumption.
Other forms of tobacco usage may be of importance in the 
development of intraoral squamous cell carcinoma. Hard palate 
cancer, relatively common in India, has been linked to the practice of 
reverse smoking, during which the lighted end of the cigarette is held 
in the mouth (Pindborg et a l , 1971). Oral cancer in general is much 
more prevalent in Asia, accounting for around 40% of all 
malignancies. This level of disease is thought to be related to long 
term betel chewing, with cancer developing at the particular site 
where the betel quid is habitually held (Hirayama, 1966). Pindborg 
(1980) states that oral cancer is only associated with betel chewing in 
regions where tobacco is present in the quid. A similar relationship 
appears to exist in the southeastern USA where "snuff-dipping" by 
females is common and oral cancer mortality rates are elevated (Blot 
and Fraumeni, 1977), especially from carcinoma of the lower gingival 
and alveolar mucosa. Winn et al (1981) found a four fold increase of
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such cancers in snuff-dippers compared to non-users in a case control 
study in North Carolina.
1.4.2. Alcohol.
Several epidemiological studies from the USA provide evidence of a 
strong correlation between excessive alcohol consumption and 
development of intraoral squamous cell carcinoma (Wynder et a l, 
1957a; Rothman and Keller, 1972; Graham et al, 1977). According to 
Wynder et al (1957a) heavy drinkers (more than six ounces of spirits 
or equivalent per day) have a ten to fifteen fold greater chance of 
developing oral cancer than occasional drinkers. The importance of 
the contribution made by alcohol to the aetiology of oral cancer is 
complicated by the fact that the majority of heavy drinkers are also 
heavy smokers (Rothman and Keller, 1972; Hinds et a l, 1980), and it 
is not easy to separate these two risk factors. There are conflicting 
reports in the literature as to whether alcohol and tobacco act 
synergistically or independently, which is more important, and what 
type of either is most likely to lead to the development of malignant 
oral disease (reviewed by Douglass et al, 1984).
To further complicate matters, no association has been found between 
alcohol intake and oral cancer in the UK (Binnie et a l, 1972). Over 
the past fifty years consumption of alcohol has increased steadily while 
the incidence of oral cancer has decreased. Binnie (1976) points out 
that there may be an association between alcohol and oral cancer in 
the USA and France where, unlike the UK, unmatured pot-stilled
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spirits (containing toxic by-products) are available. However Langdon 
(1985) remarks on the high number of alcohol abusers attending oral 
cancer clinics in the UK, in spite of the findings of Binnie and 
coworkers.
Experimental evidence for an effect of alcohol on oral mucosa is 
scant. However, in a recent study, Graham and Rennie (1987) 
describe a consistent biochemical change in the oral epithelium of 
alcoholic rats compared to control animals. These authors noted a 
reduction in the level of a high molecular weight glycoprotein and a 
concomitant increase of two smaller proteins. Histological studies 
(Mascres et al., 1984) have detected changes in epithelial thickness 
after chronic alcohol consumption.
1.4.3. Liver Cirrhosis.
A few epidemiological studies have implicated cirrhosis of the liver in 
the development of oral cancer, notably lesions of the floor of mouth. 
Vincent et al (1964) suggested that development of oral epithelial 
malignancy was accelerated in patients with liver damage induced by 
alcohol. Studies by Keller (1969, 1977) demonstrated an association 
between floor of mouth lesions and liver cirrhosis, with cancers 
appearing up to three years earlier in those suffering from liver 
damage compared to controls. It is unclear how cirrhosis might 
promote development of oral cancer, especially at a particular site, 
although one possibility might be a reduced capacity to clear toxic 
products from the body, leading to prolonged exposure of certain
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tissues and possible promotion of malignancy. Alternatively, cirrhosis 
may be coincidental in oral cancer patients who consume large 
quantities of alcohol, which probably has some topical action on the 
oral mucosa in addition to systemic consequences.
1.4.4. Industrial Factors.
Reports from both the USA (Vogler et al., 1962) and the UK (Binnie 
et al., 1972) cite textile mill workers as being at greater risk of 
developing oral cancer than the general population. Exposure of 
workers to dust produced when processing raw wool and cotton results 
in an increased incidence of oral squamous cell neoplasms (Moss and 
Lee, 1974), although the nature of the responsible agent is not known.
1.5. Precancerous Conditions.
A precancerous condition is one which might render the oral 
mucosa more susceptible to the development of cancer. Several 
precancerous conditions are recognised, the more common of which 
are described below.
1.5.1. Syphilis.
Syphilis has traditionally been described as a risk factor for 
development of oral cancer (Levin et al., 1942). The effect of
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spirochaetes may be the production of an epithelium which is more 
susceptible to further modification by toxic substances in the mouth, 
such as tobacco (McCarthy, 1984). However it is possible that oral 
cancer arising in syphilitic lesions may have been due to the action of 
toxic chemicals previously used in the treatment of the condition 
(Smith, 1973). Nowadays the importance of syphilis as an aetiological 
factor in oral malignancy is much reduced due to the uncommon 
occurrence of tertiary disease.
1.5.2. Iron Deficiency Anaemia.
Paterson (1919) and Brown-Kelly (1919) first described the 
association of iron deficiency anaemia with carcinoma of the post­
cricoid region. Ahlbom (1936) and Wynder et al. (1957b) confirmed 
the relationship of this nutritional disorder with more widespread 
pharyngeal and oral cancers. Brown-Kelly Paterson syndrome 
(Plummer-Vinson syndrome), which consists of iron deficiency 
anaemia, koilonychia, glossitis and dysphagia, is a common disease in 
middle aged Swedish females, who also have a high incidence of 
cancer of the upper gastrointestinal tract (Wynder et al., 1957b), and 
who account for the increased incidence of oral cancer in Swedish 
women (Larsson et al., 1975). Low levels of serum iron tend to result 
in atrophy of oral epithelium, and this is thought to be more 
vulnerable to the effects of irritant chemicals in much the same way as 
atrophic syphilitic epithelium. Prime et al. (1983) described an 
increased incidence of lingual carcinoma in iron deficient rats treated 
with 4-nitroquinoline-N-oxide.
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1.5.3. Oral Submucous Fibrosis.
Submucous fibrosis is a chronic disease characterised by epithelial 
inflammation, fibroelastic change in the underlying connective tissue 
and epithelial atrophy, which may make the mucosa more susceptible 
to the topical effects of carcinogens, for example constituents of 
tobacco, and alcohol. A high level of epithelial dysplasia (around 13- 
14%) has been noted in such lesions (Pindborg, 1972). The disease 
affects Asian populations, mainly Indians and Pakistanis, and in a 
study of oral cancer patients in India 40% were found to suffer from 
submucous fibrosis (Pindborg et al., 1967).
1.6. Oral Precancerous Lesions.
The World Health Organisation (1980) has defined the precancerous 
lesion as "morphologically altered tissue in which cancer is more likely 
to occur than in its apparently normal counterpart". Two such lesions 
are recognised in the oral cavity, leukoplakia and erythroplakia.
1.6.1. Leukoplakia.
The term "leukoplakia" is a clinical description of a white patch on the 
oral mucosa which does not scrape off and which can not be attributed 
to any other disease. There is no implication of a particular
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histological appearance in this description. From the clinical picture, 
several types of leukoplakia exist, including homogeneous leukoplakia, 
verrucous leukoplakia and speckled leukoplakia (a white lesion 
intermingled with red patches).
Many studies have examined the incidence of malignant 
transformation within or associated with leukoplakias (reviewed by 
MacDonald, 1975). Most investigators have concluded that 
progression of leukoplakia to malignancy is infrequent; Cawson (1969) 
stated that the majority of cases (90-95%) would not develop into 
cancers within five years. In a Swedish study (Einhorn and Wersall, 
1967) the incidence of carcinomatous change in leukoplakia was 2.4% 
over a ten year period, increasing to 4% over twenty years. Another 
large study (Banoczy and Sugar, 1972) reported that 5.9% of all 
leukoplakias in their Hungarian population developed into 
carcinomas, a similar figure to that quoted above. More interestingly, 
when these authors subdivided the lesions into three different types of 
leukoplakia, the likelihood of transformation was found to differ 
between variants. No cases of homogeneous leukoplakia developed 
into cancer; however the incidence of transformation of verrucous and 
speckled lesions was 4.6% and 28% respectively, suggesting that these 
(especially the latter) are more sinister.
1.6.2. Ervthroplakia.
Erythroplakia is similar to leukoplakia in its description, although red 
instead of white. Again the term is a clinical one, and refers to a well-
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demarcated red patch, unattributable to other causes (Mehta et a l , 
1971). It is much rarer than leukoplakia, present in around 0.02% of 
an Indian study population (Mehta et al., 1971) and is regarded as the 
most severe of precancerous lesions, often at a much later stage along 
the road to invasive cancer (Kramer, 1969).
1.7. Oncogene Activation in Oral Squamous Cell 
Carcinoma.
Only a few reports exist of the involvement of oncogenes in oral 
cancers. Spandidos et al (1985) found elevated transcription of c-Ha- 
ras, c-Ki-ras and c-myc genes in squamous cell carcinoma biopsies 
compared to levels in normal tissues, but the results are complicated 
by the use of heterogeneous material (possibly containing normal as 
well as neoplastic cells) as opposed to clonal cell lines. This, however, 
would tend to underestimate the true level of transcription of these 
genes. The same authors (Field et a l , 1986) attempted to correlate 
oncogene expression with the clinical stage of tumours, but the sample 
number was small and no significant conclusions could be drawn.
More recently, Tadokoro et al (1989) described activation of c-Ha-ras 
in two cell lines derived from oral cancers. In both lines activation 
occurred by point mutation, at codon 12 in one cell line and at codon 
13 in the other population. Amplification of the gene coding for the 
epidermal growth factor receptor (c-erbBl) and c-myc fwa  ^ also 
detected in the cell line harbouring the codon 13-mutated c-Ha-ras 
gene. The finding of amplified EGF receptor genes and their
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overexpression at the cell surface is not an uncommon finding in oral 
cancers, and has been noted by several authors (Cowley et al., 1986; 
Ozanne et a l , 1986; Ishitoya et al, 1989). Compared to other cancers 
however, information regarding the molecular biology of oral cancer 
in general and involvement of viral or cellular oncogenes in the 
disease is limited.
1.8. "Field of Growth” Theory.
The field of growth theory (reviewed by Walter and Israel, 1974) suggests 
that areas of tissue, rather than single cells, may become predisposed to 
tumour development. Within such a field one or more tumours may 
subsequently develop, perhaps from single cells which have undergone 
additional genetic events resulting in malignant progression. For example, 
multiple tumours of colon may arise from cases of polyposis coli or 
ulcerative colitis; fields of skin exposed to ultraviolet radiation may give 
rise to one or several squamous cell or basal cell carcinomas. The idea of 
field change may also serve to explain the source of recurrence of tumour 
in areas adjacent to excision sites.
The concept of an area of tissue predisposed to malignancy may reflect 
the nature of the aetiological agent. Exposure of tissue to chemical 
carcinogens or ionising radiation likely results in widespread damage to 
cells, making them more susceptible to further malignant progression. 
This may be of importance in the development of oral squamous cell 
carcinoma, where large areas of oral mucosa may be damaged by 
chemical agents and by viral infections.
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2. Viral Oncogenesis.
The idea of cancer-causing viruses is not a new one. Indeed it is 
almost eighty years since Rous (1911) demonstrated the ability to 
produce highly malignant tumours in previously normal chickens by 
injection of a cell-free filtrate from a hen sarcoma, and that the 
responsible agent (Rous sarcoma virus, RSV) could be propagated by 
serial passage through chickens. Since then, much work has been 
carried out on many different tumour viruses, establishing the ways in 
which they contribute to the transformed phenotype of the host cell, 
and giving us a fascinating insight into oncogenesis in general.
2.1 RNA Tumour Viruses.
Many RNA tumour viruses (or retroviruses) have been described 
which infect a wide range of host animals. As the classification 
suggests, their genomes consist of RNA instead of DNA, in the form 
of two single-stranded molecules complexed with core proteins. The 
viral envelope comprises virally-encoded glycoproteins embedded in a 
lipid membrane derived from the previously infected host cell.
The retroviral particle is able to enter a susceptible host cell primarily 
due to the presence of specific receptors on the cell surface. On entry 
into the host the viral genome is transcribed into a double-stranded 
DNA provirus by one of the products of the viral pol gene, an RNA- 
directed DNA polymerase (reverse transcriptase). The provirus
30
contains identical long terminal repeats (LTRs) at both ends as a 
result of duplication of sequences near the 5’ and 3’ termini of the 
RNA template, and is therefore slightly longer than the original 
genome. Transcription of proviral DNA by host polymerase produces 
viral RNA which serves firstly to encode the structural proteins of the 
viral core (from the gag gene) and the envelope (env gene products), 
but also as genomic RNA of progeny virions. These then bud from the 
cell membrane without resulting in cell lysis.
Some distinction of oncogenicity of retroviruses may be made on the 
grounds of the time required for tumour production in host animals. 
Hence these agents can be broadly categorised as either acute or 
chronic, with rapid tumour induction in the former case and a longer 
latent period in the latter.
One mechanism by which certain retroviruses transform cells is by 
transducing sequences (proto-oncogenes, proto-onc) derived from host 
genetic material and inserting them into the viral genome. The viral 
counterpart (y-onc) of the cellular gene is usually altered in some way, 
in some cases by mutation, or alteration in length as a result of 
truncation or fusion to viral DNA. The y-onc is under control of viral 
regulatory elements contained within the LTRs and may be expressed 
at high levels, leading to cell transformation.
The transactivation of cellular genes by viral proteins is a second 
possible method of oncogenesis. A form of adult T-cell leukaemia, 
endemic in some areas of the world, is closely associated with two 
related retroviruses, human T-lymphotropic virus (HTLV) types I and
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II (reviewed by Wong-Staal and Gallo, 1985). Leukaemogenesis 
caused by HTLV-I and II may be a result of trans-acting 
transcriptional regulation of the interleukin 2 (IL-2) receptor gene via 
the viral tat gene product (Seiki et al., 1986; Inoue et al., 1986); 
Greene et al., 1986).
Thirdly, proviral DNA may act in cis on adjacent cellular oncogenes 
(c-oncs) to alter the cell’s growth properties. Transformation by 
insertional mutagenesis is usually characterised by long latency, and is 
dependent on proviral sequences being adjacent to and in the same 
orientation (in the case of promotor insertion) as the cellular gene. 
Bursal lymphomas in chickens caused by avian leukosis virus (ALV) 
involve activation of the c-myc gene by promoter insertion (Neel and 
Hayward, 1981; Westaway et al., 1984), the cellular gene being under 
control of the viral LTR, and resulting in virus-cell fusion transcripts. 
A few ALV-induced lymphomas are not the result of promoter 
insertion as the proviral DNA is integrated in the opposite orientation 
to c-myc. In such situations it is likely that the proviral DNA acts via 
cis enhancer activity to regulate transcription of the cellular gene 
(Nusse, 1986).
Oncogene activation by retroviral insertion is not limited to an 
increase in transcriptional activity of a particular gene. Although the 
gene for the epidermal growth factor (EGF) receptor, c-erbBl, can be 
activated by transduction, insertional activation resulting in a 
disrupted gene product has also been shown to be important. Novel 
chimeric RNAs are produced, which undergo splicing to create erbBl 
mRNA coding for a protein with a truncated amino-terminal end
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(Nilsen et a l, 1985). This reflects its activation by retroviral 
transduction, where a similarly truncated EGF receptor is produced 
(U llriches/., 1984).
2.2 DNA Tumour Viruses.
The DNA tumour viruses comprise a heterogeneous population, from 
the small members of the papovavirus group with genomes of around 
5 kilobase pairs (kb) in size to the large herpesviruses (up to 175kb 
long). Specific nucleotide sequences are again important for cell 
transformation, but the oncogenes carried by these virus types do not 
appear to be derived from host cellular DNA, unlike the RNA tumour 
virus group.
2.2.1. Simian Virus 40 fSV401 and Polvomavirus.
SV40 and polyomavirus, members of the papovavirus family with 
double-stranded DNA genomes of 5243 and 5297 base pairs (bp) 
respectively (Fiers et al, 1978; Deninger et al, 1979; Friedmann et a l, 
1979), can interact with host cells in two ways. Firstly, a lytic cycle may 
occur in permissive monkey (SV40) and mouse (polyoma) cells, with 
production of new virus and death of infected cells. However both 
virus types have the ability to transform rodent cells in vitro, as well as 
some monkey and human cells (SV40 only).
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Transformation of host cells by SV40 and polyomaviras depends upon
the presence of a functional viral early region, which is integrated into
the host genome. Integration appears to be random, with no preferred
site in the cell DNA involved. The recombination event is thought to
be illegitimate, with only around two to five base pairs of homology
between viral and cellular sequences at the integration site,(Sambrook 
et al., 1968)
In SV40-mediated transformation expression of viral large T antigen 
(TAg) is necessary. This protein has been confirmed as the SV40 
oncogene by analysis of mutants (Martin and Chou, 1975; Osborn and 
Weber, 1975) and is required for maintenance of the transformed 
phenotype (Steinberg et al., 1978). SV40 TAg has been shown to bind 
the cellular proteins p53 (Lane and Crawford, 1979) and p l0 5 ^  (de 
Caprio et al., 1988), both of which have tumour-suppressor functions, 
and the viral oncogene may act at least partly by relieving normal 
cellular control mechanisms.
In contrast, polyomavirus large T antigen does not transform 
established rodent cells and is not required for maintenance of the 
transformed phenotype (Novak et al., 1980). This function is 
performed by the middle TAg (Treisman et al, 1981), although large 
TAg is required for immortalisation of primary cells prior to 
transformation by middle TAg (Rassoulzadegan et al., 1983). 
Polyomavirus middle TAg has been shown to complex with the 
cellular phosphoprotein pp60c-5rc, the product of the c-src proto­
oncogene, whose tyrosine kinase activity is markedly increased as a 
result (Courtneidge, 1985), and its transforming potential is inherent 
to the ability of middle TAg to bind in this way.
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2.2.2. Adenoviruses.
The human adenovirus family comprises thirty one different serotypes. 
All are double stranded DNA viruses, with a genome length of 
approximately 35kb and two types of capsomers (reviewed by 
Pettersson and Roberts, 1986). Viral transcription can be divided into 
early and late phases (Fujinaga and Green, 1970) and is known to 
occur from both strands of DNA (Landgraf-Leurs and Green, 1973).
Adenoviruses can be divided into three groups on the basis of their 
relative oncogenicity, namely highly oncogenic, weakly oncogenic and 
non-oncogenic (Huebner, 1967). McBride and Weiner (1964) were 
first to report the transformation of normal hamster kidney cells in 
vitro by adenovirus type 12 (Adl2). Freeman et al (1967) were able to 
demonstrate that even adenovirus serotypes which lack oncogenicity in 
vivo are capable of transformation of cultured cells under suitable 
conditions.
During infection of non-permissive cells viral DNA integrates into the 
genome of the host cell (Doerfler, 1968). Further analysis using 
restriction fragments of the Ad2 genome demonstrated that only 
around one half of the total viral sequences were retained in 
transformed cells (Sharp et al, 1974). The sequences necessary for 
transformation were located to the left hand end of the viral genome, 
within the Hindlll ’G’ fragment (Graham et a l, 1975). Studies by 
Houweling et al (1980) using a smaller region of the adenovirus
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genome (Hpal ’E’) showed that viral transformation involved more 
than one step, as cells transfected with this fragment became 
immortal, but not fully transformed.
The transforming region of the adenovirus genome encodes the E1A 
and E1B group of polypeptides (Esche et a l , 1980). E1A is able to 
function as a transactivator of both viral (Berk et a l , 1979) and 
cellular (Kao and Nevins, 1983) genes, and can act together with 
cellular oncogenes to co-transform cells (Ruley, 1983). More recently,
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E l A has been shown to complex with p l 0 5 ,  the product of the 
retinoblastoma gene which has tumour suppressor functions (Whyte et 
a l , 1988). Similarly, the E1B product can complex with the p53 
tumour suppressor protein (Lane and Crawford, 1979; Sarnow et a l ,
1982). These mechanisms represent important ways in which normal 
cellular control functions may be subverted by the presence of a 
transforming virus in the cell, producing an alteration in growth 
potential of affected host cells.
2.2.3. Hepatitis B Virus.
Hepatitis B virus (HBV) is present as a chronic infection in over two 
hundred and fifty million individuals world-wide, causes severe liver 
damage and has been linked with development of hepatocellular 
carcinoma (HCC) in its hosts (Beasley et al., 1981). In contrast to 
information regarding virus structure and function, little is known of 
the mechanism of HBV oncogenesis. In very few cases integrated and
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rearranged HBV DNA is able to activate cellular proto-oncogenes 
directly, such as c-myc (Moroy et al., 1986; Hsu et al., 1988).
Using a HBV transgenic mouse model, Chisari et al. (1989) have 
demonstrated that overproduction of viral large envelope protein in 
hepatocytes causes cell damage, followed by inflammatory and 
regenerative responses, which in turn lead to dysplasia, aneuploidy, 
adenoma, and finally HCC. The development of HCC in transgenic 
mice appears to mirror development of the disease in human in 
several aspects, including the randomness of viral integration and the 
presence of the same region in a functionally intact state. Malignant 
change is probably due to multiple secondary genetic events as a 
consequence of severe hepatocellular injury and hyperplasia induced 
by HBV.
2.2.3. Herpesviruses.
Seroepidemiological evidence points to an association of some of the 
human herpesviruses with specific human malignancies such as 
Epstein-Barr virus (EBV) in nasopharyngeal carcinoma (Raab-Traub 
et a l, 1987) and Burkitt’s lymphoma (Epstein et al, 1964), herpes 
simplex virus (HSV) type 2 in cervical carcinoma (Rawls et a l, 1969) 
and HSV-1 in oral squamous cell carcinoma (Shillitoe et al., 1976).
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In vivo, injection of herpesvirus into chickens produces a fatal 
lymphosarcoma, whereas introduction of attenuated virus does not 
have this effect (Okazaki et al., 1970). In vitro studies using rodent 
cells and ultraviolet (UV) light-inactivated virus types have shown that 
herpesviruses possess transforming ability (Duff and Rapp, 1971,1973; 
Albrecht and Rapp, 1973; Gelb et al., 1980).
Despite the obvious oncogenic potential of HSV-1 and 2 in tissue 
culture systems no single viral gene has been found to be expressed 
universally in virally-transformed cell lines, arguing against the 
requirement for a virus-encoded oncogene for transformation. Indeed 
continued presence or expression of viral DNA does not appear to be 
a prerequisite for maintenance of the transformed phenotype, and the 
possibility of HSV-1 and HSV-2 acting via a "hit-and-run" mechanism 
is well-reviewed by Galloway and McDougall (1983). This theory 
postulates that viral DNA would enter the cell, induce certain changes 
resulting in transformation and then be lost again, with maintenance 
of the transformed state being controlled by cellular factors from this 
stage. Changes in viral DNA content of HSV-transformed cell lines 
with continued passaging have been documented by several authors 
(Frenkel et al., 1976; Galloway et a l , 1980), with complete absence of 
viral sequences in some cases (Copple and McDougall, 1976; Hampar 
etal., 1980).
The in vitro transforming activity of HSV-1 and HSV-2 has been 
narrowed down to specific regions of the viral genomes. In the former, 
the Bglll "I" fragment has been shown to be oncogenic (Camacho and
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Spear, 1978; Reyes et al., 1979), whereas two fragments of HSV-2 
(Bglll "C" and "N") have transforming ability (Jarriwalla et a l, 1980; 
Galloway and McDougall, 1981). Further work by Galloway et al 
(1984) mapped more finely the HSV-2 Bglll "N" transforming activity 
to a 737bp stretch of DNA which could induce anchorage- 
independence in cultured rodent cells, although this fragment was not 
thought to encode a polypeptide. These authors suggest that the 
presence of insertion sequence (IS)-like elements within the 
transforming fragment may be important for transformation, and have 
demonstrated similar structures in a transforming fragment of 
cytomegalovirus (CMV) DNA.
The loss of herpesvirus DNA after the initial stages of transformation 
may explain the apparent lack of viral sequences in a large number of 
cervical carcinomas (zur Hausen et al., 1974; Pagano, 1975), although 
recent studies have been more successful (McDougall et a l, 1980; 
Eglin et al., 1981; di Luca et al., 1987), and earlier work may have 
suffered from a lack of sensitive detection methods.
Many workers have investigated the association between HSV-1 and 
oral squamous cell carcinoma. Shillitoe et al. (1984) were able to 
demonstrate that oral cancer patients had an increased IgA response 
to HSV-1 antigens present in virally-infected HEp-2 human 
epidermoid carcinoma cells (Moore et a l, 1955) compared to a 
matched control population, and also a stronger IgM response, results 
which mirror the in vivo situation (Smith et al., 1976; Shillitoe et al.,
1983). Nucleic acid hybridisation studies (Eglin et al., 1983) further 
implicated HSV as an aetiological factor in oral cancer, with viral
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RNA detected in carcinoma tissues but not in normal mucosa from 
the same patients, although the sample numbers were small.
HSV and other herpesvirus types clearly have some oncogenic 
potential, but their precise role in development of human 
malignancies is not yet totally apparent, and other factors must be 
involved in tumour progression.
2.2.5. Papillomaviruses.
Papillomaviruses have been recognised as the cause of common warts 
ever since Ciuffo (1907) demonstrated the presence of an infectious 
agent in filtered homogenates of verruca vulgaris. Since then much 
work has been done on this group of viruses which implicates them in 
the aetiology of several human diseases, including certain types of 
malignancy.
2.2.5.1. Physical and Biological Features.
Papillomaviruses are species-specific DNA tumour viruses belonging 
to the papovavirus group, along with polyomavirus, SV40, JC and BK 
viruses. They comprise a single circular double-stranded DNA 
genome complexed with histones and surrounded by a protein capsid 
of 72 capsomers, and lack a lipid envelope (Gissmann, 1984; Pfister, 
1984).
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According to Broker and Botchan (1986), the papillomaviruses 
constitute a distinct group separate from other Papovaviridae on 
several counts. Firstly, they have a larger particle size of 55nm 
diameter. Papillomavirus genomes are, on average, fifty percent larger 
(approximately 8kb long) than either SV40 or polyomavirus (section 
2.2.1) and there is no sequence similarity. Papillomaviruses are also 
transcriptionally different, with all major open reading frames (ORFs) 
present and transcribed along one strand only, in contrast to SV40 and 
polyomavirus which utilise both strands of DNA. Most 
papillomaviruses are restricted in their tissue tropism, growing only in 
epithelium. Indeed the papillomavirus life cycle is closely linked to the 
state of differentiation of the host cell, with viral DNA replication 
occurring in the lower portion of the epithelium and viral capsid 
proteins only produced in the upper differentiating layers (for reviews 
see Gissmann, 1984; Pfister, 1984).
Papillomaviruses have been isolated from a diverse range of species 
(Pfister, 1984) including rabbits, dogs, deer, elk, cattle, donkeys, mice, 
chaffinches and monkeys, as well as humans. Within some of these 
groups several different types of papillomavirus exist, based on 
different types sharing less than fifty percent DNA sequence homology 
by reassociation kinetics under highly stringent conditions (Coggin and 
zur Hausen, 1979). However, later nucleotide sequence analysis of 
some viruses shows the differences between some related types to be 
much less, as in the case of HPV-6 and HPV-11 which are identical 
over 82% of their genomes (de Villiers, 1989). For instance, there are 
six different bovine papillomavirus (BPV) types known to infect cattle,
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divided into two distinct subgroups (Jarrett et al., 1984). Subgroup A  
viruses (BPV-1, 2 and 5) are fibropapillomaviruses and infect both 
dermal fibroblasts and keratinocytes, whereas subgroup B viruses 
(BPV-3, 4 and 6) are strictly epitheliotropic. Sequence data suggests 
that subgroup B viruses lack an E6 ORF, which may be a factor 
resulting in the different tissue tropisms of these two subgroups (W. 
Pennie and S. Campo, personal communication).
Unlike other DNA tumour viruses, no in vitro system exists as yet for 
the propagation of papillomaviruses due to the strict link between 
virus replication and epithelial maturation. Fortunately the advent of 
molecular biology and recombinant DNA techniques has allowed 
detailed study of these viruses through molecular cloning, sequence 
analysis and cell transfection experiments.
Use of this technology has enabled molecular cloning of more than 
sixty six human papillomavirus (HPV) types to date (reviewed by de 
Villiers, 1989) from a variety of pathological conditions. DNA  
sequence analysis has revealed a similar genome organisation between 
those HPV types which have been sequenced thus far, and also 
between animal papillomaviruses so characterised (Giri and Danos, 
1986). The viral genome may be divided into three regions, coding for 
early and late gene products, and a non-coding region (NCR) also 
referred to as the long control region (LCR) or upstream regulatory 
region (URR). The coding regions consist of overlapping ORFs which 
are transcribed in all three frames, thus making the best use of the 
limited genomic information available.
42
The products of the early (E) ORFs are involved with viral 
replication, transcriptional regulation and cell transformation events, 
while the late (L) ORFs encode viral structural proteins. The NCR 
contains regulatory elements, including the orgin of replication, 
promoter sequences, binding sites for proteins involved in viral gene 
expression (Chong et al., 1990), and perhaps for factors which confer 
tissue specificity on the viral type (Sibbet and Campo, 1990).
2 2 5 2 .  Oncogenic Activity of Papillomaviruses.
The majority of papillomavirus infections result in the production of 
proliferative epithelial or mucosal lesions which are characteristically 
benign (Gissmann, 1984), and which usually regress. However in some 
instances, in the presence of cofactors, lesions may progress to 
malignancy.
A good animal model system for papillomavirus oncogenicity is that of 
the cottontail rabbit papillomavirus (CRPV), the first DNA tumour 
virus to be isolated and characterised (Shope and Hurst, 1933; 
reviewed by Kreider, 1980). While the virus induces warts in its 
natural host, progression of these to carcinomas is approximately 
three times more frequent in domestic rabbits (Syverton, 1952), 
suggesting that perhaps some genetic factor is involved. Painting 
CRPV-induced warts in cottontail rabbits with chemical carcinogens 
also results in a higher frequency of malignant progression than with 
either virus or carcinogen alone (Rous and Kidd, 1938; Orth et al.,
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1977). However no infectious viral particles were able to be isolated 
from primary carcinomas or metastases (Kidd and Rous, 1940).
Another example of the carcinogenic effect of papillomaviruses is 
afforded by the system first described by Jarrett et al. (1978). Bovine 
papillomavirus type 4 (BPV-4) induces papillomatosis of the oral 
cavity and upper alimentary canal of cattle. If infected animals feed on 
bracken fern, which contains carcinogens and immunosuppressants, 
progression from papilloma to carcinoma is observed. These events 
can be reproduced in an experimental situation where cattle infected 
with BPV-4 and fed on bracken are seen to develop carcinomas 
(Campo and Jarrett, 1986). In both cases viral DNA is present in the 
benign lesions but is lost as progression occurs, suggesting that the 
virus is not required for maintenance of the transformed phenotype 
(Campo et al., 1985). This observation is further confirmed by work by 
Smith and Campo (1988), in which cultured cells transformed in vitro 
by BPV-4 DNA were seen to lose viral sequences after several 
passages without reversion to a non-tumorigenic phenotype.
2.2.5.3. Papillomaviruses in Human Cancers.
As mentioned above, more than sixty six types of human 
papillomavirus (HPV) have been isolated from mainly benign 
pathological lesions at various sites, including skin (Heilman et al., 
1980; Kremsdorf et al., 1984), genital mucosa (De Villiers et al., 1981; 
Beaudenon et al., 1987a) and laryngeal mucosa (Gissmann et al., 
1982). However a large body of evidence has now been obtained
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implicating human papillomaviruses in the aetiology of several human 
cancers.
The first evidence of the oncogenic potential of HPVs came from 
clinical cases of epidermodysplasia verruciformis (EV), a rare 
inherited skin disease which persists throughout the life of the patient. 
It is characterised by defects in cell-mediated immunity and 
disseminated skin warts containing specific HPV types (de Villiers,
1989) which usually appear in childhood. Around thirty percent of EV 
sufferers develop squamous cell carcinomas of the skin, mainly at sites 
exposed to UV radiation, after a variable timespan (Lutzner, 1978) 
which are locally aggressive and eventually fatal if left untreated.
Various workers (Orth et al., 1980; Pfister et al., 1983a) have 
demonstrated the presence of viral DNA in carcinomas from EV 
patients, a similar finding to CRPV in the rabbit model. In addition, 
Ostrow et al. (1982) found HPV-5 DNA in a metastatic lesion. 
However it is as yet unclear whether or not viral sequences are 
required for maintenance of the transformed state. Orth et al. (1980) 
used an in situ hybridisation technique to show that not all cells in a 
lesion were uniformly infected, implying that different amounts of 
viral DNA replication may occur in different cells. Ultrastructural 
studies did not show any evidence of productive viral infection, again 
paralleling the CRPV findings. Development of HPV-containing 
carcinomas at sites exposed to actinic radiation may be another 
example of carcinogenesis involving virus plus cofactors.
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Other categories of immunosuppressed individuals are prone to suffer 
from HPV infections. Renal transplant recipients whose immune 
responses are necessarily depressed show an increased incidence of 
skin warts, and are thirty five times more likely to develop carcinomas 
than the population at large (Pfister, 1984). Patients with acquired 
immune deficiency as a result of infection with the human 
immunodeficiency virus (HIV) also commonly develop warts at 
various bodily sites (Greenspan et al., 1988), and HPV-associated 
anogenital malignancies have been documented in male homosexuals 
so infected (Melbye et a l , 1990).
Laryngeal papillomas in children and young adults have been 
associated with HPV-6 (Gissmann et al., 1983) and HPV-11 
(Gissmann et al., 1982; Mounts et al., 1982). In the past, treatment of 
laryngeal warts (reviewed by zur Hausen, 1977) consisted of X- 
irradiation, but this resulted in progression to malignancy in some 
cases after a variable period of five to forty years, suggesting synergism 
between HPV types and X-rays (Pfister, 1984).
Adult onset laryngeal warts have a different potential for 
transformation, with progression to carcinoma occurring in over 
twenty percent of cases (Kleinsasser and Oliveira e Cruz, 1973); the 
necessary cofactor is probably heavy cigarette smoking (Pfister, 1984). 
Although initial investigations failed to isolate any papillomavirus 
sequences from the carcinomas (Gissmann et al., 1982), more recent 
studies have been successful resulting in the detection of HPV-16 
(Brandsma et al., 1986) and HPV-30 (Kahn et al., 1986) DNA in 
laryngeal carcinomas.
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Epidemiological evidence has long suggested the involvement of a 
transmissible agent in the aetiology of human genital cancer (Rotkin, 
1973), much attention in the past having been focussed on HSV-2 
(section 2.2.4.) but with limited success. Warts of the genital tract 
were shown to contain papillomavirus particles by electron microscopy 
(Dunn and Ogilvie, 1968) and several authors have reported 
malignant conversion of these lesions (reviewed by zur Hausen, 1976). 
Further investigations detected viral structural antigen (Woodruff et 
al., 1980) and viral DNA (Gissmann and zur Hausen, 1980; Gissmann 
et al., 1982) in genital condylomata, leading zur Hausen (1977, 1982) 
to propose that specific papillomaviruses might be the infective agents 
in anogenital malignancies and that they might act synergistically with 
HSV to effect malignant transformation.
Much evidence has since accumulated regarding HPVs and their 
possible role in genital carcinogenesis. Durst et al. (1983) were the 
first authors to report the isolation of a new HPV type, HPV-16, from 
cervical carcinoma specimens, which was followed by the discovery of 
a related type in another series of tumours (HPV-18, Boshart et al., 
1984). Later work enabled isolation and characterisation of several 
additional viral types associated with genital cancers (reviewed by de 
Villiers, 1989), including HPV-31 (Lorincz et al., 1986), HPV-33 
(Beaudenon et al., 1986) and HPV-35 (Lorincz et al., 1987). DNAs of 
these papillomaviruses have been demonstrated in around ninety 
percent of anogenital malignancies of both sexes, although HPV-16 
(50%) and HPV-18 (20%) are more prevalent (zur Hausen, 1988). 
Viral DNA has also been detected in cell lines developed from
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cervical tumours such as HeLa (HPV-18) and Caski and SiHa (HPV- 
16).
Papillomavirus DNA in genital cancers is frequently, but not 
invariably, integrated into the host cell genome either in single copy or 
in multiple tandemly repeated structures (Lehn et al., 1985; 
Matsukuru et al., 1986), and this may be an early event in the process 
of neoplasia (Schneider-Maunoury et al., 1987). As the viral genome 
is naturally circular, the integration event requires linearisation of 
HPV DNA. This split almost invariably occurs in the E2 region of the 
viral genome (Schwarz et al., 1985), which has important consequences 
for regulation of viral gene expression. Integration in this way disrupts 
the E2 coding sequence, resulting in removal of E2-mediated 
repression and increasing E6 and E7 transcription, which are the 
major RNAs found to be expressed in cervical carcinomas (Schwarz et 
al., 1985; Yee et al., 1985; Schneider-Gadicke and Schwarz, 1986).
The continued presence and expression of HPV DNA and expression 
of specific viral gene products in genital cancers and cell lines derived 
from these indicates that papillomavirus types may play an important 
role in the aetiology of such tumours. More recent studies have 
addressed the question of the oncogenicity of genital HPV types in in 
vitro assays. Work by Matlashewski et al. (1987, 1988) showed that 
HPV-16 DNA together with an activated ras oncogene was sufficient 
for transformation of primary human fibroblasts and primary rodent 
epithelium in a cotransfection assay, whereas neither alone resulted in 
transformation, reinforcing the need for cooperative effects in HPV- 
induced carcinogenesis. The transforming function was localised to
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the E6-E7 region of the viral genome. Cells harbouring HPV-16 DNA 
alone appeared to have an extended lifespan. Bedell et al. (1989) 
similarly identified the transforming genes of HPV-18 as the E6 and 
E7 using NIH3T3 and Rat-1 fibroblast cell lines. Further evidence has 
been provided for HPV-16 oncogenicity. Le and Defendi (1988) were 
able to fully transform NIH3T3 cells in culture using a DNA fragment 
containing part of the viral NCR, the E6, E7 and part of the El, and 
adjacent cellular sequences. When HPV-16 and HPV-18 DNAs were 
transfected into primary cells (Pirisi et al., 1987; Kaur and McDougall, 
1988) they became immortal; human cervical epithelial cells 
previously immortalised by HPV-16 but lacking tumorigenicity 
(Woodworth et al., 1988) became fully malignant when a viral Harvey 
ras oncogene was added to the system (DiPaolo et al., 1989).
Using a hormone-inducible promoter construct, Crook et al. (1989b) 
demonstrated the continued requirement for expression of HPV-16 
E7 protein for maintenance of the transformed phenotype of baby rat 
kidney (BRK) cells transformed with HPV-16 and activated ras. 
HPV-16 is also able to cooperate with v-fos to transform baby mouse 
kidney cells (Crook et al., 1988), but is dependent on the continued 
presence of dexamethasone or progesterone in the culture medium 
when gene expression is driven from the viral promoter, an effect 
presumably mediated through the glucocorticoid responsive element 
in the viral NCR (Gloss et al., 1987). However at later passages these 
cells lose the requirement for steroid hormones, with a concurrent 
amplification and overexpression of c-myc (Crook et al., 1989c) which 
appears to confer hormone independence on HPV-16 transformed 
cell lines (Crook et al., 1989a). Lees et al. (1990) extended this work by
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demonstrating that cotransformation of BRK cells by HPV-16 and 
activated ras was increased when the viral E2 protein was 
overexpressed using an E2 construct cotransfected into the cells, which 
was shown to transactivate the HPV-16 early promoter.
Further analysis of the HPV-16 E7 ORF confirmed its role in HPV- 
mediated transformation. Edmonds and Vousden (1989) created a 
series of point mutations throughout the E7 which would alter the 
coding potential, and tested these by transfection into NIH3T3 cells. 
Mutation of the "zinc-finger" (Barbosa et al., 1987) motif near the 
carboxy terminus of the E7 protein was found to considerably 
decrease transforming ability, while mutations in the region of 
homology to adenovirus E1A and SV40 large T completely abolished 
the E7 transformation function. Similar experiments by Watanabe et 
al. (1990) reinforced these results using point-mutated E7 constructs 
in a variety of different cell lines.
Whereas complete genomes or viral early regions from those HPV 
types frequently associated in vivo with genital carcinomas (HPV-16, 
18 and 33) are competent in cotransformation assays of primary cells, 
HPV-6 and HPV-11 DNAs (mainly found in benign lesions) are not 
(Storey et al., 1988). The reason for this may lie in the ability of the 
highly oncogenic HPVs to produce a spliced E7 message not possible 
in either HPV-6 or 11, due to lack of necessary sites within the E6 
ORF (Smotkin et al., 1989). Indeed, when constructs containing the 
HPV-6 or HPV-11 E7 ORF alone are transfected into BRK cells 
together with activated ras, these viral types give rise to transformed 
cells albeit at a lower efficiency than HPV-16, 18 or 33 DNAs (Storey
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et al., 1990), although cells transformed by HPV-6 and HPV-11 E7 are 
equally as tumorigenic in immunocompetent animals as those 
transformed by HPV-16 plus ras. These authors were able to 
demonstrate that the cotransforming activity of HPV DNA is separate 
from its transactivation function, as stimulation of a chloramphenicol 
acetyltransferase (CAT) gene linked to the adenovirus E2 promoter 
was equally elevated by either HPV-11 E7 or HPV-16 E7 plasmids, 
suggesting that transformation by HPVs is not wholly a result of 
transactivation.
Two of the three regions of the HPV-16 E7 protein important for
transformation (Edmonds and Vousden, 1989) show marked
homology to areas of both SV40 large T antigen and adenovirus E1A
(Phelps et al., 1988; Dyson et al., 1989), well-recognised DNA tumour
virus oncoproteins (sections 2.2.1. and 2.2.2.) which have been shown
to bind the retinoblastoma gene (Rb) product p l0 5 ^  (section 2.2.1.
and 2.2.2; Whyte et al., 1988; DeCaprio et al., 1988). The regions of
E1A and T Ag responsible for binding the Rb protein are critical for
transformation and are those which share homology with
papillomavirus E7, so it is not surprising that E7 is also capable of
binding p l0 5 ^  (Dyson et al., 1989). Functional similarity between
these three viral oncogenes has been confirmed by Vousden and Jat
(1989), who were able to rescue cells transformed with a thermolabile
SV40 T Ag from growth arrest at non-permissive temperature by
Rhcomplementation with HPV-16 E7. Thus sequestration of pl05 
present in the cell is one possible mechanism by which HPVs could 
contribute to neoplasia, with a major role for the viral E7 gene 
product. Furthermore, the E7 protein of HPV-6, a type found only
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rarely in malignant lesions, is able to bind only much smaller amounts 
of the Rb protein (3 6 to 6.5 fold less, Barbosa et al., 1990). The Rb 
binding domain also harbours a potential casein kinase (CK) II site, 
and it has been shown that HPV-6 E7 is phosphorylated two to four 
fold less efficiently than either HPV-16 or HPV-18 E7 (Barbosa et al.,
1990). These authors also demonstrated that mutations in either the 
Rb binding domain or the CKII site of HPV-16 E7 decreased the 
ability of the virus to transform NIH3T3 cells.
In addition to E7, the papillomavirus E6 protein is also important for 
cell transformation. Hawley-Nelson et al. (1989) described a 
cooperative effect between the E6 and E7 ORFs of HPV-16 in the 
immortalisation of primary human keratinocytes, whereas neither 
alone produced this effect. Vousden and Jat (1989) showed that, 
although HPV-16 E7 was the major factor in rescue of cells 
transformed with mutant SV40 (as described above), the E6 could also 
perform this function. Work by Barbosa and Schlegel (1989) 
documented the transformation of human keratinocytes by HPV-18 
E6 and E7, although they did not analyse the functions of each ORF 
individually. In the same way as the E7 protein has been shown to 
bind p l0 5 ^ ,  an association between the E6 protein and p53 gene 
product has been reported recently (Werness et al., 1990). Binding of 
the SV40 T Ag and adenovirus E1B oncogenes to p53 has been 
similarly found (section 2.2.2; Lane and Crawford, 1979; Sarnow et a l , 
1982).
Kloster et al. (1988) described an animal system which mimics the 
pattern of development of human cervical carcinoma. A novel
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papillomavirus type, the rhesus monkey papillomavirus (RHPV), was 
isolated from an active mating population of rhesus monkeys, around 
ten percent of which had invasive genital neoplasms similar to those 
seen in humans. These authors subsequently used cloned RHPV DNA 
to transform primary cells in culture with a similar efficiency to that 
obtained with HPV-16, and reported that RHPV has the ability to 
cooperate with activated ras in the transformation of these cells (R. 
Ostrow, personal communication), again similar to HPV-16.
To partly confound the above results, several authors have reported 
finding DNA of so-called "oncogenic" HPV types in clinically and 
histologically normal cervical epithelium (Cox et al., 1986; MacNab et 
al., 1986) and some doubt has been cast on the role of 
papillomaviruses in cervical cancer on epidemiological grounds 
(Munoz et al., 1988). It would seem that latent infection by 
papillomaviruses in genital mucosa does occur, and that the majority 
of HPV infections do not progress to malignancy, a fact in keeping 
with theories of multistage carcinogenesis. However a major 
difference between HPV in anogenital malignancies compared with 
normal tissue is the amount of viral DNA present. While viral nucleic 
acids are readily detected in carcinomas by Southern blot 
hybridisation, much of the data citing HPV DNA in healthy tissue has 
relied on the use of a very sensitive technique, polymerase chain 
reaction (PCR), for detection of papillomavirus sequences, sometimes 
without the use of adequate controls (reviewed by zur Hausen, 1988). 
Therefore, as seen in the experimental systems detailed above, there 
may be an important dose effect of HPV on genital mucosa.
53
Thus much evidence has accumulated implicating specific HPV types 
as being of importance in the aetiology of human anogenital cancer, 
with recent work detailing similarities which exist between 
papillomaviruses and other DNA tumour viruses as regards their 
oncogenic mechanisms, although additional factors are clearly 
necessary for malignant progression of lesions induced by HPVs both 
in vivo and in vitro.
2.2A3. Human Papillomaviruses in Oral Disease.
Oral papillomas and other related benign mucosal proliferations are 
not an uncommon occurrence (Tyldesley, 1981). Several reports exist 
in the literature demonstrating papillomavirus structural antigens in 
such lesions (Jenson et al., 1982; Syrjanen et al., 1984; Jin and Toto,
1984), while Praetorius-Clausen and Willis (1971) observed virus 
particles in focal epithelial hyperplasia (FEH, Heck’s disease), a rare 
familial condition which is particularly prevalent in certain 
populations such as North American Indians and Eskimos in 
Greenland, where the incidence approaches thirty five percent 
(Praetorius-Clausen, 1972).
DNA hybridisation studies have revealed that oral mucosa is subject 
to infection by a number of types of human papillomavirus including 
HPV-2, 4, 6 , 11, 13, 16, 32 and 57 (Adler-Storthz et a l , 1986a; 
Naghashfar et al., 1985; Pfister et al., 1983b; Beaudenon et a l, 1987b; 
Garlick et al, 1989; de Villiers et al., 1989). Greenspan et al. (1988) 
found mainly HPV-7 DNA (41%) in a series of oral warts from
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patients seropositive for the human immunodeficiency virus (HIV). 
They suggested that patients suffering from acquired 
immunodeficiency syndrome (AIDS) may be subject to infection by 
unusual HPV types, which is perhaps not surprising considering the 
other opportunistic infections to which this population is susceptible, 
and the pattern of infection in other immunosuppressed individuals 
(such as EV patients).
In parallel with cervical cancer, the involvement of an infectious agent 
has been suggested in the aetiology of oral squamous cell carcinoma, 
previously thought to be one of the herpes simplex viruses (Lehner et 
al., 1973; Shillitoe et al., 1976), although data has not always been 
consistent (section 2.2.3.) and the prevalence of HSV-1 in the general 
population is high.
In view of the obvious oncogenic potential of some human 
papillomaviruses, the close similarity between oral and genital 
mucosa, and evidence from other systems of malignant progression of 
virally-induced oral lesions (Sundberg et al., 1985), the possibility of a 
causative role for certain HPV types in oral cancer would not seem to 
be remote. Initial investigations, purely at the histological level, 
showed features reminiscent of viral infection in pathological sections 
of oral verrucous carcinoma (Syrjanen et al., 1983; Eisenberg et al.,
1985). Additionally, the former group reported positive staining of 
some samples using an antibody to a papillomavirus structural 
antigen.
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Further investigations utilising hybridisation technology have enabled 
the viral types present in such lesions to be established. De Villiers et 
al. (1985) found largely episomal HPV sequences in three of seven 
tongue carcinomas by Southern blot analysis, HPV-16 being present 
twice while one lesion harboured HPV-2 DNA, a type not previously 
associated with malignancy, at a high level (around fifty copies per 
cell). Adler-Storthz et al. (1986b) also detected HPV-2 DNA in three 
of nine patients with verrucous carcinoma using in situ hybridisation 
on histological material. Other workers (Milde and Loning, 1986; 
Syrjanen et al., 1988) have reported the "genital" HPV types 16 and 18 
to be present in oral squamous cell carcinomas, and some parallels 
seem to exist with HPV in genital lesions as Syrjanen et al. (1988) 
found HPV-6  and 11 DNA in oral dysplasias but not in carcinomas. 
Ostrow et al. (1987) found HPV-16 episomes in a lymph node 
metastasis of a primary tongue carcinoma at a level of approximately 
twenty to forty copies per cell. A recent study by Chang and coworkers 
(1989) documented a high prevalence of HPV-16 DNA in oral 
carcinomas in Taiwanese patients, seventy six percent of whom were 
positive for viral sequences by Southern blot analysis. Only one out of 
seventeen controls of normal gingival mucosa contained HPV DNA; 
this was unable to be typed by the investigators, but was not HPV-16. 
The incidence of both smoking (82%) and betel quid chewing (57%) 
were high in cancer patients, and may reflect both a viral and chemical 
aetiology of oral carcinoma.
Interestingly, Maitland et al. (1987) reported finding a variant of HPV- 
16 in forty six percent of a series of oral cancer biopsies studied by 
Southern blot hybridisation. This viral type differed from the
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prototype HPV-16 DNA in its digestion pattern using the restriction 
enzyme PstI, although no variation was observed on digestion with 
Dral. The PstI ’C’ fragment, visible as a 1.55kb band in digests of 
prototype HPV-16, was consistently absent from the majority of 
biopsies examined; however on reprobing with a specific subgenomic 
fragment the 1.55kb band became visible, but only at very low levels 
(M.F. Cox, personal communication). This suggests that a small 
minority of viral DNA present in the samples was prototype HPV-16, 
the remainder having some alteration in the L2-L1 region of the 
genome compared to the wild-type virus.
Furthermore, these authors discovered that distribution of the variant 
HPV-16 was not limited to malignant epithelium alone. Seven out of 
eight biopsies of lichen planus, not a recognised premalignant 
condition of the oral cavity, contained HPV-16 sequences as did five 
out of twelve samples of normal oral mucosa, approximately the same 
percentage as virus-positive carcinomas. Other ill-defined benign 
lesions termed non-specific keratosis and reactive keratosis also 
harboured viral nucleic acids. These results were the first report of 
HPV DNA in clinically and histologically normal oral epithelium, in 
line with previous findings regarding papillomaviruses in human 
cervix.
From the data presente^^PV-16 DNA appeared to be episomal in all 
but one case, a sample of normal oral epithelium; thus the situation 
may be somewhat different to that of HPV-16 and 18 in cervical 
tissues, where viral DNA is frequently integrated in carcinomas, 
probably from an early stage in the neoplastic process.
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More recent work by Maitland and coworkers (1989) used the 
polymerase chain reaction to facilitate detection of HPV sequences in 
biopsies of oral mucosa and in cell lines derived from these, using 
oligonucleotide primers specific for the E6 ORF which is 
preferentially retained in carcinomas and which was detectable by 
Southern blotting. The results obtained supported those of the 
previous study, with around fifty percent of oral carcinomas containing 
HPV-16 DNA, although no data on prevalence of viral DNA in 
normal tissue by PCR detection were discussed, and no HPV types 
other than HPV-16 were screened for (N. Maitland, personal 
communication).
Attempts by these authors to amplify DNA from the viral late region 
using specific primers in the PCR were unsuccessful, either due to a 
lack of the DNA or to gross sequence divergence resulting in failure of 
the primers to anneal. They suggested that in the former case the virus 
would not be viable and while this may be correct, it would not 
necessarily preclude viral sequences from being involved in 
tumorigenesis as the E6 and E7 ORFs would still be present and able 
to be expressed, as in cervical carcinomas.
Another feature noted by this group was the apparent increase in the 
proportion of HPV-16 containing cells in cultures of oral carcinomas 
at higher passage numbers, suggesting that the presence of viral DNA 
might confer some growth advantage on such cells, while uninfected 
cells would senesce. This would be consistent with an immortalising
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role for papillomaviruses in cell transformation (Hawley-Nelson et al., 
1989).
The precise role of HPVs in the aetiology of oral squamous cell 
carcinoma is not, as yet, well understood. Scully et al. (1988) proposed 
that the oral cavity might serve as a reservoir of latent human 
papillomaviruses which could subsequently infect anogenital 
epithelium following orogenital contact. However if the variant HPV- 
16 does indeed lack late viral sequences coding for structural proteins, 
as suggested by Maitland et al. (1989), this would not represent a 
feasible route for infection of genital mucosa. Although viral DNA has 
been demonstrated in normal epithelium, this does not exclude an 
involvement in oral carcinogenesis, as the effect may indeed be an 
early one such as an increase in cell proliferation or immortalisation, 
after which the viral DNA is no longer required (as for BPV-4 
transformation), or the process may be dependent on viral copy 
number with a threshold level required to trigger further events.
2.2.6. Objectives of the Current Study.
The present work is an attempt to identify the papillomavirus types 
which might be present in oral squamous cell carcinomas, and 
therefore possibly of importance in the aetiology of such lesions. 
Although several workers have reported HPV DNA in oral cancers, 
no endeavour has been made to analyse the distribution of viral 
sequences in adjacent dysplastic or clinically normal tissue samples, 
which would seem important in the light of results obtained from 
screening biopsies of normal oral mucosa from patients (presumably)
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without cancer (Maitland et al., 1987). This would enable levels of 
viral DNA to be compared in epithelia of varying degrees of 
neoplasia, perhaps substantiating the idea of a dose effect of HPVs in 
transformation, and comparing samples between cancer and non­
cancer sufferers.
Although HPV-16 DNA is the most widely reported type in malignant 
oral mucosa sequences of other HPVs have been detected, and may 
reflect a geographic variance. A different distribution of HPV types 
with area has been noted for cervical samples (Millan et al., 1986; 
Meanwell et al., 1987) and this could also be the case in oral cancers 
from different regions.
The possibility of new or variant viral types in oral samples must be 
considered. The HPV-16 variant first described by Maitland et al. 
(1987) merits further investigation to ascertain the nature of the 
sequence alteration and its likely effect on viral function. These 
authors together with Chang et al. (1989) found unidentifiable viral 
sequences showing different degrees of homology to HPV-16, and 
might likely represent new papillomavirus types.
To confront these possibilities, thirty nine samples of primary intraoral 
squamous cell carcinoma, together with adjacent normal tissue (and 
dysplastic and lymph node metastases where present) have been 
investigated for the presence of DNA of several papillomavirus types 
by Southern blot hybridisation and by PCR. Further analyses included 
cloning of a viral genome from one lesion and mapping structural 
abnormalities in HPV DNA present in other samples.
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3. Materials and Methods.
3.1 Materials.
3.1.1. Chemicals.
All chemicals used in this work were of analytical reagent grade, and 
were purchased from either BDH Limited or from the Sigma 
Chemical Company.
Radioisotopes of a-[^P]-dCTP ( > l l l  TBqmmor^), ^-[^P]-dATP 
(>185 TBqmmol”^ ) and a-[^S]-dATP (>22.2 TBqmmol"^) were 
obtained from Amersham International pic, Aylesbury, Bucks.
Caesium chloride, agarose, urea and guanidinium isothiocyanate were 
supplied by Gibco BRL, Paisley, Scotland.
Tris(hydroxymethyl)aminoethane was obtained from Boehringer 
Mannheim UK (BCL), Lewes, East Sussex.
Reagents for use in polymerase chain reaction experiments were 
purchased from Perkin-Elmer Limited, Beaconsfield, 
Buckinghamshire.
Distilled phenol was supplied by Rathburn Chemicals, Walkerburn, 
Scotland.
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3.1.2. Enzymes and Markers.
All restriction endonucleases used were obtained from Gibco BRL, as 
were bacteriophage T4 DNA ligase, Hindlll-digested bacteriophage 
lambda DNA and Haelll-digested bacteriophage 0x174 DNA 
markers.
BCL were the suppliers of T4 polynucleotide kinase, calf intestinal 
alkaline phosphatase and random primed DNA labelling reagents.
3.1.3. Stock Solutions.
TE. lOmM Tris-HCl pH8.0 
ImM EDTA
lOxTBE 0.89M Tris
0.89M boric acid
25mM EDTA
50xTAE 2M Tris-acetate
0.1M EDTA (pH8.0)
20x SSC 3M NaCl
0.3M sodium citrate
20x SSPE 3.6M NaCl
0.2M Na2HP04/NaH2 P04 
0.02M EDTA pH7.7
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phenol/chloroform 25 vols. TE-saturated phenol 
24 vols. chloroform 
1 vol. isoamyl alcohol
SM 0.1M NaCl
0.05M Tris-HCl pH7.5 
8mM MgS0 4 .7 H2 0
3.1.4. Growth Media.
L-broth 1% (w/v) bacto tryptone
0.5% (w/v) bacto yeast extract 
170mM NaCl
L-agar 1.5% (w/v) bacto-agar in L-broth,
autoclaved and cooled to 42°C 
prior to addition of antibiotics 
(as required).
SOC 2% (w/v) bactotryptone
0.5% (w/v) yeast extract 
lOmMNaCl 
2.5mM KC1 
lOmM MgCl2  
lOmM MgS04 
20mM glucose
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NZY broth 85mM NaCl 
lOmM MgCl2  
0.5% (w/v) yeast extract 
1% (w/v) NZ amine
3.1.5. Cloning Vectors and Host Strains.
Construction of genomic DNA libraries was performed using BamHI- 
digested arms of bacteriophage lambda EMBL3 (Frischauf et al., 
1983), obtained from Stratagene. Recombinants were plated on the E. 
coli host strains LE392 and P2392.
The plasmid vector pBR322 (Bolivar et al., 1977) was used in 
molecular cloning experiments and was supplied by Gibco BRL. 
Recombinant clones were used to transform library-efficient E. coli 
strain DH5-a (Gibco BRL).
3.1.6. Recombinant HPV Clones.
The genomes of HPV types 1-7, 11, 13, 16 and 18 cloned in pBR322 
were as originally described (Heilman et al., 1980; Kremsdorf et al., 
1983; Kremsdorf et al., 1982; de Villiers et al., 1981; Oltersdorf et al., 
1986; Gissmann et al., 1982; Pfister et al., 1983b; Durst et al., 1983; 
Boshart et al., 1984).
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3.1.7. Other Materials.
Nylon transfer membranes were purchased from Amersham 
International pic (Hybond N +) and from Biorad (Pall Biodyne A).
Eastman-Kodak supplied X-Omat S and X-Omat XAR-5 film for use 
in autoradiography.
3.2. Methods.
3.2.1. General Methods.
3.2.1.1. Sterilisation of Materials and Solutions.
All glass centrifuge tubes, plastic Eppendorf tubes and disposable 
pipette tips were sterilised prior to use, in order to prevent subsequent 
degradation of DNA by nucleases. This was achieved by autoclaving in 
a domestic pressure cooker for fifteen minutes in the presence of a 
suitable indicator tape (3M). Most solutions were similarly treated. 
Those containing heat-labile components were sterilised by filtration 
through Gelman Acrodisc filters of pore size 0.2mm.
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3.2.I.2. Handling of Bacteria.
All bacterial cultures were manipulated under Category I 
containment.
3.2.1.3. Handling of Radioactive Isotopes.
All work involving the use of radionuclides was carried out according 
to the Local Rules as specified in the Beatson Institute Safety Manual.
3.2.1.4. Phenol/Chloroform Extraction.
Contaminating protein was removed from DNA samples by extraction 
with phenol/chloroform, prepared as described above. An equal 
volume of phenol/chloroform was added to the DNA solution and 
mixed by vortexing. The two phases were then separated by 
centrifugation in an Eppendorf centrifuge for fifteen seconds at 
1 2 0 0 0g (small volumes) or in a bench top centrifuge for five minutes 
at 4000g (larger volumes). The (upper) aqueous phase was removed to 
a fresh tube and extracted for a second time. DNA was recovered by 
ethanol precipitation and the pellet washed with 70% ethanol.
3.2.1.5. Ethanol Precipitation.
DNA was precipitated from solution by the following method. Two 
volumes of ethanol and 0.1 volume of 3M sodium acetate pH5.5 were 
added, mixed and stored at -20 9C for one hour. Recovery of DNA  
was achieved by centrifugation in an Eppendorf centrifuge (small
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volumes) at 1 2 0 0 0 g for ten minutes, or by centrifugation in a benchtop 
centrifuge for thirty minutes at 4000g. The supernatant was decanted, 
and the pellet washed in 70% ethanol. After removal of the majority 
of the wash supernatant, the pellet was dried briefly in a vacuum 
dessicator and resuspended in TE buffer pH8.0.
3.2.I.6. Spectrophotometric Quantitation of 
Nucleic Acids.
The approximate concentrations of solutions of DNA and 
oligonucleotides were determined by measuring the optical density of 
the solution at 260nm, using the following data (Maniatis et al., 1982):
An OD260nm =1-0 represents approximately the 
following concentrations:
50mgml"  ^for dsDNA 
2 0 mgml“^  for oligonucleotides
3.2.I.7. Collection and Sampling of Human Tissue 
Specimens.
Tissue specimens were obtained from the Plastic Surgery Unit, 
Canniesburn Hospital, Glasgow, from patients undergoing major head 
and neck surgery for treatment of oral squamous cell carcinoma, 
under the care of Mr. D.S. Soutar and Mr. M.H.C. Webster.
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(a)
sam ple age site
1 71 re t ro m o la r
2 77 com m isure
3 84 pa la te
4 82 pa la te
5 66 FOM
6 73 FOM
7 72 tongue
8 46 tongue
9 82 FOM
10 66 com m isu re
11 74 pa la te
12 74 tongue
13 54 FOM
14 51 FOM
15 62 FOM
18 65 alveolus
19 79 FOM/tongue
20 55 tongue
21 65 FOM
22 53 tongue
23 77 alveolus
24 44 FOM
25 56 tongue
26 55 tongue/FOM
27 69 tongue
28 52 tongue/FOM
29 64 alveolus
30 71 buccal
33 63 FOM
34 67 tonsilla r
35 45 tongue
37 47 FOM
38 68 soft pa la te
39 72 FOM
40 71 re tro m o la r
41 74 buccal
42 84 alveolus
43 61 buccal/FOM
45 67 buccal
(b)
sam ple age site
N1 60 buccal
N2 69 II
N3 67 II
N4 47 n
N5 53 it
N6 69 ii
N7 47 n
N8 71 n
N9 76 ii
N10 54 ti
N il 69 11
N12 56 i i
N13 60 ii
N14 60 ii
N15 73 ii
N16 73 u
N17 63 ii
N18 47 ii
N19 61 ii
N20 46 it
N21 67 i i
N22 57 n
N23 76 n
N24 75 n
N25 74 ii
Sites of biopsies and 
p a t ie n t  ages for (a) 
carc inom a sam ples 
and (b) no rm al controls. 
FOM=floor of m outh .
At the time of surgery, resection specimens were collected in theatre, 
examined visually and obvious areas of carcinomatous, dysplastic and 
normal mucosa identified. A biopsy was made from the resection 
material to include tissues of normal appearance through to frank 
carcinoma. Care was taken to record the site of biopsy on the 
pathology form for the pathologist’s ease of interpretation, and to 
ensure that removal of material did not hamper the histological 
assessment of the specimen.
Tissue samples were divided into carcinoma, dysplastic (if present) 
and normal, snap frozen separately in liquid nitrogen and stored at 
-70 °C until required. In cases where lymph nodes were removed, 
these were similarly biopsied and stored.
Samples of clinically and histologically normal mucosa to act as 
external controls were obtained from patients attending outpatient 
clinics for surgical treatment of various non-malignant disorders. Prior 
approval of the West Ethical Committee of the Greater Glasgow 
Health Board was obtained, as was the informed consent of each 
patient. A small piece (approximately three cubic millimetres) of 
buccal mucosa was removed by the surgeon using a sterile disposable 
plastic biopsy punch (Stiefel Laboratories) under local anaesthesia, 
and the resulting defect required no suture. The specimens were 
bisected, one half being snap frozen in liquid nitrogen and stored at 
-70 9G, while the remainder was fixed in 10% formalin and sent for 
histological analysis.
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3.2.2. Manipulation of Nucleic Acids.
3.2.2.1. Preparation of DNA and RNA from Stored 
Tissue.
Nucleic acids were prepared from frozen samples of human tissue by 
the method of Chirgwin et al. (1979) with minor modifications. 
Samples were removed from storage at -70 °C into a container of 
liquid nitrogen. The tissue was then fragmented rapidly using a mortar 
and pestle and transferred immediately to a teflon grinding chamber 
containing a teflon-coated steel grinding ball 10mm in diameter, both 
of which had been chilled by immersion in liquid nitrogen (Krieg et al., 
1983). The chamber with added tissue was further cooled prior to 
grinding in a Mikro-Dismembrator II (B. Braun, Melsungen AG, 
Braun Apparate, 3508 Melsungen, FRG). This treatment reduced the 
tissue sample to a fine powder which could then be removed from the 
chamber and transferred to a 15ml sterile tube (Falcon) containing 
9ml of 4M guanidinium isothiocyanate, 0.5% (w/v) sodium N-lauryl 
sarcosine, 25mM sodium citrate pH7.0 and 0.1M 2-mercaptoethanol.
4ml gradients of caesium chloride comprising steps of 2ml each of 
1.7gcm"3 and 1.6gcm"  ^ CsCl in 25mM sodium acetate were prepared 
in 14ml polyallomer tubes (Kontron). Samples in guanidinium 
isothiocyanate solution were then layered carefully on top and the 
tubes balanced with liquid paraffin. Centrifugation was carried out in 
a TFT41.14 6 x 14 titanium rotor in a Centrikon ultracentrifuge 
(Kontron) at 20°C for sixteen hours at 136,000g.
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DNA was harvested from the interface between the CsCl steps using a 
sterile pipette, transferred to a 15ml tube and precipitated in 3 
volumes of 70% ethanol at 4°C for one hour. Samples were spun at 
4000g for thirty minutes at 4°C in a benchtop centrifuge, the 
supernatant decanted, the pellet washed in 70% ethanol, 
recentrifuged, air dried and resuspended in 1ml TE buffer pH8.0. Any 
contaminating protein was removed by extraction with an equal 
volume of phenol-chloroform as previously described, the DNA 
precipitated, pelleted and washed as before. After air drying, purified 
DNA was resuspended in a small volume of TE pH8.0, the optical 
density (OD) measured at 260nm and 280nm, and the 260:280 ratio 
calculated which allows estimation of the purity of the DNA solution, 
as a pure solution is expected to have a 260:280 value of 1 .8  to 2 .0  
(Maniatis et al., 1982). Any samples with a ratio outside this range 
were re-extracted with phenol/chloroform until satisfactory values 
were obtained. Samples of genomic DNA were stored at 4°C prior to 
analysis.
The RNA pellets remaining after centrifugation through CsCl were 
resuspended in 1ml 7.5M guanidinium hydrochloride, 25mM sodium 
citrate pH7.0, 5mM DTT to ensure removal of any contaminating 
nuclease activity and precipitated with 0.5 volumes of absolute ethanol 
and 0.025 volumes of 1M acetic acid at -20°C overnight. RNA was 
recovered by centrifugation at 12,000g in an Eppendorf centrifuge for 
15 minutes at 4°C. Pellets were resuspended in RNase-free distilled 
water and the 260:280 ratio measured, as pure RNA is known to have 
a value of 2.0 (Maniatis et al., 1982). Samples with a value lower than 
this were reprecipitated with 0.1 volumes of 3M sodium acetate and 3 
volumes of absolute ethanol, and RNA recovered as before. Pelleted
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RNAs were resuspended in RNase-free distilled water and stored at 
-2 0  £  until use.
3.2.22. Transformation of Host Bacteria with 
Plasmid DNA.
E. coli strain HB101 was used for the propagation of the recombinant 
HPV clones detailed in section 3.1.6. using the calcium chloride 
method of transformation (Mandel and Higa, 1970) as described by 
Maniatis et al. (1982). 1ml of LB broth was inoculated with a single 
bacterial colony and grown overnight at 37°C with shaking. The 
following day this was added to 100ml of LB broth prewarmed at 37°C 
and allowed to grow until the O.D.5 5 0  was 0.5, at which point the 
culture was chilled on ice and then centrifuged at 4000g for ten 
minutes at 4°C. The bacterial pellet was resuspended in 0.5 volumes 
of ice-cold lOOmM CaCl2 , recentrifuged, resuspended in 0.25 volumes 
of ice-cold 50mM CaCl2  and allowed to stand on ice for twenty 
minutes. Bacterial cells were centrifuged as before, resuspended in 
0.05 volumes of 50mM CaCl2 , aliquoted in 0.5ml volumes into chilled 
tubes and stored overnight at 4°C to increase the efficiency of 
transformation (Dagert and Ehrlich, 1979). Cells were then either 
used or frozen in a dry ice and ethanol bath and stored at -70 °C 
until required.
Transformation reactions were performed by addition of between 1 
and 40ng (routinely lOng) of HPV recombinant plasmid DNA or 
pBR322 control DNA in TE buffer pH8.0 to 200/il of competent 
HB101 cells and chilled on ice for forty minutes. Cells were heat-
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shocked for two minutes in a water bath at 42°C, 1.0ml of LB. broth 
added (containing 50/igml"  ^ ampicillin) and incubated at 37°C with 
shaking for one hour. Cultures were then plated on LB agar 
containing ampicillin and incubated overnight at 37°C.
3.2.2.3. Small Scale Plasmid DNA Preparation.
Plasmid DNA was prepared basically as described by Maniatis et al. 
(1982) with some minor modifications. Single recombinant clones 
grown on selective media were inoculated into 5ml sterile plastic vials 
containing 3ml LB broth plus ampicillin and incubated at 37°C for 
four hours with shaking. 1.5 ml of culture was centrifuged at 12000g in 
an Eppendorf centrifuge for five minutes, the supernatant decanted 
and the bacterial pellet resuspended in 100/xl of 50mM glucose, lOmM 
EDTA, 25mM Tris HC1 pH8.0. To this was added 200/il of a freshly- 
prepared ice-cold solution of 0.2N NaOH, 1% SDS, mixed by 
inversion and stored on ice for five minutes. Following addition of 
150/xl of ice-cold potassium acetate pH4.8 the tube was vortexed, 
stored on ice for five minutes and centrifuged as before. The 
supernatant was extracted twice with an equal volume of 
phenol/chloroform and precipitated with two volumes of ethanol. 
DNA was recovered by centrifugation at 12000g for fifteen minutes at 
4°C, the pellet washed in 70% ethanol and air-dried. Plasmid DNA 
was resuspended in 50jli1 TE pH8.0 containing 20/igml"  ^ DNase-free 
RNase, a lOjul aliquot removed and digested with one unit of an 
appropriate restriction endonuclease at 37°C for one hour to release 
the insert DNA from the vector. The products were then analysed by 
agarose gel electrophoresis.
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3.2.2A. Large Scale Plasmid DNA Preparation.
A single bacterial colony containing the appropriate recombinant 
plasmid was inoculated into 10ml LB broth with ampicillin in a sterile 
universal container and grown overnight at 37°C with shaking. The 
culture was then transferred to a flask containing 500ml of the same 
culture medium and propagated for a further 16-24 hours at 37°C.
DNA was prepared by the method of Birnboim and Doly (1979), 
modified as described by Maniatis et al. (1982). Large scale cultures 
were centrifuged at 3000g for ten minutes, the supernatant discarded 
and the bacterial pellet resuspended in 10ml of 50mM glucose, 25mM 
Tris HC1 pH8.0, lOmM EDTA, 5mgml“^  (w/v) lysozyme and 
incubated at room temperature for five minutes. Two volumes of 0.2N 
NaOH, 1% SDS were added, mixed gently by inversion, incubated at 
0°C for ten minutes, 1.5 volumes of 5M potassium acetate added, 
incubated for a further ten minutes and the bacterial debris pelleted 
by centrifugation at lOOOOg for twenty minutes at 4°C. Plasmid DNA 
was precipitated for fifteen minutes at room temperature by addition 
of 0 .6  volumes of isopropanol to the supernatant and recovered by 
centrifugation at 12000g for thirty minutes. The pellet was washed in 
70% ethanol, dried under vacuum, resuspended in TE pH8.0 and solid 
caesium chloride added to a final density of 1.06gml‘ .^ 0.42ml of a 
lOmgmT1 stock of ethidium bromide was added to the solution and 
centrifugation was carried out at 160000g for forty hours at 20°C. 
Supercoiled plasmid DNA was harvested from caesium chloride 
gradients and the ethidium bromide removed by two extractions with
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water-saturated butanol. DNA was ethanol-precipitated, centrifuged, 
resuspended in TE pH8.0 and any contaminating protein removed by 
three phenol-chloroform extractions. DNA was then precipitated, the 
pellet washed with 70% ethanol, air-dried, resuspended in TE pH8.0 
and the recovery quantified by spectrophotometry as previously 
described. Plasmid DNA was stored at 4°C prior to use.
3.2.2.5. Restriction Enzyme Digestion of DNA.
DNA was digested in sterile Eppendorf tubes by addition on ice of 0.1 
of the final volume of lOx digestion buffer as recommended by the 
supplier, lU/ig”^  of the appropriate enzyme and the volume made up 
with sterile distilled water. Samples were mixed by vortexing, spun 
briefly in a microfuge and incubated at 37°C or as described in the 
manufacturer’s data sheet. Routinely, plasmid DNAs were digested 
for one hour, while cellular DNAs were incubated overnight. Samples 
were then analysed by electrophoresis in agarose gels.
3.2.2.6. Agarose Gel Electrophoresis.
Electrophoresis of DNA in agarose was performed as described by 
Maniatis et al. (1982), using TAE or TBE buffers containing 0.5/igml"  ^
ethidium bromide. The concentration of agarose in the gel was 
dependent on the size of the DNA to be analysed, routinely 0.8-1% 
(w/v) for restriction enzyme-digested genomic DNAs. One fifth 
volume of 6x electrophoresis buffer consisting of 0.25% bromophenol 
blue, 0.25% xylene cyanol FF, 15% ficoll 400, was added to samples,
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mixed by vortexing, spun briefly and loaded onto the gel. Molecular 
weight markers of known size were Hindlll-digested bacteriophage 
lambda DNA and or bacteriophage 0x174 RF DNA digested with 
Haem, and were co-electrophoresed with sample DNAs. Gels were 
run at 3-4Vcm"  ^ for 12-16 hours, examined on a UV  
transilluminator and photographed using Polaroid Type 57 or Type 55 
film.
2)22.1. Polyacrylamide Gel Electrophoresis.
Electrophoresis in polyacrylamide was used primarily for analysis of 
polymerase chain reaction (PCR) products. Non-denaturing gels 
consisted of 6 % acrylamide, 0.5% bis in lx TBE buffer, polymerisation 
being effected by addition of 50/zl of TEMED and 0.3ml of 10% 
ammonium persulphate per 50ml volume of solution. Polymerisation 
was allowed to occur at room temperature. Denaturing gels were 
made as described above, but with 8 M urea added and dissolved by 
warming to 37°C prior to addition of TEMED and ammonium 
persulphate. Sample buffer was added as previously described and 
electrophoresis carried out at 10 Vcm"  ^ for 1.5 hours. Gels were
-j
stained for 10 minutes in running buffer containing 0.5 /igml" 
ethidium bromide and examined as detailed above.
3.22.8. Purification of DNA by Electroelution.
DNA fragments electrophoresed in TBE-agarose were excised from 
the gel and transferred to individual dialysis bags prepared as
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described by Maniatis et al. (1982). 3ml of O.lx TBE buffer was added, 
the bag sealed and the DNA eluted at 200V for 1 hour. The bag was 
removed from the electrophoresis tank, examined by UV 
transillumination to ensure that all of the sample had been eluted 
from the gel slice, and then returned to the tank and the polarity 
reversed briefly to remove any DNA adherent to the side of the 
dialysis bag. The solution was removed to a 15ml tube, the bag washed 
with a further 3ml of buffer and pooled with the original sample. Solid 
NaCl was added to the eluate to a final concentration of 0.2M and 
purified by chromatography on Elutip-d columns (Anderman and 
Company Ltd., Kingston Upon Thames). Columns were hydrated in 
2ml of high salt buffer (1.0M NaCl, 20mM Tris HC1, ImM EDTA 
pH7.5), then equilibrated in 4ml of low salt buffer (0.2M NaCl, 20mM 
Tris HC1, ImM EDTA pH7.5). The sample was loaded onto the 
column, allowing the DNA to bind, loaded on a second time and then 
washed with 10ml low salt buffer. DNA was eluted in 1ml of high salt 
buffer, precipitated with 2 volumes of ethanol at -20°C, recovered by 
centrifugation at 12000g and the pellet washed with 70% ethanol. 
DNA was resuspended in TE pH8.0 and quantified 
spectrophotometrically.
Alternatively electroelution was carried out with the aid of an LKB 
electroelutor (Pharmacia LKB), used in accordance with the 
manufacturer’s instructions. Gel slices immersed in O.lx TBE were 
subjected to a constant voltage of 80V for 45 minutes, the DNA being 
eluted into a v-shaped well containing 400/xl of 7.5M ammonium 
acetate with 0 .0 1  volumes of 6x electrophoresis sample buffer to aid 
collection. The eluate was removed by pipette, a fresh aliquot of 
collection buffer added to the well and elution carried out as before.
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DNA was recovered by ethanol precipitation, washed and 
resuspended as above.
3.2.2.9. DNA Purification on a Silica Matrix.
DNA fragments separated in TAE-agarose were excised from the gel,
weighed, transferred to either a 1.5ml Eppendorf tube or a 15ml
Falcon tube, and cut into smaller pieces. Purification from agarose
was achieved using a Geneclean kit (Bio 101, La Jolla, CA) following
the manufacturer’s instructions. 2.5 volumes of a 6 M stock solution of
Nal were added to the gel slice, mixed by vortexing and placed in a
water bath at 55°C for 3 minutes, removed to mix and then replaced
(Vogelstein and Gillespie, 1979) 
for a further two minutes. 'Glassmilk^ was added to the solution as
suggested in the supplied protocol, mixed by vortexing and incubated
on ice for 30 minutes, with further mixing at 10 minute intervals.
DNA bound to glassmilk was pelleted, the supernatant removed, and
the pellet resuspended in 700/zl of NEW wash (NaCl, Tris pH7.0-8.5,
50% ethanol) and re-centrifuged. This wash procedure was repeated
twice, the pellet resuspended in TE pH8.0 and DNA eluted at 55°C
for 5 minutes. The glassmilk was pelleted and the supernatant
containing the eluted DNA retained. Two further elution steps were
performed to ensure maximum recovery of DNA. DNA was
quantified by spectrophotometric analysis, after which the sample was
ready for use. Typical recovery was 40-70% of the starting amount.
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3.2.2.10. Southern Transfer.
DNA samples in agarose gels were immobilised on nylon membranes 
by the method of Southern (1975) with several alterations. Following 
visualisation and photography, gels were soaked for 10  minutes in 
0.25M HC1, rinsed in distilled water and transferred to Hybond N + 
membrane (Amersham) by capillary action using a procedure similar 
to that described by Maniatis et al. (1982), but with 0.4M NaOH as the 
transfer buffer. Transfer was allowed to procede for a maximum of 
four hours, after which the membrane was rinsed in 2x SSPE for 5 
minutes and then prehybridised or wrapped in Saran-Wrap and stored 
at 4°C. The gel was restained with ethidium bromide and examined to 
ensure that all of the samples had been efficiently transferred.
3.2.2.11. Preparation of Radiolabelled DNA Probes.
Cloned HPV genomes obtained from large scale plasmid preparations 
as previously described were released from the cloning vector by 
digestion with the appropriate restriction endonuclease. Viral DNA 
was purified free from plasmid sequences by electrophoresis through 
1% agarose. The HPV DNA was recovered either by the 
electroelution or glass-bead purification methods detailed above.
HPV DNA was labelled by the random primer method of Feinberg 
and Vogelstein (1983) using a commercially available kit (BCL). 
Twenty five nanogrammes of linearised viral DNA was denatured at 
95°C for 10 minutes and cooled rapidly on ice to prevent reannealing 
of the complementary strands. To this was added dATP, dGTP and
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dTTP to a final concentration of 25/xM each, 0.1 volume of a lOx 
mixture of random hexanucleotides, 50/iCi of a-[^P]-dCTP, distilled 
water to 19/xl and 1 unit of Klenow DNA polymerase. The solution 
was mixed by vortexing, spun briefly and incubated at 37°C for 30-60 
minutes. The labelling reaction was terminated by addition of 0.1 
volume of 0.2mM EDTA pH8.0.
Alternatively, probes were labelled by nick-translation (Rigby et aL, 
1977). To 1/zg of HPV DNA in an Eppendorf tube was added dATP, 
dGTP and dTTP to give a final concentration of 20mM each 
deoxyribonucleotide, 50/iCi of a-[*^P]-dCTP, 0.1 volume of a lOx nick 
translation buffer solution (0.5M Tris-HCl pH7.5, 0.1M MgSC>4 , ImM 
DTT, 0.5mgml"  ^ BSA) and distilled water to 48/xl. Finally 1/zl of a 
lOngml"  ^solution of DNase I and 1 unit of E. coli DNA polymerase I 
were added, mixed, centrifuged and incubated at 14°C for 1.5 hours. 
One tenth volume of 0.2M EDTA was added to stop the reaction.
Oligonucleotides to be used as probes were end-labelled withy-[^P]- 
dATP by the following protocol. lOng of oligonucleotide was 
incubated with 50/xCi ofJf[^P]-dATP and 1 unit of bacteriophage T4 
polynucleotide kinase in 50mM Tris-HCl pH7.6, lOmM MgCl2 , 5mM 
DTT, O.lmM spermidine, O.lmM EDTA at 37°C for 40 minutes. The 
labelled reaction product was purified as described below.
3.2.2.12. Purification of Radiolabelled Probes.
DNA fragments labelled by nick translation or random priming were 
purified by Elutip-d column chromatography, as described above.
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The DNA was eluted into a 1.5ml Eppendorf tube in 1ml of high salt 
buffer. 1/xl of eluate was removed and counted in a liquid scintillation 
counter to verify that incorporation of radiolabel had occurred and to 
estimate the specific activity of the probe. Random primer labelling 
routinely resulted in specific activities between 1-1.5 x 10  ^cpm/xg"  ^of 
DNA, whereas lower activities were achieved using the nick 
translation method (around 1 x 10  ^- 1  x 10  ^cpm/ig-  ^ ).
End-labelled oligonucleotides were purified by chromatography 
through commercially available columns (Nick^M columns, 
Pharmacia) containing Sephadex G-50. The column was equilibrated 
in lOmM Tris HC1 pH7.5, ImM EDTA. The sample was added in 
IOOmI of buffer, washed on with 400/xl and eluted into an Eppendorf 
tube with a further 400/zl.
3.2.2.13. Prehybridisation of Southern Blots.
Filters were placed in a plastic bag to which 20ml of prehybridisation 
buffer (5 x SSPE, 0.5% SDS, 5mgml'^ dried milk, 50/xgml"  ^denatured 
calf thymus DNA) was added, and the bag sealed using a domestic 
heat-sealer. Prehybridisation was carried out for a minimum of 1 hour 
in a shaking water bath at the same temperature as was to be used for 
the subsequent hybridisation reaction. The prehybridisation solution 
was removed prior to addition of hybridisation buffer.
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3.2.2.14. Hybridisation of Southern Filters.
Hybridisation solution was essentially the same as prehybridisation 
buffer, but contained radiolabelled probe DNA denatured by heating 
at 100°C for 5 minutes and cooled on ice. For initial screening of 
tumour samples for HPV sequences, hybridisation was carried out 
under conditions of low stringency at Tm-36°C, where Tm is the 
melting temperature of the DNA-DNA hybrid, calculated by the 
formula:
Tm =81.5°C-16.6(logi0[Na+ ])
+ 0.41(%G+ C)-0.63(%formamide)-(600//) 
assuming an average G+C content of 40% for HPV genomes and 
where I is the length of the hybrid formed in base pairs (Sambrook et 
al., 1989). Subsequent hybridisations were performed under conditions 
of high stringency, at a temperature of Tm -10°C. Hybridisation was 
allowed to proceed for 16-20 hours in a shaking water bath, after 
which the hybridisation solution was removed and stored at 4°C for 
further use if required.
3.2.2.15. Washing of Southern Blots.
Filters were washed in 2x SSC, 0.1% SDS for 45 minutes with three 
changes in a shaking water bath at the hybridisation temperature. An 
additional wash was performed in O.lx SSC, 0.1% SDS for 15 minutes 
if a higher level of stringency was desired. Filters were partially air- 
dried on 3MM paper, wrapped in Saran-Wrap and exposed to Kodak 
X-Omat S or X-AR5 film in cassettes with intensifying screens for 10 
minutes to 2  weeks a t-80 °t.
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3.2.2.16. Removal of Probe DNA From Southern Blots.
Following autoradiography, DNA probes were removed by immersion 
of filters in O.lx SSC, 0.1% SDS at 95°C and the solution allowed to 
cool to room temperature. To ensure adequate stripping, filters were 
then re-exposed to X-AR5 film overnight, wrapped in Saran-Wrap and 
stored until required.
3.2.3. Molecular Cloning.
3.2.3.I. Construction of Genomic DNA Libraries.
Thirty microgrammes of tumour DNA was digested with the 
restriction enzyme BamHI, a known single-cutter enzyme for 
prototype HPV-4, as described above. The sample was divided 2:1 and 
electrophoresed in 0.8% TBE-agarose alongside a control of cloned 
purified linear HPV-4. The gel was stained and photographed as 
before, and the lanes containing the lesser amount of genomic DNA 
and the control were Southern blotted and hybridised at high 
stringency (Tm-10°C) to a radiolabelled HPV-4 DNA probe. The gel 
slice containing the 20/zg sample of tumour DNA was covered with 
Saran-Wrap and stored at 4°C prior to excision of the area 
corresponding to the positive band on the Southern blot. In practice, a 
size-cut was selected to include DNA fragments in the 6-10kb range. 
DNA was purified free from agarose by electroelution into a dialysis
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bag, passed through an Elutip-d column, recovered by ethanol 
precipitation and resuspended in TE pH8.0.
Purified size-selected DNA was ligated into the BamHI cloning site of 
the commercially-available bacteriophage vector EMBL3 
(Stratagene). An equal molar ratio of insert to vector DNA was used, 
calculated as 0.2/zg genomic digest to 1/jg EMBL3 arms, assuming an 
8kb average size for the insert and a vector size of 40kb. Insert and 
vector DNAs were heated to 42°C and allowed to anneal for 1 hour. 
Ligation was carried out for 48 hours at 4°C in 50mM Tris HC1 pH8.0, 
7mM MgCl2 , ImM dithiothreitol, ImM ATP with 2 units of T4 DNA 
ligase in a total volume of 5 .0 /d.
The ligation reaction products were packaged using Gigapack II Gold 
packaging extracts (Stratagene), using one extract per microlitre of 
ligation. Packaging was carried out for 2 hours at room temperature 
according to the instructions supplied. Packaged bacteriophage 
particles were diluted in 0.5ml SM buffer, and debris removed by 
addition of 20/xl chloroform followed by brief centrifugation. The 
library was titred by adsorption and plating on host bacterial strains 
LE392 and P2392 (the latter being selective for recombinant 
bacteriophages), and plaques were counted after incubation of plates 
at 37°C for 8  hours. Titres ranging from 5 x 10  ^to 5 x 10  ^pfu/xg"  ^ of 
test DNA were obtained for libraries prepared in this manner.
Screening of genomic libraries was carried out by the plaque lift 
hybridisation procedure, described by Grunstein and Hogness (1975) 
for identification of recombinant clones. Recombinant bacteriophages 
were selected by plating on P2392 host cells on 22cnr NZY agar
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plates, incubated as described above. Plates were chilled at 4°C for 
several hours prior to lifting onto Pall Biodyne A nylon membrane. 
Filters were denatured in 1.5M NaCl, 0.5M NaOH for five minutes, 
neutralised in 3.0M sodium acetate pH5.5 for five minutes, air dried 
and baked at 80°C in a vacuum oven for 1 hour. Prehybridisation and 
hybridisation were carried out as previously described for Southern 
blots, washed and exposed to radiographic film for 30 minutes to 5 
days.
Positive plaques were picked from the original plate using a sterile 
Pasteur pipette, transferred to an Eppendorf tube containing 0.5ml of 
SM buffer and allowed to stand at room temperature for 2 hours after 
addition of 1/xl of chloroform to facilitate release of bacteriophage 
particles. Isolates were purified, usually through 3-4 additional rounds 
of screening, until free from contaminant clones.
Bacteriophage DNA was prepared according to Chisholm (1989). Ten 
to 100/xl of eluted bacteriophages were preadsorbed on P2392 host 
bacteria and grown in 37ml of NZCYM for 12 to 15 hours with gentle 
shaking, until complete lysis had occurred. Culture were transferred to 
50ml Falcon tubes, lOO/zl chloroform added and mixed gently. 
Bacterial nucleic acids were removed by addition of 0.37ml of a 
nuclease solution (50mg DNase I, 50mg RNase A in 10ml of 50% 
glycerol, 30mM sodium acetate pH6 .8 ) at 37°C for 30 minutes. NaCl 
(2 .1g) was added, mixed gently and the bacterial debris removed by 
centrifugation at lOOOOg for 20 minutes at 4°C. Bacteriophage 
particles were precipitated from the resulting supernatant with 3.7g of 
polyethylene glycol (PEG) on ice for 1 hour and recovered by 
centrifugation as above. Bacteriophages were resuspended gently in
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0.5ml of SM buffer for 30 to 60 minutes and extracted with an equal 
volume of chloroform.
Bacteriophage DNA was prepared by incubation of the bacteriophage 
suspension obtained above with 20/zl of 0.5M EDTA, 5^1 of 20% SDS 
and lOjitl of 5mgml'^ proteinase K at 65°C for 30 minutes, followed by 
three phenol/chloroform extractions. DNA was precipitated with 
170/zl of 6 M ammonium acetate and 0.7ml of isopropanol at room 
temperature and recovered by centrifugation in an Eppendorf 
centrifuge for 15 minutes at 4°C. The pellet was washed twice in 70% 
ethanol, vacuum-dried and gently resuspended in TE pH8.0. An 
aliquot of DNA was digested with the appropriate restriction enzyme 
to release the insert and analysed by electrophoresis in 0.7% agarose. 
The gel was transferred to Hybond N + membrane and hybridised to a 
radiolabelled DNA probe to confirm the presence of the desired 
fragment.
3.2.3.2. Subcloning of DNA Into Plasmid Vectors.
DNA cloned in bacteriophage was excised from the vector and
purified free of vector sequences by gel electrophoresis and
electroelution as previously described. The purified fragment was then
ligated into an appropriate cloning site of the plasmid vector pBR322.
The ligation reaction was carried out overnight at 15°C in 50mM Tris
HC1 pH7.5, 7mM MgCl2 , ImM DTT, ImM ATP and 1 unit of T4
DNA ligase with a threefold molar excess of insert to vector. The
contents of the reaction were diluted fivefold in TE pH7.5 and used to
«
transform library efficiency DH5-a competent cells (Gibco BRL)
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using the supplier’s modification of the procedure of Hanahan (1983). 
Transformed cells were grown in 1ml SOC at 37°C for 1 hour, plated 
on LB agar plates containing ampicillin and incubated overnight at 
37°C.
Colonies were picked, grown in 5ml of LB broth with ampicillin for 4 
hours to overnight, and plasmid DNA prepared as described above. 
The insert DNA was released from the plasmid vector by restriction 
endonuclease digestion and analysed by gel electrophoresis followed 
by Southern blotting and hybridisation, together with appropriate 
controls. Large scale production of the desired plasmid was then 
carried out.
3.2.4. Sequencing of Double-stranded DNA Templates.
Nucleotide sequencing of double-stranded DNA was carried out by 
the dideoxy chain termination procedure of Sanger et al. (1977) using 
a commercially available kit (Sequenase version 2.0, United States 
Biochemical Corporation, Cleveland, Ohio, USA).
Sequencing templates were prepared as follows. Plasmid DNA (4/zg) 
in a total volume of 18/zl was denatured for 5 minutes at room 
temperature by addition of 2/zl of 2M NaOH. DNA was precipitated 
with 0.4 volumes of 5M ammonium acetate pH7.5 and 5 volumes of 
absolute ethanol on a dry ice-ethanol bath for 5 minutes, and 
recovered by centrifugation at 12000g for 15 minutes at 4°C. The 
pellet was washed with 70% ethanol, the supernatant removed and the
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denatured template dried in a vacuum dessicator. DNA was either 
used immediately in a sequencing reaction or stored dry at -70°C.
Template DNA was resuspended in 7/il of distilled water, 2/il of 5x 
sequencing buffer (200mM Tris HC1 pH7.5, lOOmM MgCl2 , 250mM 
NaCl) and 1/zl (0.5pmol) oligonucleotide sequencing primer added, 
and the primer and template annealed at 37°C for 20 minutes. To the 
template-primer mix was added, on ice, 1/zl 0.1M DTT, 2/jI of a 1:20 
dilution of 5x labelling mix (7.5mM each of dGTP, dCTP and dTTP), 
0.5/jI of a-[ 3%]-dATP (lOOOammol -1) and 2/xl of a 1:8 
dilution of Sequenase v.2.0 enzyme in TE pH8.0. The sample was 
mixed by pipetting and incubated at room temperature for 3 minutes 
before termination by addition of equal volumes (3.5/xl) of labelling 
reaction to each of four tubes containing 2.5/xl of A, G, C or T 
termination mixes (80/zM of each dNTP, 50mM NaCl and 8 /iM of one 
dideoxynucleotide) preheated to 37°C. Termination was carried out 
for 2 minutes at 37°C and stopped by addition of 4/il of stop solution 
which comprised 95% formamide, 20mM EDTA, 0.05% bromophenol 
blue, 0.05% xylene cyanol.
Sequencing reaction products were denatured at 80°C for 2 minutes 
and loaded immediately onto a 6 % polyacrylamide, 8 M urea 
denaturing gel which had been pre-run for 30 minutes. Samples were 
electrophoresed at 1400V for 1 to 6  hours, depending on the distance 
to be read from the primer sequence. Following electrophoresis, 
sequencing gels were fixed in 1 0 % acetic acid, 1 2 % methanol for 2 0  
minutes and dried under vacuum onto 3MM paper at 80°C for 1 to 2 
hours. Autoradiography was carried out at room temperature from 
overnight to several days.
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3.2.5. Polymerase Chain Reaction.
3.2.5.I. Precautions.
Due to the high sensitivity of the PCR technique, several general 
precautions were taken to avoid contamination of reagents and 
samples. As far as was practically possible, the suggestions of Kwok 
and Higuchi (1989) were followed. Disposable gloves were worn when 
dealing with samples or reagents. In addition, a disposable mask and 
cap were worn. PCR products were analysed on a separate bench from 
that used to set up reactions. Positive displacement pipettes, 
dedicated for PCR work, were used which avoided the production of 
aerosols, and sample and reagent tubes were briefly centrifuged prior 
to careful opening to ensure no splashing occurred. Mixes of reagents 
were made, sufficient for the number of reactions being undertaken, 
to ensure consistency between samples and controls. Reaction mixes 
were aliquoted into tubes, with target DNA being added last (except 
for the enzyme) to reduce the possibility of accidental transfer 
between samples, and a new capillary and piston assembly was used 
for each pipetting action.
Positive and negative controls were included in each set of reactions 
performed. The use of cloned DNA as a positive control was avoided, 
where possible, to minimise the risk of contamination, with 
HPV-containing genomic DNA samples being preferred. Where 
these were not available 1 to lOpg of HPV plasmid was used, but set 
up in isolation from the remaining samples. A known negative control 
such as commercially available calf thymus DNA or salmon sperm 
DNA was included, as was a control without template DNA in order
88
to exclude possible contamination of PCR reagents with potential 
target sequences.
3.2.5.2. Reaction Conditions.
Polymerase chain reaction experiments were performed using 
GeneAmp kits (Cetus Corporation, Emeryville, CA, USA) or a similar 
set of reagents. Reactions were carried out in final volumes of 50jli1 or 
100/il in lOmM Tris HC1 pH8.3, 50mM KC1, 1.5mM MgCl2 , 2.5 units 
of Taq polymerase (Cetus or BRL), with 0.5fig of each oligonucleotide 
primer and 1 fig of genomic DNA. Sample buffer minus DNA and 
enzyme was aliquoted into 0.5ml Eppendorf tubes and overlayed with 
0.5 volumes of light paraffin oil to prevent evaporation during the 
reaction procedure. Target DNA was then added, mixed by vortexing, 
centrifuged briefly and denatured in a water bath for 10  minutes at 
95°C. Samples were re-centrifuged, placed on ice and Taq 
polymerase added. Tubes were again mixed, spun briefly and placed in 
a thermal cycler (Cetus Corporation) pre-programmed to perform a 
specified number of cycles (usually 30 to 40) of denaturation, 
annealing of primers and template, and extension. Denaturation was 
routinely carried out at 94°C for 1 minute. The annealing step also 
lasted for 1 minute, but the temperature was dependent on the 
primers being used and was determined empirically for each primer 
pair to allow the minimum of non-specific binding, and was usually in 
the range of 50-60°C. Extension of newly primed DNA strands 
occurred at 72°C, the duration of this step being dependent on the 
length of the DNA being synthesised. For short (50-400bp) PCR 
products an extension time of 1 minute was used. Extension for
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products of intermediate size (up to 2.5kb) was 2.5 minutes, whereas 
longer syntheses required 5 minute extension times. All PCR 
protocols were concluded with annealing (1  minute) without 
denaturation and a final extension step of 10  minutes’ duration to 
complete all strands being synthesised. Completed reactions were 
stored at 4°C prior to analysis.
3.2.5.3. Analysis of PCR Products.
Routinely one tenth of the total reaction product was analysed by 
electrophoresis in 6 % polyacrylamide under non-denaturing 
conditions, as described above. Occasionally denaturing gels were 
used which contained, additionally, 8 M urea. Electrophoresis was 
carried out at 4-5 Vcm"  ^for 1 to 2 hours, depending on the anticipated 
size of the PCR product. In cases where the expected fragment size 
was l.Okb or greater, 1% to 2% agarose gels were used to improve 
resolution. Products were visualised on a UV transilluminator 
following staining with ethidium bromide (0.5/igml"  ^ in TBE), and 
photographed.
Polyacrylamide gels were blotted onto Hybond N+ membrane as 
previously described, although transfer times were halved (2  hours) in 
view of the small DNA fragment size. Filters were treated as before 
and hybridised totf'-^P] endlabelled oligonucleotide probes internal 
to the amplified fragment overnight in 6x SSC, 0.1% SDS at Tm-10 0  
C, washed for 30 minutes at room temperature in 2x SSC, 0.1% SDS 
with two changes followed by 5 minutes at 50°C. Autoradiography was
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carried out for 2 0  minutes to 2  days as previously described for *^P- 
labelled probes.
3.2.5.4. Sequencing of Polymerase Chain Reaction 
Products.
PCR products were sequenced using the Sequenase method described 
above, with a few modifications to the protocol. DNA fragments were 
purified from polyacrylamide gel slices by elution into 1 0 0 /xl to 2 0 0 /il 
of 0.5M NH4 CI, lOmM EDTA overnight at 37°C. Supernatant was 
removed to another tube and the eluted DNA precipitated with 0.1 
volume of 7.5M ammonium acetate and 2 volumes of absolute ethanol 
at -20°C for 1 hour. DNA was pelleted at 12000g for 10 minutes in a 
microfuge, washed once with 70% ethanol and dried under vacuum.
Purified DNA was resuspended in 7/zl of distilled water, sequencing 
buffer and primer added as before, and 0.1 volume of DMSO included 
to counteract reannealing of complementary strands of template DNA 
following denaturation (Winship, 1989). DNA was denatured by 
heating at 100°C for 5 minutes and cooled rapidly on a dry-ice-ethanol 
bath for 5 minutes. To the thawed primer-template mix sequencing 
reagents were added as before, with additional DMSO (0.1 volume), 
and the labelling reaction performed on the bench for 3 minutes. 
Termination was carried out as described above, again in the presence 
of 10% DMSO. Denaturation, electrophoresis and autoradiography 
were as previously described.
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3.2.6. Culture of Keratinocvtes from Oral Squamous
Cell Carcinomas.
3.2.6.1. Preparation of Feeder Cells.
Swiss 3T3 cells (Todaro and Green, 1963) were grown in DMEM 
supplemented with 1 0 % (v/v) bovine serum in an atmosphere of 1 0 % 
CC>2/90% air at 37°C. Cells were subcultured by exposure to 0.1% 
trypsin for 5 minutes and harvested in growth medium, after which 
they were replated at 1 x 10  ^ cells per 9cm dish. The remainder was 
exposed to 6000 rads of ^ -irradiation from a ^ C o source. Irradiated 
feeder cells were plated at a density of 5 x 10  ^ cells per 9cm dish and 
incubated in DMEM with 2% FBS and 0.4/xgml"  ^ hydrocortisone for 
24 hours prior to seeding of keratinocytes.
3.2.6.2. Preparation of Cells from Carcinoma 
Biopsies.
Biopsy specimens of approximately 5mm^, obtained at the time of 
resection, were transferred to sterile universals containing 10ml of 
DMEM supplemented with 2% serum, penicillin (50Uml"^), 
streptomycin (50/xgml"  ^ ), kanamycin (50/xgmT  ^ ) and amphotericin 
B (2.5/xgml'- )^. Samples were stored at 4°C until ready for use, up to 
seven days later. No adverse effect of storage was noted on the ability 
of samples to establish a primary culture.
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Tissues thus obtained were washed twice in fresh culture medium 
supplemented as above, transferred to a culture dish and dissected 
into fragments of approximately lmm^. These were transferred to a 
sterile universal container, washed twice in culture medium and then 
plated onto a feeder layer of one-third confluent lethally-irradiated 
Swiss 313 murine fibroblasts, known to suppress the proliferation of 
dermal fibroblasts (Rheinwald and Beckett, 1981).
Alternatively, the dissected tissue was incubated in culture medium 
supplemented with 2% FBS, antibiotics as described above, and 
200Uml'^ collagenase type VII (Sigma) at 37°C for one to five days, 
as described by Freshney (1987). The supernatant containing 
collagenase and fibroblasts was aspirated, and the epithelial cell 
clusters washed by resuspension and settling. Keratinocytes were then 
plated onto irradiated feeder cells as described above, in DMEM 
supplemented with 2% FBS and 0.4/xgml'  ^hydrocortisone (Rheinwald 
and Green, 1975; Rheinwald and Beckett, 1981) in order to inhibit 
growth of normal keratinocytes.
3.2.6.3. Subculture of Keratinocytes.
Cultures grown on feeder layers were incubated briefly (30 seconds) in 
a solution of 0.02% EDTA at 37°C followed by vigorous pipetting of 
PBS against the dish to remove the feeder cells. Keratinocytes were 
harvested by incubation with equal volumes of 0 .1% trypsin and 0 .0 2 % 
EDTA at 37°C for 10 minutes. Cell counting was performed using a 
haemocytometer and replated (5 x 10  ^cells per 9cm dish) onto a fresh 
batch of feeder cells.
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To ensure that a stock of cells was available, cells were cryopreserved 
at each passage by addition of 10% (v/v) DMSO to 1 x 10  ^ cells in a 
sterile plastic ampoule on ice. In order to ensure good viability, cells 
were frozen slowly, wrapped in cotton wool, first at -20 °C for 30 
minutes and then at -70°C overnight. The following day ampoules 
were placed in liquid nitrogen for permanent storage.
3.2.6.4. Immunocytochemistrv.
Cultured keratinocytes were stained with an anti-keratin antibody, to 
prove that they were truly of epithelial origin. Cells were grown on 
feeder layers on 13mm round glass coverslips for several days, under 
the conditions described above, and fixed in 50:50 acetone and 
methanol (Lane, 1982) for 10 minutes at room temperature. SCC25 
oral carcinoma cells (Rheinwald and Beckett, 1981) and Swiss 3T3 
murine fibroblasts were used as positive and negative controls, 
respectively. Coverslips were incubated with normal goat serum from 
a Vectastain anti-mouse IgG kit (Vector Laboratories), washed three 
times in PBS and then incubated overnight at 4°C with a mouse 
antikeratin monoclonal antibody (LP34, a kind gift from Dr. E.B. 
Lane). The antibody solution was removed by washing three times in 
PBS for 10 minutes and the second antibody, an anti-mouse IgG 
antibody conjugated to alkaline phosphatase (Vector) was added for 
one hour at room temperature. After removal of the second antibody 
with PBS as before, the alkaline phosphatase substrate was added and 
the coverslips were incubated in the dark for 25 minutes at room 
temperature. Final washing was carried out in PBS and the coverslips
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mounted using an aqueous mounting medium. The cells were 
examined using a light microscope.
Alternatively, cells were treated as described above, but a FITC- 
conjugated second antibody was substituted for the alkaline 
phosphatase-linked IgG second antibody, and allowed to bind in the 
dark at 37°C. In this case, fluorescence microscopy was used to 
visualise the cells.
3.2.6.5. Preparation of Nucleic Acids from 
Keratinocvte Cultures.
Cells were trypsinised as described above, transferred to a universal 
container, pelleted, resuspended and washed twice in PBS. The cell 
pellet was resuspended in 9ml of guanidinium isothiocyanate solution 
(section 3.2.2.2.) and centrifuged through caesium chloride gradients 
as for tissue biopsy material.
3.2.6.6. In Vivo Tumorigenicitv Studies.
Trypsinised oral keratinocytes were washed twice in PBS and 
resuspended at concentrations of 4 x 10  ^ or 4 x 107  cellsml" .^ Cell 
suspensions were injected subcutaneously into athymic mice at levels 
of 1 x 10  ^ or 1 x 107  cells per animal. On the first occasion the lower 
number of cells was used. The experiment was repeated using a 
tenfold greater cell number in the event of no tumour formation. 
Positive and negative controls of SCC25 and Swiss 3T3 cells were
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used. Tumorigenicity experiments were performed in quadruplicate. 
Tumour development was allowed to occur for twelve weeks, or until 
the lesion was 1cm in diameter, at which time the animals were 
sacrificed.
3.2.7. Computer Analysis of DNA Sequence Data.
Nucleotide sequences of PCR products or cloned DNAs were 
analysed on an Opus PCV Turbo microcomputer running the 
VAX/VMS operating system and the University of Wisconsin 
Genetics Computer Group (UWGCG) sequence analysis software 
package (Devereux et al., 1984). Sequences were entered using 
SEQED. Homology studies were performed by means of the 
programmes BESTFIT and GAP. Screening of sequences against 
those already present in the EMBL and Genbank databases was 
carried out using WORDSEARCH. Nucleotide sequences were 
translated into peptide sequences using TRANSLATE and compared 
using BESTFIT.
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4. Results.
4.1. Southern Blot Analysis of Human DNA Samples.
Genomic DNA was prepared from tissue samples collected from thirty 
nine patients undergoing major head and neck surgery for the 
treatment of oral squamous cell carcinoma. Samples included both 
malignant and normal oral mucosa; adjacent clinically dysplastic tissue 
and resected lymph nodes were also obtained, where present. 
Additionally, DNA was prepared from samples of normal buccal 
mucosa from twenty five consenting volunteers who were cancer-free.
Southern blots of 10/zg aliquots of each DNA sample digested with 
PstI or Hpall were probed sequentially with DNA probes of cloned 
HPV types 1-7,11,13,16 and 18, together with appropriate HPV 
controls. Initial hybridisation was carried out under conditions of low 
stringency to facilitate detection of non-homologous HPV types. 
Subsequently blots were hybridised and washed at high stringency to 
positively identify any HPV types present in cellular DNA samples.
Using this strategy, three out of thirty nine samples from oral cancer 
patients were shown to harbour HPV sequences. One carcinoma 
specimen (Cl) was positive for HPV-18 DNA, another (C2) for HPV- 
16 DNA and the third (C4) contained HPV-4 sequences, as shown in 
Figure 4.1. No viral sequences were detected in samples of DNA 
prepared from dysplastic or normal epithelia adjacent to these three 
cancers, or in the twenty five external control samples of normal 
buccal mucosa by this method.
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Sample Cl contained HPV-18 DNA, as judged by hybridisation to a 
homologous DNA probe at high stringency. The PstI digestion pattern 
(Figure 4.1, lane Cla) revealed an additional restriction site compared 
to prototype HPV-18 DNA, with the expected 6.33kb fragment being 
cleaved into two smaller fragments. An extra Hpall site was also 
present (lane Clb). Polymorphism of restriction sites of HPV-18 has 
been reported previously in a cervical carcinoma biopsy from the west 
of Scotland (Millan et al., 1986), perhaps reflecting a geographical 
variation of this viral type.
In sample C2 (Figure 4.1, lanes C2a and b) HPV-16 sequences were 
detected. The PstI restriction pattern (lane C2a) is atypical, as the 
1.55kb PstI "C" fragment of prototype HPV-16 DNA, which maps to 
the L2-L1 region of the viral genome, is absent. The Hpall digestion 
pattern of the HPV-16 DNA in C2 was also variant: the expected 
2 .6kb fragment was absent, but an additional band of approximately 
0.9kb was visible. The 2.6kb Hpall and 1.55kb PstI fragments overlap 
(Figure 4.2) and, as viral DNA was episomal rather than integrated, 
these data point to an alteration in the late region of the HPV-16 
genome. This has been investigated further (section 4.5).
HPV-4 DNA was found in cancer sample C4 (Figure 4.1, lanes C4a 
and b). No variation from the wild-type HPV-4 restriction patterns was 
noted for either enzyme. The presence of HPV-4 DNA in this sample 
was the first association of this viral type with a malignant lesion, 
although it has previously been reported in one lesion of oral verruca 
vulgaris by in situ hybridisation (Adler-Storthz et al., 1986a).
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In all three cases viral DNA was present as episomes with no evidence 
of integration (Figure 4.3), although integration of a single copy into 
the cellular DNA can not be ruled out. Multiple copies of each HPV 
type were present in the cancer DNAs, as judged by the relative 
intensities of the viral sequences compared to the lOng of cloned 
DNA controls run in parallel. Assuming that one viral genome per cell 
is represented by 26pg of viral DNA in 10/zg of cellular DNA, the 
controls in Figure 4.1 represent 384 genomes of HPV DNA per cell. 
Therefore approximately 50 copies of HPV-18 were detected in Cl, 
200 copies of HPV-16 in C2 and 50 copies of HPV-4 in C4. The 
controls were viral genomes linearised at the EcoRI site (HPV-18) or 
the BamHI site (HPV-4 and HPV-16) and digested with PstI or 
Hpall, thus in each case additional bands are visible than would be 
expected on digestion of the normally circular viral DNA; the 1.55kb 
PstI band of HPV-16 is cleaved to produce bands of 0.9 lkb and 
0.64kb, the 6.33kb Hpall band of HPV-18 is reduced to two 
fragments of 4.0kb and 3.33kb, and the 0.35kb Hpall band of HPV-4 
is cut on linearisation withBamHIinto bands of 0.2kb and 0.15kb.
Exposure of the Southern blot in Figure 4.1 for up to two weeks did 
not result in the appearance of the wild type HPV-16 bands which 
were absent. In addition, reprobing the blot with the 0.9 lkb and 
0.64kb Pstl-BamHI subgenomic fragments of HPV-16 failed to 
detect any more viral sequences. No viral DNA was detected in 
dysplastic or normal DNA samples after a longer exposure, and no 
HPV sequences were found in any of the other thirty six sets of DNAs 
from oral cancer patients or in any of the twenty five normal control 
samples with any of the HPV probes used, even under conditions of 
low stringency. These data suggest that these samples do not harbour
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HPV sequences, or are present below the limit of detection of this 
technique (one HPV genome per cell in 10/xg of genomic DNA), or 
that other HPV types which do not cross-hybridise to any of the 
probes used, even at low stringency, were present. The use of a more 
sensitive detection method, involving amplification of low abundance 
viral sequences in the polymerase chain reaction (section 4.4), has 
enabled these questions to be addressed.
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Figure 4.1.
Southern blot of cellular DNA (10/xg) from carcinoma (C), dysplastic (D) 
and normal (N) tissue from oral cancer biopsies 1, 2 and 4 digested with 
(a) PstI or (b) Hpall. The blot was sequentially hybridised to -^P-labelled 
DNAs of HP Vs 1-7, 11, 13, 16 and 18 as described in the text. In C l, the 
position of the two small PstI fragments of HPV-18 are indicated by 
lines to the left of lane (a). In C2, the closed arrowheads point to the 
missing PstI and H pall fragments of HPV-16, whilst the open arrowhead 
indicates the additional H pall band. In C4, the H pall doublet and the 
smallest band of HPV-4 are indicated by lines to the right of lane (b). 
Molecular weights indicated are the sizes of the Pstl-BamHI fragments 
of HPV-16 and the large H pall band of HPV-4 (4.0kb).
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Figure 4.3.
Southern  blot of lOug aliquots of undiges ted  Cl, C2 and C4 genomic 
DNA, hybridised to HPV-18, HPV-16 and HPV-4 respectively. Linear 
(form III) and relaxed c ircular  (form II) DNA can be seen. No evidence 
of in tegra t ion  was observed in any of the  samples.  HPV-4 DNA in C4 
was badly degraded, and only l inear  DNA was visible.
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4.2. Molecular Cloning of HPV-4 DNA From Cancer 
C4.
The cancer DNA sample C4 contained HPV-4 sequences, the first 
demonstration of this viral type in a malignant lesion. As such, it was 
decided to molecularly clone the viral DNA to enable a more detailed 
analysis to be carried out.
4.2.1. Isolation of HPV-4 DNA.
Cellular DNA from C4 was digested with BamHI, a known 
single-cutter enzyme for HPV-4, and DNA fragments in the size 
range 6-10kb ligated into the BamHI site of the bacteriophage lambda 
replacement vector EMBL3 (Figure 4.4; Frischauf et a l, 1983). 
Screening of 5 x 10  ^recombinant plaques resulted in detection of two 
positive clones. These were further purified, bacteriophage DNA 
prepared and digested with BamHI or Sail to release the insert DNA.
Figure 4.5(a) shows the restriction pattern of two clones, A and B, 
which were positive for HPV-4 sequences on plaque lift analysis, 
together with a control of linearised HPV-4 DNA. Clone A failed to 
digest with an excess of BamHI, even when incubated for up to 24 
hours, and only partial release of the right vector arm was achieved 
with Sail. Clone A did not hybridise to HPV-4 probe on the Southern 
blot shown in Figure 4.5(b), which suggests that the plaque isolated 
was not one containing viral sequences, or that the HPV-4 DNA was 
lost during the growth of the bacteriophage in culture. Digestion of
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clone B with BamHI or Sail produced left and right vector arms plus 
three insert bands, implying that the bacteriophage stock was not 
homogeneous. The three BamHI insert bands, a,b and c, of 
approximately 9.0kb, 8.0kb and 6.0kb respectively, hybridised to HPV- 
4 DNA at high stringency (Figure 4.5(b)). Band b corresponds to full- 
length HPV-4 DNA.
Full-length HPV-4 DNA purified free from bacteriophage sequences 
was subcloned into the plasmid vector pBR322. Colonies were 
screened for the presence of recombinant plasmid by small-scale 
plasmid DNA preparation, restriction enzyme digestion, Southern 
blotting and hybridisation to a HPV-4 probe. Six identical clones were 
positive for HPV-4 DNA (Figure 4.6(a)). The 9.0kb and 6.0kb bands 
were similarly subcloned, as can be seen in Figure 4.6(b), but blotting 
and hybridisation of these samples to a HPV-4 probe detected only 
the 6.0kb band (Figure 4.6(c)). It is likely that the 9.0kb band which 
was subcloned was the right vector arm.
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Figure 4.5.
(a) Restr ic tion enzyme analysis of two clones, A and B, which hybridised to 
a HPV-4 probe on plaque lift analysis. Both cloned DNAs were d igested with 
BamHI (left lanes) and Sail (right lanes) which cuts  outwith the  cloning site.
A control  HPV-4 plasmid was digested with BamHI and c o -e le c t ro p h o re se d .
Clone A did not  digest with BamHI and only part ial ly  with Sail. Clone B gave 
th ree  in se r t  bands (arrowed a,b and c) on digestion with BamHI, of approxim ate ly  
9.0kb, 8.0kb and 6.0kb, in addit ion to left and r ight  vector  a rms,  suggest ing 
t h a t  the  ’c lone’ was not  a pure  isolate, (b). Southern  blot of the  sam ples  in (a) 
hybridised to HPV-4. No hybridisat ion was d e tec ted  to clone A. All t h r e e  BamHI 
in se r t  bands  hybridised to the  HPV-4 probe,  and were subcloned. Band b is full 
length HPV-4.
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Figure 4.6.
(a) Sou thern  blot of BamHI-digested m iniprep  DNA from 10 clones,
hybridised to HPV-4 DNA at  high s tr ingency.  Lanes 1,2,6,7,8 and  10 
show HPV-4 sequences  to be present ,  (b). Ethidium b r o m id e - s t a in e d  
agarose  gel of subcloned DNA of the  HPV-4 positive 9.0kb and 6.0kb 
bands  seen in Figure 4.5, digested with BamHI. Inser ts  of the  expec ted  
sizes appea r  to have been cloned, (c). Southern  blot of the  gel in (b) 
hybridised to the  HPV-4 probe.  Only the  6.0kb band hybridised.
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4.2.2. Comparative Restriction Analysis of HPV-4 
DNA.
Cloned prototype HPV-4 DNA and the oral HPV-4 clone, linearised 
at the BamHI site and purified free from the cloning vector, were 
digested with twelve restriction endonucleases in an attempt to detect 
any polymorphisms which might be present between the two isolates.
Figure 4.7 is a Southern blot of restriction endonuclease-digested 
prototype and oral isolates of HPV-4 DNA hybridised to a HPV-4 
DNA probe at high stringency. No differences in restriction pattern 
are visible in any of the lanes. The additional bands in the Sau3AI 
digest of prototype HPV-4 DNA are products of partial digestion.
The absence of polymorphism for these few enzymes does not imply 
that the two isolates of HPV-4 are identical. Obviously sequence 
differences may be present which do not alter these specific restriction 
sites, and would therefore not be apparent on such a limited analysis. 
Although further restriction mapping might possibly reveal restriction 
enzyme polymorphisms, a definitive answer would be provided by 
obtaining the complete nucleotide sequence of both HPV-4 isolates.
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Figure 4.7.
Southern blot of prototype and oral isolates of HPV-4 DNA digested 
with twelve restriction enzymes and hybridised to a HPV-4 probe. No 
alteration was visible in any of the restriction patterns. The Sau3AI digest 
of prototype HPV-4 shows partial digestion.
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4.2.3. Restriction Analysis of the 6kb Fragment.
The 6kb band which was seen to hybridise to HPV-4 in Figure 4.6(c) 
was purified free from vector sequences and digested with PvuII, 
Hpall and EcoRI, as detailed in Figure 4.8.
PvuII did not cut within the cloned sequence (as is the case for full 
length HPV-4 DNA), as judged from its co-migration with 
unrestricted DNA. In the Hpall digest, 4.4kb and 1.6kb prototype 
bands were visible, but the 1.5kb band, which maps to the right of the 
BamHI-linearised HPV-4 genome, was absent. Digestion with 
EcoRI produced the 0.9kb prototype band plus a band of 
approximately 5.lkb, not seen on digestion of prototype HPV-4 DNA 
with this restriction enzyme; two prototype EcoRI bands of 4.4kb and 
2.9kb were also missing. These map to the middle (4.4kb) and right 
(2.9kb) of the BamHI-linearised prototype HPV-4 genome; it is 
likely that the variant 5. lkb EcoRI band described above reflects the 
prototype 4.4kb band plus part of the 2.9kb band, as the 4.4kb Hpall 
fragment and the 4.4kb EcoRI fragment overlap (Figure 4.8(b)). This 
suggests that a region of viral DNA to the right of the 
BamHI-linearised genome is missing in the 6kb clone. The most 
likely explanation is that the 6kb band hybridising to the HPV-4 
probe at high stringency represents the leftmost region of full-length 
HPV-4 DNA, and as such is an artefact of the cloning procedure. 
Alternatively it could represent a second, deleted viral genome 
present in the cancer DNA sample; however no evidence of such is 
visible by Southern blot analysis (Figure 4.1).
I l l
bp
6108 _  
5090 — 
4072 —
3054 —
2036 — 
1636 —
1018 —
Figure 4.8(a).
Restr ic tion digestion of the  6kb band (Figure 4.6(c)) with th e  
enzymes indicated.  Molecular weight m a rk e r s  were a lkb  ladder.
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0.9 | 4.4 | 2.9 EcoRI
1 4 A  i U3 1 1.5 I Hpall
Figure 4.8(b).
Restr ic t ion m ap  of p ro to type  HPV-4 DNA showing the  EcoRI and 
Hpall sites  within th e  viral genome, l inearised a t  th e  BamHI site. 
Shaded regions r e p re se n t  the  a reas  p re s e n t  in the  6kb clone. Sizes 
of res t r ic t io n  f ragm en ts  are  in kb.
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4.3. Nucleotide Sequencing of HPV-4 Isolates.
4.3.1. The Partial Nucleotide Sequence of HPV-4.
A region of the nucleotide sequence of prototype HPV-4 DNA was 
determined, primarily to facilitate the design of specific 
oligonucleotide primers for use in polymerase chain reaction 
screening of genomic DNA samples. In addition, comparison of this 
with a similar region of sequence from the oral isolate of HPV-4 
described above might reveal base changes not apparent on a limited 
restriction endonuclease analysis.
Three hundred and eighty bases of the prototype HPV-4 sequence 
immediately adjacent to the vector-viral junction were determined, 
using the seventeen base oligomer 5’-GCCGGCCACGATGCGTC-3’ 
as sequencing primer, which corresponds to nucleotides 406-390 of the 
pBR322 genome (Sutcliffe, 1979). The sequence obtained read from 5’ 
to the HincII site at map coordinates 0.018 through the Hindlll site at 
0.036 (Heilman et al., 1980).
The prototype HPV-4 sequence determined is listed in Figure 4.9(a), 
and the restriction sites indicated. Homology comparison analysis was 
performed in both orientations with the HPV sequences present in the 
EMBL and Genbank databases, using the GAP programme in the 
UWGCG sequence analysis software package. No convincing regions 
of homology were revealed at the nucleotide level with any of the 
HPV sequences available. This reflects and confirms the isolated 
position of HPV-4 in the phylogenetic tree of papillomaviruses as
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previously reported (Pfister, 1984). The full-length clone of oral 
HPV-4 was similarly sequenced. The data obtained demonstrated 
identity between these two isolates over the region sequenced. This 
suggests that the oral and prototype isolates of HPV-4 are the same, 
or are at least identical in this region.
Using the TRANSLATE programme, it was possible to identify a 
putative protein coding region within the available HPV-4 sequence, 
reading in frame one up to the TAA stop codon at nucleotides 232- 
234 as shown in figure 4.9(a). No ATG start codon could be found for 
this sequence; therefore the protein is likely to represent the product 
of the 3’ end of a larger coding region starting 5’ to the available 
sequence.
Using BESTFIT to compare this region with protein sequences from 
other sequenced papillomaviruses, homology was noted with the E2 
proteins of HPV-6b, HPV-16 and HPV-18, as shown in Figure 
4.9(b). The putative HPV-4 protein is homologous to the 3’ end of 
the coding region in each case, consistent with the sequence obtained 
above. As can be seen from the alignment several conserved amino 
acid motifs are present, probably reflecting their functional 
importance.
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4.3.2. Sequence Analysis of the 6kb Clone.
A region of the 6kb clone (Figure 4.6(b and c)) was sequenced using 
the same oligonucleotide primer as above. Over the 150 bases 
sequenced, the sequence was identical to that obtained for HPV-4 
DNA (not shown). These data support the conclusion that the 6kb 
fragment is an artefact of cloning, although this will only be confirmed 
by comparison of the entire nucleotide sequences of the full-length 
clone and the 6kb band, or by heteroduplex analysis.
1 1 6
48
TTG TTA AAG GGC ACA GCA AAT TCT TTG AAA TGT TGG AGA TAT AGA AAA
1 L L K G T A N S L K C W R Y R K
2 C - R A Q Q I L - N V G D I E
3 V K G H S K F F E M L E I  - K
H in c I I  96
GTT AAC TCA AAT TGC TGC AAC TTC TTA TTC ATG AGT ACT GTT TGG AAC 
V N S  N C C N F L F M S T V W N  
K L T Q I A A T S Y S  V L F G
S - L K L L Q L L I H E Y C L E
144
TGG GTT GGA GAT TGC TCA CAT AAT CAT CGT CGC ATG CTT ATT GCA TTT 
W V  G D C  S H N H R R M L I A F  
T G L E I A H I I I V A C L L H  
L G W R L L T  - S S S H A Y C I
192
GAT AGC ACT GAC CAA AGA GAC GCT TTT GTA AAA CAC AAC CTT TTT CCT 
D S T D Q R D A F V K H N L F P  
L I A L T K E T L L - N T T F F  
H - P K R R F C K T Q P F S
241
AAA CTG TGT ACA TAT ACC TAC GGC TCA TTG AAT AGT TTA TAA AAT CGA 
K L C T Y T Y G S L N S L - N R  
L N C V H I P T A H  - I V Y K I  
T V Y I Y L R L I E  - F I K S
H i n d l l l  288
AAG CTT GAG TAG AAG GAA AGA GAT TCA GTT CCA AAC AGT ACT CAT GAA 
K L E - K E R D S V P N S T H E  
E S L S R R K E I Q F Q T V L M  
K A - V E G K R F S S K Q Y S
H in c I I  336
TAA GAA GTT GCA GCA ATT TGA GTT AAC TTT TCT ATA TCT CCA ACA TTT 
E V A A I  - V N F S I S P T F
N K K L Q Q F E L T F L Y L Q H  
I R S C S N L S  - L F Y I S N I
380
CAA AGA ATT TGT CTG TGC CCT TTA ACA ATA TCA TAG GCG GAT CC 
Q R I C L C P L T I S  - A D  
F K E  F V  C A L - Q Y H R R  I  
S K N L S V P F N N I I G G S
F ig u re  4 . 9 .  P a r t i a l  n u c le o t id e  se q u en c e  o f  p r o to ty p e  HPV-4 DNA 
r e a d in g  from  5 ' o f  th e  H in c I I  s i t e  a t  map c o o r d in a te  0 .0 1 8  th ro u g h  
th e  H in c I I  s i t e  a t  0 . 05  map u n i t s .  R e s t r i c t i o n  s i t e s  a r e  i n d i c a t e d ,  
and  th e  seq u en c e  t r a n s l a t e d  i n  a l l  t h r e e  r e a d in g  f ra m e s . I n  fram e  
o n e , a  p o t e n t i a l  c o d in g  r e g io n  c a n  be  i d e n t i f i e d  r e a d in g  th ro u g h  to  
th e  TAA s to p  codon a t  n u c le o t id e s  2 3 3 -2 3 5 . The o r a l  i s o l a t e  o f  HPV-4 
was i d e n t i c a l  to  th e  p r o to ty p e  DNA o v e r  th e  r e g io n  se q u e n c e d .
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H PV-18 LKGDRNSLKCLRYR. LRKHSDHYRDISST. WHWTGAGNE. K
HPV-16 LKGDANTLKCLRYR. FKKHCTLYTAVSST. WHWTGHNVKHK
H PV-6b FQGESNCLKCFRYRLNDRHRHLFDLISST. WHWASSKAPHK
HPV-4 LKGTANSLKCWRYRKVNSNCCNFLFM. STVWNWVGDCSHNH
H PV-18 TGILTVTYHSETQRTKFLNTVAIPDSVQILVGYMT
H PV-16 SAIVTLTYDSEWQRDQFLSQVKIPKTITVSTGFM.S
H PV-6b HAIVTVTYDSEEQRQQFLDWKIPPTISHKLGFM.SLHLL
HPV-4 RRMLIA. FDSTDQRDAFVKHNLFPKLCTYTYGS LNSL
Figure 4.9(b). Alignment of a putative HPV-4 peptide with regions 
of the E2 proteins of human papillomavirus types 6b, 16 and 18. 
Highly conserved amino acids between the HPV-4 sequence and the 
other papillomavirus types are highlighted. Dots in the sequences 
indicate spaces which have been inserted in order to align the proteins 
with maximum homology.
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4.4. PCR Screening of Genomic DNA Samples For HPV 
DNA.
Polymerase chain reaction amplification of specific fragments of HPV 
DNA was used to increase the amount of material available prior to 
Southern blotting and hybridisation, thus increasing the overall 
sensitivity of the screening procedure to considerably less than one 
viral genome per cell. According to Maitland et al (1989) this should 
enable detection of one copy of a specific sequence in a background of 
up to 1 x 104 uninfected cells.
Areas of the E6 ORFs of HPV-16 and HPV-18, selectively retained in 
cervical carcinomas and detectable in oral samples C2 and Cl (section 
4.1), were chosen for amplification, as was a region of the HPV-4 
sequence determined previously (section 4.3). Oligonucleotide primer 
pairs used in the PCR are listed in Table 4.1, together with the 
expected sizes of the amplified fragments for each set of primers. 
Listed in Table 4.2 are the sequences of two 40-base oligomers 
(16-Int and 18-Int), internal to the HPV-16 and HPV-18 
amplification products, which were used as hybridisation probes to 
ensure that the sequence amplified was the correct one.
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O l ig o n u c leo t id e  P r i m e r s  fo r  P o l y m e r a s e Chain R e a c t io n
L o c a tio n
E x p e c te d  
f r a g m e n t  s iz e
5 ’ TTAATTAGGTGTATTAACTG 3 ’ 
TGCATGATTACAGCTGGGTT
4 0 1 - 4 2 0
5 6 6 - 5 4 7
16E6 1 6 6 b p
GATACACCTACATTGCATGA
GATGGGGCACACAATTCCTA
5 7 1 - 5 9 0
8 4 0 - 8 2 1
16E7 2 7 0 b p
GATTTAAGTACTATTGATCCTGC
GCGTCCTAAAGGAAACTGATCTAGG
5 2 2 0 - 5 2 4 2
7 0 3 5 -7 0 1 1
16La
16Lb
1 8 1 6 b p
ATCTGTGCACGGAACTGAAC
AATGCAAATTCAAATACCTC
1 5 1 - 1 7 0
2 5 0 - 2 3 1
18E6 lOObp
AAAGGGCACAGCAAATTCTT 4 - 2 3
ATGCAATAAGCATGCGACTA 1 4 0 -1 2 1
H4 1 3 7 b p
GACGGAATATAAGCTGGTGG
TGGATGGTCAGCGCACTCTT
1 6 6 8 -1 6 8 7
1 7 3 0 -1 7 1 1
HA 12 
HB12
63bp
T able  4.1
Oligonucleot ide  p r i m e r s  used  in t h e  p o ly m e ra s e  c h a in  r e a c t io n .
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I n t e r n a l  O l igo n u c leo t id e  P r o b e s
GACAAAAAGCAAAGATTCCATAATATAAGGGGTCGGTGGA 4 6 1 - 5 0 0 IN T -1 6
CTGCAAGACATAGAAATAACCTGTGTATATTGCAAGACAG 1 7 7 - 2 1 5 IN T -1 8
Table 4.2. Ol igonucleot ides  u se d  as p ro b e s  fo r  HPV-16 a n d  HPV-18 
E6 reg ion  DNAs.
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4.4.1. PCR Screening For HPV-4 Sequences.
PCR screening of case and control DNA samples did not increase the 
percentage positive for HPV-4 DNA (3%; one out of thirty nine 
cases), with only sample 4 harbouring HPV-4 sequences. However, by 
increasing the sensitivity of the detection technique, it was possible to 
demonstrate that viral sequences were not confined to the DNA from 
the cancer biopsy alone.
Figure 4.10 is a Southern blot of PCR products from carcinoma (C), 
dysplastic (D) and normal (N) DNAs from sample 4, amplified using 
the HPV-4 primers and hybridised to a ^  P-labelled probe 
comprising the complete genome of HPV-4. Viral sequences are 
present in lanes D4 and N4 as well as in C4, which was positive by 
conventional Southern blot (Figure 4.1). Lane C4 contains one tenth 
of the amount of PCR product of either lanes D4 or N4. Thus it 
appears that viral sequences are present in non-malignant epithelia, 
albeit at lower copy number.
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Figure 4.10
(a) HPV-4 PCR p r im ers  derived from the  nucleotide  
sequence in Figure 4.9, expected to amplify a 136bp 
f ragm ent ,  (b) Southern  blot of PCR p ro d uc ts  from 
sample  4; the  probe was to ta l  HPV-4 DNA. C = carc inom a,  
D=dysplastic, N=normal.  Lane C4 has tenfold less sample  
th an  D4 or N4.
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4.4.2. Screening For HPV-16 Sequences By PCR.
By Southern blotting of PCR products obtained using the HPV-16 E6 
primers detailed above and subsequent hybridisation to an internal 
oligonucleotide probe, ten out of the thirty nine case DNA samples 
(25.6%) were shown to contain HPV-16 E6 sequences. A  
representative blot is shown in Figure 4.11. None of the twenty five 
normal control samples from cancer-free individuals were found to 
harbour HPV-16 DNA sequences.
Where HPV-16 DNA was present in carcinoma DNA samples, 
adjacent normal epithelia were also found to contain viral sequences. 
Figure 4.12 shows a Southern blot of PCR products from dysplastic 
(D) and normal (N) DNAs from tissues adjacent to carcinoma C2, 
which was positive for a variant of HPV-16 by conventional Southern 
blot analysis (Figure 4.1). HPV-16 related sequences are clearly 
present in these tissues, although apparently at lower copy number 
than in the carcinoma.
The nucleotide sequence of the HPV-16 fragment amplified from 
sample D2 was determined in both orientations, using both PCR 
primers as sequencing primers. No base changes were found when 
compared to cloned HPV-16 DNA in either the forward orientation 
(Figure 4.13) or the reverse (data not shown). Although the entire 166 
nucleotides were not sequenced, data were obtained to within five 
bases of the primer.
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In the light of results obtained by other workers (Maitland et al., 
1987; 1989) and the altered restriction digestion patterns apparent in 
sample C2 by Southern blot analysis, sequencing of a region of the 
HPV-16 E7 ORF amplified from samples of cellular DNA by PCR 
was carried out using the 16E7 primers (Table 4.1), in order to 
establish whether or not the E6 and E7 ORFs were retained 
unaltered. In each case, no base changes were found when compared 
to prototype HPV-16 DNA Figure 4.14 shows the nucleotide 
sequence of a region of the E7 PCR product from the HPV-16 
control and sample N30 (DNA from normal epithelium adjacent to a 
carcinoma). Although the entire fragments were sequenced, only 
those bases from nucleotides 736 to 833 are shown. Sequencing primer 
was the forward PCR primer. This suggests that the E7 ORF and the 
region of the E6 ORF sequenced are conserved between oral and 
prototype isolates of HPV-16, probably reflecting their functional 
importance.
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0 1 .0  2 .0 k b  . .  7 .9 k b  H P V - 1 6
' 1  1
544 855
E7
( a )  65 556
E6
4 0 1 - 4 2 0  5 4 7 - 5 6 6
Figure 4.11.
(a) HPV-16 PCR pr im ers  (16E6), expected  to amplify 
a 166bp f ragm en t  from the  HPV-16 E6-E7 region.
(b) Sou thern  blot of PCR produc ts  amplified from 
samples  3,5,13 and 19, using the  p r im ers  in (a). C = 
carcinoma, N=normal,  HPV- 16=contro l  t em p la te  of 
lpg of HPV-16 plasmid, No DNA=control sample  m inus  
DNA tem pla te .
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Figure 4.12.
Southern  blot of PCR p roduc ts  from samples D2 and N2 
using the  16E6 primers .  D=dysplastic, N=normal,  Controls 
were HPV—16 plasmid, calf thym us  DNA (CT) and a reac t ion  
containing no DNA. Hybridisation probe was the  in te rna l  
ol igonucleotide 16-Int .
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Figure 4.13.
Direct nucleotide  sequence  of PCR p roduc ts  obtained  from HPV-16 plasmid 
and sample D2 (Figure 4.12). No nucleotide  differences were observed.
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H P V - 1 6  N 3 0
G A T C G A T C
Figure 4.14.
Direct nucleotide  sequence  of HPV-16 E7 region PCR p ro du c ts  amplified from 
HPV-16 plasmid and sample N30, using the  16E7 p r im e r  pa ir  (Table 4.1). The 
en t i re  f rag m en t  was sequenced, although only a section is shown. No changes  
in base  composit ion were detected .
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4.4.3. PCR-Mediated Detection of HPV-18 DNA.
Eight out of thirty nine cases (20.5%) were found to harbour HPV-18 
sequences using the HPV-18 E6 region PCR primers described 
above (Table 4.1). As was the case for detection of HPV-4 and 
HPV-16 DNAs, where viral DNA was present in the carcinoma 
sample it was also present in the corresponding normal sample, except 
in two cases. Figure 4.15 is a representative Southern blot of samples 
containing HPV-18 E6 DNA hybridised to an internal oligonuleotide 
probe. The negative control of DNA from T45 cells, an oral 
carcinoma cell culture (Parkinson and Yeudall, in press) containing 
HPV-16 DNA by PCR, and the control reaction of reagents minus 
template DNA show that the amplification was specific for HPV-18 
sequences.
In addition to HPV-18 positive cancer case samples, two out of 
twenty five (8%) control samples of DNA from normal buccal mucosa 
of healthy volunteers also contained DNA of this viral type, the only 
HPV type found in cancer-free subjects in this study.
In order to discover if, as in the case of HPV-16 positive samples, the 
amplified HPV-18 E6 region was identical to the wild-type sequence, 
direct nucleotide sequencing was carried out on PCR products from 
carcinoma sample Cl and from the two HPV-18 positive normal 
samples N12 and N18. As Figure 4.16 shows, no nucleotide differences 
were observed between these samples and the PCR product amplified 
from cloned prototype HPV-18 DNA.
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1 5 1 - 1 7 0  2 3 1 - 2 5 0
Figure 4.15.
(a). HPV-18 oligonucleotide p r im ers  (18E6) used to amplify 
a lOObp f ragm en t  of the  viral E6 ORF by PCR. (b). Sou thern  
blot of HPV-18 specific PCR produc ts  from case sam ples  and 
two ex ternal  controls  (NIC and N18). Controls were HPV-18 
plasmid (lpg), DNA from a HPV-16 containing cell line (T45) 
and a reac t ion  m inus DNA. The in te rnal  ol igonucleot ide 1 8 - In t  
was used as hybridisat ion probe.
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Figure 4.16.
Direct nucleotide sequence of HPV-18 E6 PCR products from HPV-18 
plasmid, carcinoma Cl, and external control samples N12 and N18. The 
upstream PCR primer was used as sequencing primer. No alterations in 
nucleotide sequences were seen over the region sequenced.
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4.4.4. Use of Anticontamination Primers.
To control for possible contamination of samples by cloned HPV 
DNAs present in the laboratory, two sets of anticontamination primers 
were used, one pair for HPV-18 and the other for HPV-16, and were 
as detailed in Table 4.3. These were designed to amplify a fragment 
of DNA spanning the cloning site, and in the case of plasmid 
contamination the size of the amplified product would be greater by 
the length of the cloning vector, 4365bp for DNAs cloned in pBR322, 
as outlined in Figure 4.17.
As the length of any potential contaminating plasmid fragment 
amplified by these primers was considerably greater than the HPV 
target sequence, and thus less likely to be copied in total by the 
polymerase, the sensitivity of the anticontamination primers was 
tested using cloned HPV-16 and HPV-18 DNA templates over a range 
of concentrations. The extension step of each cycle was carried out at 
72°C for five minutes to maximise completion of each copy of the long 
(4545bp for pHPV-18) sequence. Figure 4.18 shows the amplification 
products for both pairs of primers using template DNA concentrations 
of lOOng, lOng, lng, lOOpg, lOpg and lpg in a 100/xl reaction volume. 
In both cases the amplification product was visible in all but the lpg 
sample after hybridisation and a short (10 minutes) exposure to XAR- 
5 film. No amplification was detected in the samples containing lpg of 
template DNA, even after several days’ exposure. This suggests that 
the sensitivity of the anticontamination primers to amplify a large 
fragment of DNA is much reduced, compared to the ability to amplify 
a short sequence of a few hundred nucleotides.
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Although the sensitivity of these primers was reduced when amplifying 
longer sequences, their use did not present any problems in the case of 
samples positive for HPV-18 E6 DNA. All such samples were shown 
to be true positives as the fragment amplified was of the expected size 
for wild type HPV-18 DNA (170bp). No evidence of plasmid 
contamination was found. A representative autoradiograph of 
amplified HPV-18 DNA hybridised to a ^P-labelled probe 
comprising the complete genome of HPV-18 is shown in Figure 4.19.
Annealing of the anticontamination primers to sequences in genomic 
DNA samples shown to contain HPV-16 E6 and E7 DNA proved, 
however, to be impossible, although no problem was encountered in 
annealing to wild-type HPV-16 sequence. In view of the Southern blot 
results for sample C2 (section 4.1) and those of Maitland et al. (1989) 
for oral mucosal biopsy DNAs, this may be due to sequence 
rearrangement or deletion in this region of the viral genome.
No evidence of plasmid contamination was found in any of the 
samples positive for the HPV-16 early region DNA. However this was 
inferred by the lack of amplification of the viral-vector PCR product.
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A n t ic o n ta m in a t io n P r im e r s
L o c a tio n
E x p e c te d  
f r a g m e n t  s iz e
TGCTAGTGCTTATGCAGCAA 6 0 3 0 -6 0 4 9
16AC 151bp
ATTTACTGCAACATTGGGTA 6 1 8 0 -6 1 6 2
AAATCATATTTTGGAATGAG 2 3 8 1 - 2 4 0 0
18AC 1 7 0 b p
GCATTTCTCATATAGGTATC 2 5 5 0 -2 5 3 1
Table 4.3.
Oligonucleotide p r im ers  flanking the  cloning sites  of HPV-16 
(16AC) and HPV-18 (18AC), used to contro l for c o n tam in a tio n  
of PCR sam ples by HPV p lasm ids p re se n t  in th e  labora to ry . In 
th e  event of p lasm id con tam ina tion , th e  size of th e  amplified 
f rag m en t would be g re a te r  by 4365bp, th e  length  of th e  p lasm id  
vector.
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BamHI pBR322
BamHI BamHI
pHPV-16
12269bp
HPV-16
HPV-16
7904bp
(a) (b)
Figure 4.17.
A nticon tam ination  p r im ers  (Table 4.3), s i tu a te d  on e i th e r  side 
of the  cloning site  were used to amplify across  th is  region  of 
HPV-16 (diagram  a) and HPV-18. In th e  case  of co n tam in a tio n  
of sam ples by HPV plasm ids (d iagram  b) the  amplified f rag m e n t  
would be longer by th e  size of th e  pBR322 v ec to r  (4365bp).
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Figure 4.18.
Southern  blot of PCR amplificat ion p roduc ts  using the  a n t ico n tam ina t io n  
p r im ers  for HPV-16 as listed in Table 4.3. Template DNA consis ted  of 
of dilutions of HPV-16 plasmid from lOOng to lpg of DNA as indicated.  
The blot shown above was exposed for 10 minutes .  A signal was de tec ted  
for each concen tra t io n  of t em p la te  DNA except  t h a t  which con ta ined  lpg 
of s ta r t ing  mater ia l .  A longer  exposure  (2 days) did not  reveal a band in 
the  lpg sample.
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Cl C14 C37 C40 N12 N18
Figure 4.19.
Southern  blot of PCR p roduc ts  amplified from case and contro l  samples  
using the  HPV-18 an t icon tam ina t ion  pr imers .  All bands  were of the  
expec ted  size for episomal viral DNA minus plasmid. No evidence of 
plasmid con tam ina t ion  was found.
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4.5. Late Region Alterations in HPV-16 From Oral
Samples.
The data obtained from the Southern blot hybridisation pattern of 
HPV-16 DNA in sample C2 implies that the L2-L1 region of the viral 
genome has undergone a deletion or recombination event, as the 
prototype PstI ’C’ fragment of 1.55kb and the 2.6kb fragment in the 
Hpall-restricted sample are absent; an additional band of 
approximately 0.9-1.0kb is present in the Hpall lane (Figure 4.20).
Possibly the best way in which to address this question would have 
been to molecularly clone the entire viral genome from the tumour 
sample and then obtain the nucleotide sequence. Due to the small 
biopsy size, however, no sample DNA remained from which to isolate 
the variant HPV-16 DNA. It was decided, therefore, to use a PCR- 
based strategy in order to amplify a fragment of DNA spanning the 
area of interest, using a pair of oligonucleotide primers further 
upstream and downstream of the alteration, presumably in regions of 
unchanged sequence. The strategy is outlined briefly and the primers 
(16La/b, Table 4.1) detailed in Figure 4.21. These primers also serve 
as anticontamination primers, as they are situated on either side of the 
BamHI cloning site of prototype HPV-16.
4.5.1. PCR Amplification of HPV-16 Late Region 
Sequences.
Initially two samples, C3 and C5, positive for HPV-16 sequences 
using the E6-specific primers were used to attempt the amplification
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procedure described above. Figure 4.22 shows the result of 
electrophoresis of the PCR products of C3, C5 and a control of 
recircularised prototype HPV-16 DNA in a 2% agarose gel, stained 
with ethidium bromide. In the HPV-16 control lane the expected 
amplification product of 1.8 lkb is visible. This fragment is absent in 
both C3 and C5 lanes, but a band of approximately 0.9-1.0kb is 
present. No evidence of plasmid contamination of these samples was 
apparent. No amplification of a similar product occurred in the 
negative control sample, which lacked template DNA in the reaction 
mix. This fragment of DNA was unable to be amplified from seven 
other samples of genomic DNA previously shown to contain HPV-16 
sequences by PCR using the E6 ORF primers (section 4.4.2). 
Additionally, PCR performed on paraffin-embedded tissue sections 
from cancer C2 (which contained HPV-16 DNA detectable by 
Southern blot hybridisation) failed to amplify any HPV-16 late region 
sequence, although part of exon 1 of the human c-Ha-ras gene could 
be easily amplified using primers HA12 and HB12 (Table 4.1; Figure 
4.23).
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a b
H P V -1 6
a
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1.78
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0.91
0.64
kb
Figure 4.20.
Sou the rn  blot of to ta l  cel lular DNA from sample C2, digested with (a) PstI 
and (b) Hpall hybridised to a probe comprising the  complete  genom e of 
p ro to type  HPV-16. The control  was lOng of BamHI l inear  HPV-16 DNA cu t  
with PstI. The 1.55kb PstI and 2.6kb Hpall wild type bands a re  a b se n t  f rom 
the  sample (open arrowheads), and an addit ional  band of a pp rox im ate ly  
0 .9 -1 .0kb  is p re sen t  in lane b (closed arrowhead).
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Figure 4.23.
Ethidium bromide s ta ined gel showing the  
amplification of a 75bp f ragm en t  of DNA 
from th ree  different  t issue sect ions f rom a 
p a ra f f in -e m b e d d e d  specimen from ca rc inom a  
C2 (lanes P 2a-c ) .  lOpg of the  pT24 c - H a - ra s  
plasmid (Santos et  ah, 1982) was used as a 
positive control  for the  react ion.  A negative 
control  of reac t ion  mix m inus  t em p la te  DNA 
was also included, as before.
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4.5.2. DNA Sequence Analysis of HPV-16 Late Region 
PCR Products.
PCR products amplified from tumour DNAs C3 and C5 using the 
16La/16Lb primer pair were gel-purified, isolated and partially 
sequenced using oligonucleotide 16La as the sequencing primer. The 
nucleotide sequences thus obtained are listed in Figure 4.24
Homology comparison with the expected 1.8 lkb sequence from 
prototype HPV-16 was performed for both C3 and C5 sequences using 
the UWGCG software. Both sequences showed only very poor 
homology with HPV-16 DNA, in the regions shown in Figure 4.25, and 
very poor homology with each other. However only a short region of 
each DNA was successfully sequenced, and it is possible that a greater 
degree of sequence similarity might be observed if the entire 
nucleotide sequences of these PCR products were available. The poor 
homology is suggestive of recombination of viral sequences in this 
region.
145
(a) C3
TGTGTCCTTG
ATGGAGTCCC
GCAACGTGGT
AAAGGGCGCG
TTAAGGATTG
ACTGTTTCTG
AGCTAAAGAT
ACACAGGCAG
TACGTTTAAT
GTGGTCAAGT
GATACTGCAA
A
CTTGATTCCG
GCGTAGCTAA
CCTGATTAGC
AGCCTTGTGC
AGATGATACT
GCGAAAGAGC
(b) C5
ATTTGCTATT
AATATAGAAT
GTTGCTATAC
ATTATCTCTA
TTATCAGTAG
TAGCTCATCA
ATATATAAGC
Figure 4.24.
TTCATGGTGG
GAATCAATAG
AAGCATTAGG
CTTAATAGAG
CGTGTCGTAT
CTTCCGATAC
TAACATACGA
TGGGGTTCAT
TCCAATAACT
CTAAATATTA
ATTTATAGGT
ACGAGAGATC
GATTGAGTTT
TCTAGATCTC
ACTGTTTGCG
CGTACTTTTA
TAGTGATTGT
CACGATACGT
TCGGATTATA
GAGATATCTA
AATTC
TTTACGTCAT
TAGATCTCTA
CTAGCTATGG
TCTAAGTCTA
AGAAGTTATA
GCTCTTGCTC
Nucleotide sequences  ob tained  by d irec t  sequencing of th e  l.Okb PCR 
p ro d u c ts  from  (a) C3 and (b) C5 (Figure 4.22). Sequencing p r im e r  was 
th e  16La oligonucleotide. Sequence com parison  revealed  only poor 
homology with th e  p ro to ty pe  HPV-16 la te  region in bo th  cases.
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4.5.3. Hybridisation of C3 and C5 DNAs to Genomic
Sequences.
Genomic DNAs from tumour and normal biopsy samples were 
digested with PstI and analysed by Southern blotting and hybridisation 
to ^P-labelled C3 and C5 PCR products initially under conditions of 
low stringency (Tm-40°C), washed and autoradiographed for 2 days. 
Blots were subsequently washed at high stringency (Tm-10 (t )  and 
exposed to radiographic film as before. The results of hybridisation of 
a C3 probe to 10/ig aliquots of tumour DNAs and to normal DNAs 
(lO/xg) can be seen in Figures 4.26 (a) and (b) respectively. No 
discreet bands were observed in any of the samples. The probe 
hybridised to the smear of genomic DNA in both cases. The difference 
in signal intensity between the two autoradiograms is probably due to 
decay of the probe as both blots were hybridised independently, the 
filter containing normal samples being hybridised after that containing 
the tumour DNAs. However the possibility of amplification of specific 
sequences in the tumour DNA samples can not be ruled out. 
Hybridisation of a C5 probe to the same filters produced a similar 
result (not shown). This suggests that the DNA fragments amplified 
from samples C3 and C5 by polymerase chain reaction were either 
repetitive human genomic elements, or were viral products 
recombined with repetitive cellular sequences.
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Figure 4.26.
Southern  blot of P s t l -d ig e s te d  tota l  cel lular  DNAs from (a) ca rc in o m a  and
(b) normal  samples to the  C3 l.Okb PCR f ragm ent  probe a t  high s t r ingency  . 
The same resu l t  was obtained  probing with the  C5 l.Okb PCR product .
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4.5.4. Hybridisation of C3 and C5 PCR Products to 
Prototype HPV-16 DNA.
To further analyse the l.Okb DNA fragments amplified from tumours 
C3 and C5 in the PCR, each was isolated, labelled and hybridised to 
Southern blots of BamHI linear prototype HPV-16 DNA digested 
with PstI and Hpall under conditions of low stringency. The 
hybridisation pattern for the C3 fragment is shown in Figure 4.27(a). 
Both PCR products hybridised to the 1.78kb PstI fragment, but not to 
the 0.91kb or 0.64kb BamHI-Pstl fragments of prototype HPV-16. 
Hybridisation also occurred in both cases to the 1.8 lkb BamHI-Hpall 
fragment of HPV-16, but not to the 0.8kb BamHI-Hpall fragment, 
which is colinear with the 1.55kb PstI fragment between map 
coordinates 5375 to 6787 in the prototype genome (Figure 4.27(b)). In 
view of the nucleotide sequence data obtained for these DNA 
fragments, which showed little homology with HPV-16 DNA in this 
region, the lack of hybridisation to the 1.55kb PstI and 0.8kb 
BamHI-Hpall fragments is not surprising. These data suggest that 
viral sequences are conserved in the late region of the HPV-16 
genomes present in tumours C3 and C5, downstream from position 
6787.
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P s t I  H p a l l
(a)
1 .8 k b !  •
Figure 4.27.
(a) Sou thern  blot of BamHI l inear  HPV-16 DNA digested 
with PstI and Hpall and hybridised to labelled C3 PCR 
p ro d uc t  a t  m o d e ra te  str ingency. No hybridisat ion was 
observed to the  0.91kb or 0.64kb BamHI-Pst l  bands,  or 
to the  0.8kb BamHI-Hpall band. Hybridisation occu rred  
to the  1.78kb PstI and 1.81kb BamHI-Hpall f rag m en ts  of 
HPV-16, which are  s i tua ted  3 ’ to the  r ea r ran g e m en t .  The 
re la t ionship  of these  res t r ic t ion  f ragm en ts  is shown in (b). 
PstI and Hpall sites are  shown. F ragm ent  sizes are  listed 
in kilobases. The shaded boxes r ep re se n t  the  hybridising 
regions seen in (a) above.
(b)
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4.6. Culture of Keratinocvtes from Oral Tumour 
Biopsies.
4.6.1. Establishment of Cells in Culture.
One primary culture of cells was established from an oral squamous 
cell carcinoma biopsy (C45). The cells, designated T45, were 
dependent on 3T3 feeder cells for growth, and were cultured in 
medium supplemented with 2% bovine serum, a level at which normal 
keratinocytes would not be expected to grow. A colony of T45 cells is 
shown in Figure 4.28, which exhibit morphology typical of 
keratinocytes in culture.
To verify that the cultured cells were indeed human keratinocytes, 
they were grown on coverslips on 313 feeders for 2 to 3 days, fixed and 
stained with a mouse monoclonal antibody (LP34) to human keratin, 
followed by an enzyme-linked secondary antibody. Figure 4.29 shows 
that the T45 cells stain positively with the LP34 antibody. 3T3 
fibroblasts present adjacent to the keratinocytes remained unstained.
4.6.2. Tumorigenicity of T45 Cells.
T45 cells were injected subcutaneously into athymic mice, with 
appropriate positive and negative control cell lines, firstly at a lower 
cell number (1 x 10  ^ cells per animal) and secondly using a tenfold
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greater number of cells. Tumours were allowed to develop for twelve 
weeks, or until they reached 1cm in diameter.
Injection of T45 cells, even at ten million cells per mouse, never 
produced tumours. SCC25 malignant oral keratinocytes always 
resulted in tumour development after two weeks, even at 1 x 10  ^cells 
per animal, as did A431 epidermoid carcinoma cells. Swiss 3T3 
fibroblasts were consistently negative for tumour formation. This 
suggests that, while the T45 cells were derived from a malignant lesion 
and grow at low serum concentrations, they are not overtly malignant, 
and may require additional events to be capable of tumour production 
in vivo.
4.6.3. HPV Status ofT45 Cells.
Genomic DNA prepared from T45 cells was analysed by PCR using 
the HPV-16 E6 region primers, together with appropriate controls. A 
Southern blot of the PCR products was hybridised to a ^P-labelled 
internal oligonucleotide probe, and Figure 4.30(a) shows that 
HPV-16 DNA can be amplified from the cell line DNA as well as 
from the original tumour biopsy DNA (C45). No viral sequence was 
amplified from negative controls of A431 DNA, calf thymus DNA, or 
from a sample lacking any DNA.
The PCR products shown in Figure 4.30(a) were isolated and 
sequenced using the forward PCR primer as sequencing primer. The 
nucleotide sequences obtained from the HPV-16 control and from 
T45 cell DNA are shown in Figure 4.30(b). No alterations in
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nucleotide sequence were observed in this region of the viral genome, 
suggesting that the E6 ORF is conserved.
Use of the HPV-16 late region PCR primers consistently failed to 
amplify any sequences from the T45 DNA sample, or from the 
original C45 carcinoma DNA. This may reflect rearrangement of the 
viral genome in this region, perhaps to a greater extent than seen in 
samples C3 and C5. Alternatively, the viral DNA could have become 
integrated into the host genome near this site, thus preventing 
amplification of the expected fragment of DNA by PCR.
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Figure 4.28.
Phase  c o n t r a s t  m ic rograph  showing a colony of T45 cells, grown on a 
feeder  layer of l e th a l ly - i r r a d ia te d  Swiss 3T3 fibroblasts. Bar =200um.
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Figure 4.29.
T45 cells s ta ined  with the  LP34 a n t ik e ra t in  monoclonal  antibody 
and an alkaline p h o sp h a ta s e -c o n ju g a te d  secondary  antibody, 
confirming th a t  they  are  a ke ra t inocy te  populat ion.  Bar =100um.
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Figure 4.30.
(a). Sou thern  blot of PCR p roduc ts  amplified from a HPV-16 plasmid 
control ,  T45 cell DNA and carc inom a samples C5 and C45, using the  
16E6 PCR pr imers .  CT=calf thym us  DNA; no DNA=control reac t ion  
m inus  t a rg e t  DNA; A431= DNA from A431 epidermoid ca rc in o m a  cells.
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H P V - 1 6 T45
G A T C  G A T  C
Figure 4.30(b).
Nucleotide sequence  obtained by direct  sequencing of the  HPV-16 contro l  
and T45 PCR p ro du c ts  in (a). No a l te ra t ions  in sequence  were observed.
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5. Discussion.
Cancer of the oral cavity accounts for three to forty percent of all 
human cancer, depending on geographical location. Although the 
incidence of the disease has decreased since the early part of this 
century, morbidity and mortality associated with oral malignancy 
remain considerable.
The aetiology of oral cancer is poorly understood; several agents of 
both chemical and viral origin, together with other predisposing 
factors, are possibly involved in the development of the disease, which 
is almost certainly a multistage process comprising several events over 
many years. Members, of the human papillomavirus group are 
potentially oncogenic, and this study has examined their association 
with oral squamous cell carcinomas and dysplasias, as well as their 
incidence in clinically and histologically normal oral mucosa from 
cancer patients and from a control population free from malignancy.
5.1. Detection of Viral DNA in Oral Biopsies.
Currently, several methods are available for the detection of specific 
DNA sequences within heterogeneous nucleic acid samples. This 
study used Southern blot hybridisation (Southern, 1975) and 
amplification of DNA by polymerase chain reaction using a
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thermostable polymerase (Saiki et al., 1988) in order to detect human 
papillomavirus sequences in normal and malignant oral tissue 
biopsies.
The sensitivities of these techniques differ; using DNA probes 
radiolabelled with and a conventional Southern blot hybridisation 
protocol, it was possible to detect a single copy cellular gene (c-myc) 
in 10/xg restriction enzyme digests of genomic DNA. Thirty picogram 
aliquots of complete HPV genomes (approximately equivalent to one 
copy of an 8kb genome per cell in 10/xg of cellular DNA) could also be 
detected by this method. In samples Cl, C2 and C4 viral DNA present 
in multiple copies was easily visible within several hours of exposure 
to high speed radiographic film.
In contrast, the use of the polymerase chain reaction enables detection 
of DNAs which are present at an apparent frequency of much less 
than one copy per cell. Although HPV-4 DNA was only visible in the 
cancer DNA from sample 4 when conventional Southern blot 
hybridisation was used, viral sequences were clearly present in the 
dysplastic and normal DNA preparations from the same patient when 
a fragment of the HPV-4 sequence was amplified using specific 
oligonucleotide primers, Southern blotted and hybridised to a 
radiolabelled homologous DNA probe. Other cancer DNA samples, 
previously negative for viral DNA by Southern blot hybridisation, 
were also shown to contain HPV-16 and HPV-18 sequences by this 
method.
The presence of viral DNA at less than one copy per diploid genome 
arises because of the nature of the samples being analysed. If the study
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had utilised clonal cell populations one would expect HPV sequences 
to be present in all cells or in none, dependant on whether or not the 
original cell from which the clone was derived contained viral DNA. 
That is, the minimum viral copy number in an HPV-positive clone 
would be one HPV genome per cell. However when dealing with 
tissue biopsies the population is naturally heterogeneous. Malignant 
keratinocytes may be contaminated with normal cells or with 
underlying fibroblasts, muscle cells and inflammatory cells, and it is 
virtually impossible to prevent this completely, although as much care 
as possible was taken when sampling resected material^ to separate 
normal and malignant epithelia from each other and from other tissue 
types. As a result, DNA prepared from carcinoma biopsies probably 
contained some contaminating normal DNA, providing the first 
dilution factor.
A second and probably more significant factor is involved in reducing 
the overall level of viral sequences found in biopsy DNAs. From 
previous studies of benign and malignant HPV-associated oral disease 
using in situ hybridisation of HPV probes on histological sections 
(Adler-Storthz et al., 1986a,b; Syrjanen et a l , 1986; Milde and Loning,
1986) it is clear that not all cells in a lesion contain viral DNA. On the 
contrary, cells harbouring HPV DNA tend to be found clustered 
together throughout the epithelium. Furthermore, some HPV-positive 
cells contain greater or lesser amounts of viral DNA than others. A  
similar type of distribution of viral DNA is also seen in cervical 
epithelia infected with human papillomavirus types (Wells et al.,
1987). However the in situ technique is limiting in its sensitivity; the 
lower limit of detection is around five to twenty copies of HPV 
sequence per cell and, while of much use where there is a productive
1 6 1
viral infection, in view of the results obtained here would not have 
been a viable alternative method of detecting papillomavirus genomes 
in oral samples.
Primary cell cultures derived from oral squamous cell carcinomas also 
appear to harbour viral sequences in less than one hundred percent of 
cells, as seen in the T45 culture in this study and in those derived by 
other workers (Maitland et a l, 1989). Interestingly, these authors 
describe the possible selection against cells containing HPV DNA 
with passaging in tissue culture. This may reflect an early role for 
papillomaviruses in cell transformation, with cellular genes taking 
over the maintenance of the transformed phenotype, as is seen in 
BPV-4-induced transformation of bovine epithelium (Campo et al,
1985) and C127 fibroblasts in culture (Smith and Campo, 1988), and 
viral sequences being no longer required.
Amplification of specific short regions of HPV DNA in the 
polymerase chain reaction is extremely useful for detection of low 
amounts of viral nucleic acids in a background of uninfected cells 
(Maitland et al, 1989). However the problem of contamination of 
samples with viral DNA from external sources is not inconsiderable, in 
view of the sensitive nature of the assay. Such sources include cloned 
HPV plasmids present in the laboratory, products of previous 
amplification reactions and, probably to a lesser extent in this case, 
contamination from the operator.
Potential contamination was successfully overcome in this study by 
several means. Firstly, a facemask and disposable gloves were 
routinely worn; gloves were changed frequently. A separate set of
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automatic pipetting devices was used for setting up PCR samples, 
distinct from those used for other manipulations in the laboratory, in 
case these had become contaminated by aerosols. The problem of 
aerosol-mediated contamination was further reduced by using only 
positive displacement pipettes, which expel the solution from the 
pipette tip by means of a piston in contact with the solution. 
Additionally, microfuge tubes containing reactants which had been 
incubated at 95°C to denature the DNA template were centrifuged 
briefly to remove traces of solution from the undersurface of the tube 
cap, before careful opening to avoid splashing of contents. Completed 
reactions were similarly treated.
Where possible, the use of cloned DNA as a positive control was 
avoided, HPV-containing cell lines (such as SiHa and HeLa) being 
preferred. When HPV plasmids were used, only femtogram amounts 
were added to the reaction mixture, which was set up separately from 
the case samples. Negative controls were also included for each set of 
reactions performed. These included 1/xg aliquots of commercially- 
available calf thymus or salmon sperm DNA, as well as a tube which 
contained each component of the reaction mix except template DNA. 
This was routinely pipetted last, in order to control for the possibility 
of contamination during the setup procedure. ( target sequences 
consistently failed to be amplified from such negative controls, as 
would be expected.
Spatial separation of polymerase chain reaction components from the 
products of amplification reactions was also ensured in this study. 
Although a second room was not used for analysis of PCR products, 
gel samples were prepared, loaded and isolated on a separate bench,
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distant from that used to prepare reaction mixtures. The combination 
of all these points led to successful avoidance of sample contamination 
in all experiments involving PCR amplification of HPV sequences.
In order to confirm that HPV sequences detected in some samples 
were not due to the presence of small amounts of HPV plasmids, a 
second amplification was performed on each using anticontamination 
primers situated on either side of the cloning site of the original 
plasmid, BamHI for HPV-16 and EcoRI in the case of HPV-18. 
This resulted in amplification of a short product (170bp) from all 
samples which had previously been shown to contain HPV-18 DNA 
using the E6 region PCR primers. If the E6 region product had been 
due to the presence of contaminating HPV plasmid, the 170bp band 
would not have been amplified. Instead, one would have expected to 
see a band of 4535bp, reflecting the length of the viral sequence plus 
the intervening pBR322 sequence.
However, the use of the anticontamination primers described above 
have several disadvantages. Firstly, as the length of the amplified 
fragment is increased, the efficiency of amplification appears to be 
reduced. The lower limit of detection of a 4.5 kb HPV-plasmid hybrid 
sequence was reached when attempting to amplify from cloned HPV 
DNA present at lOpg in a 100/zl reaction. Taq polymerase is able to 
synthesise new DNA strands at a rate of 2000-4000 bases per minute. 
Although an extension time of five minutes should have been more 
than adequate to synthesise a DNA strand of this length, it is probable 
that the lack of amplification resulted from inadequate processivity of 
the enzyme during the early stages of the reaction, failing to provide 
sufficient new DNA template for priming in subsequent cycles. In
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retrospect, the use of one primer within the HPV sequence and a 
second within the plasmid would have been a more sensible 
combination, and would have resulted in easy and efficient 
amplification of any available HPV-plasmid target sequence present 
in the samples. To facilitate design of a primer within the plasmid 
sequence, the orientation of the cloned HPV would need to be known.
Another disadvantage of the HPV-16 anticontamination primers 
employed in this study arises because of their location within the viral 
genome. Both were situated within the LI open reading frame, a 
region which is frequently lost in cervical carcinomas during 
integration into the host genome (Wilczynski et a l , 1988) and which 
other workers have previously failed to amplify from oral tissues 
(Maitland et a l , 1989), possibly due to a variation in nucleotide 
sequence in this area compared to the prototype HPV-16 DNA. The 
hybridisation pattern seen on the Southern blot of sample C2, the 
reduced size of the PCR products from C3 and C5, and the variant 
sequences of the latter suggests that this was also a problem in the 
current study. It is highly likely that the lack of the expected 152bp 
HPV-16 band in samples previously shown to be positive for 
HPV-16 sequences using the E6 and E7 region PCR primers was due 
to the failure of the late region oligonucleotides to anneal to their 
intended target sequences due to absence or rearrangement. The use 
of a set of primers spanning the virus-plasmid junction, as described 
above, would have resulted in amplification of a short PCR product in 
the case of plasmid contamination, or no product in samples where 
the HPV-16 DNA had integrated or showed sequence divergence of 
the late region of the genome.
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5.2. Frequency of HPV Sequences in Oral Tissues.
Southern blot analysis of DNA from oral squamous cell carcinoma 
biopsies revealed a low level of HPV DNA (7.7%), with three 
carcinomas out of a total of thirty nine found to harbour the DNA of 
HPV-18, HPV-16 and HPV-4. Compared to some previous reports 
(Maitland et a l , 1987; Chang et a l , 1989), which described viral DNA 
in 46% and 76% of oral cancers respectively using a similar screening 
procedure, the incidence of HPV DNA as detected by Southern blot 
hybridisation in this study was much reduced. The reason for this 
difference is unclear; it is possible that the prevalence of 
papillomaviruses varies between the different geographical regions 
from which the sample populations were derived, and that patients are 
infected to a different degree.
When the PCR method of screening was employed, however, the 
frequency of papillomavirus DNA found in carcinoma DNA samples 
in this study increased to 48.7% (nineteen out of thirty nine samples). 
This may reflect an overall lower level of infection in the population 
studied here compared to those analysed by other workers. 
Alternatively, it may be a consequence of different procedures for 
sampling tissues by different groups, with HPV-containing cells 
diluted to a degree by the presence of uninfected cells.
In the three samples positive for papillomavirus sequences by 
Southern blot hybridisation, no viral DNA was detected in dysplastic
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or normal tissues adjacent to the carcinomas by this method. 
Amplification of viral DNA in the polymerase chain reaction coupled 
with Southern blotting and hybridisation proved to be a more sensitive 
method of detecting viral nucleic acids in biopsy samples, as described 
in the previous section. This enabled the demonstration of HPV DNA 
in the non-malignant tissues adjacent to the HPV positive cancers, 
present at a greatly reduced level compared to the corresponding 
carcinomas. Furthermore, the same type of viral DNA was present in 
carcinomas, dysplasias and normals in all three cases. No evidence of 
multiple papillomavirus infection was observed in any of the samples 
studied. It is unclear why this should be so. One could argue that 
increased levels of viral DNA might be directly responsible for the 
transition of normal epithelium to a malignant state. Increased viral 
copy number, perhaps resulting in higher overall levels of the 
HPV-16 and HPV-18 oncoproteins might be one way of forcing 
previously initiated epithelial cells towards malignancy. Although the 
E6 and E7 gene products of cervical isolates of HPV-16 are 
recognised as performing immortalising functions (Hawley-Nelson et 
a l , 1989; Bedell et a l , 1989), HPV-16 DNA is also capable of 
inducing malignant transformation of previously immortalised cell 
lines such as NIH3T3 (Yasumoto et a l , 1986). However this does not 
explain why the remaining sixteen HPV-positive carcinomas were 
found to harbour viral sequences at low levels, similar to those found 
in the corresponding dysplastic and normal biopsies.
Using this approach to rescreen the available material forty eight 
percent of samples from cancer patients were found to harbour 
papillomavirus sequences, a similar overall incidence to that reported 
by Maitland et al (1987). However these authors found only HPV-16
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DNA, whereas in this study the prevalence of HPV-16 was only 
marginally greater than that of HPV-18 DNA (26% and 20.5% 
respectively), with HPV-4 sequences being an isolated finding. Other 
workers in the USA have found HPV-18 DNA more frequently than 
HPV-16 in oral cancers (K. Storthz, personal communication).
In all cases, except for two containing HPV-18 DNA, viral sequences 
were detected in cellular DNA from both normal and malignant 
samples, and in DNA prepared from associated lymph nodes (present 
in three cases). This is the first study to examine the distribution of 
HPV DNA in tissues adjacent to oral carcinomas, and strongly 
suggests that not only carcinoma cells harbour viral nucleic acids. It is 
possible that, due to the sensitivity of the PCR technique, a small 
amount of contamination of normal cells may have resulted from the 
nearby carcinoma. However there is no reason to suspect that the 
tissues adjacent to HPV-infected carcinoma cells should be free from 
viral sequences, as several reports have documented HPV DNA in 
normal genital and oral mucosa (MacNab et a l , 1986; Maitland et a l ,
1987). From the data presented here, it is likely that equivalent 
amounts of papillomavirus DNA were present in normal and 
malignant oral epithelium in the majority of cases in the present study, 
as viral sequences were amplified to the same degree from both tissue 
types and no viral sequences were detected in either by conventional 
Southern blotting.
An accurate estimation of copy number and comparative levels of 
HPV infection between normal and malignant tissues could be 
achieved by using a co-amplification strategy, such as that described 
by Frye et al (1989). A standard PCR protocol using HPV primers
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together with a pair of primers for a single copy cellular gene would 
control for unequal levels of amplification between samples, thus 
allowing a meaningful comparison to be made.
The majority of investigations of papillomaviruses in human cancers 
have concentrated on the association of the so-called oncogenic 
genital viruses, mainly HPV-16 and HPV-18, with squamous cell 
carcinoma of the uterine cervix. The frequency of HPV infection in 
human genital cancers is high. Around 90% of biopsies from such 
lesions harbour HPV sequences (reviewed by zur Hausen, 1988); 50% 
contain HPV-16 DNA, 20% contain HPV-18 DNA and a further 
20% other HPV types. Compared to this, the frequency of 
papillomavirus infection in oral carcinomas is low, according to the 
data available thus far.
One explanation for this is that new HPV types exist in oral 
epithelium, which either do not cross-hybridise to the probes which 
are currently available, or are present at such low levels that they are 
outwith the detection limits of Southern blot hybridisation. This may 
indeed be so, if consideration is given to the amounts of HPV DNA 
found in this study. If polymerase chain reaction technology is 
required to render oral HPV infections detectable, then this will 
present a problem for the isolation of new virus types, unless there is 
some degree of redundancy of oligonucleotides primers used which 
could then anneal to a region of the new HPV sequence. PCR primers 
with several base mismatches have been used by other workers to 
amplify several different HPV types (Snijders et al, 1990). If regions 
of the genome showing high degrees of homology between 
papillomavirus types were used as amplification targets, together with
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a reduced stringency of primer annealing, the PCR could be a useful 
tool for isolation of novel HPV types present at low abundance in oral 
and other tissues.
Another possibility which might account for the different frequencies 
of HPV DNA in cervical and oral epithelia is that the viral DNA has a 
different role to play at each site. In cervical carcinoma biopsies and 
cell lines studied to date, continued transcription of the E6 and E7 
ORFs has been shown to occur (Yee et a l , 1985; Schwarz et a l , 1985; 
Schneider-Gadicke and Schwarz, 1986). This is entirely consistent with 
the in vitro evidence, which demonstrates that the E6 and E7 gene 
products of HPV-16 and HPV-18 are competent in the 
transformation of primary cells together with a second oncogene 
(Storey et a l , 1988; Barbosa and Schlegel, 1989), and that continued 
expression of the E7 ORF is required for maintenance of the 
transformed state of these cells (Crook et a l , 1989b). In contrast, no 
data have been published so far on the expression of these viral gene 
products in either oral carcinoma biopsies or cell lines. If E6-E7 
expression does not occur in oral carcinomas, one might be tempted to 
speculate that the virus acts during the earlier stages of malignant 
progression, perhaps switching on a cellular target sequence or acting 
as an insertional mutagen.
Continued presence and expression of papillomavirus transforming 
genes may not be necessary for oral keratinocytes to retain their 
malignant phenotype, as seems to be the case in the HPV model of 
cervical carcinogenesis. Other in vitro systems have been described 
where papillomavirus DNA has been shown to transform cells in 
culture where, in spite of the loss of viral sequences with passaging of
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the cells, the transformed phenotype is maintained. Transfection of 
C127 mouse fibroblasts with the DNA of HPV-6b produced 
transformed cells which, after several passages, exhibited 
tumorigenicity in vivo (Morgan et a l , 1990). These cells contained 
little or no viral DNA, suggesting that the transformed phenotype did 
not require the continued presence of HPV-6b sequences. To 
exclude the possibility that viral sequences were suppressing 
tumorigenicity, these authors also demonstrated that the transformed 
nature of the cells was maintained even when virus-containing cells 
were selected for. This strongly suggests that, firstly, HPV-6b DNA 
has transforming activity and, secondly, it acts as an initiator of 
transformation in these cells, after which it is no longer required. 
Maintenance functions might then be attributable to activity of 
specific cellular genes which had perhaps been subject to cis- or trans- 
activation by the papillomavirus DNA. However, Morgan and 
coworkers (1990) were unable to detect any increase in the 
transcriptional activity of a variety of cellular oncogenes, or any 
transforming mutations of ras oncogenes.
A similar situation has also been shown to exist where C127 
fibroblasts are transfected with BPV-4 DNA (Smith and Campo,
1988). After several passages viral DNA is lost from the vast majority 
of cells, although they remain transformed. This mirrors the situation 
in vivo, where BPV-4 DNA can be isolated from benign neoplasms of 
the upper alimentary canal of cattle, but is rarely present in malignant 
tumours (Campo et al, 1985). Furthermore, in the in vitro situation, it 
has been demonstrated that the introduction of viral DNA results in 
amplification of specific cellular sequences, which in subsequent
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transfection experiments are capable of inducing cell transformation 
(Smith and Campo, 1989).
It is therefore clear that papillomaviruses are capable of inducing 
cellular transformation by more than one means, dependant on the 
type of virus involved and the nature of the target cell. Thus HPV 
DNA might not be required to be present in transformed oral 
keratinocytes for the malignant phenotype to be maintained. This 
would help to account for the differing incidence of HPV DNA in oral 
and cervical squamous cell carcinomas reported to date.
The possibility exists, however, that the presence of HPV DNA in oral 
cancer tissues is unrelated to the development of malignancy. 
Chemical carcinogens alone might be capable of initiation of oral 
epithelium and, subsequently, tumour promotion, or they could act 
together with other environmental or genetic factors (such as allelic 
deletion of a tumour suppressor gene). Papillomavirus infection might 
then be secondary to tumour development, with the virus taking 
advantage of an impaired host immune system to opportunistically 
infect the oral mucosa. Papillomavirus infection is a well-recognised 
feature of several diseases where there is a defect of host immunity. 
Patients suffering from epidermodysplasia verruciformis become 
infected with a variety of HPV types, some of which are associated 
with malignant progression of skin warts to frank carcinomas at sites 
exposed to UV radiation. Renal transplant recipients who are 
chemically immunosuppressed also frequently develop skin warts, and 
HIV infection predisposes sufferers to HPV-associated disease, 
frequently in the oral cavity (Greenspan et a l , 1988). Such infections 
may be the result of a defective cell-mediated host immune response
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where cells infected with virus (or indeed transformed) are unable to 
be recognised as foreign, thus escaping the normal immune 
surveillance mechanism.
Alteration of immunological recognition mechanisms as a result of 
HLA class I gene rearrangements has previously been shown to occur 
in several human tumours (Bar-Eli et a l, 1988; Natali et a l , 1989; 
Lopez-Nevot et a l, 1989), and although no data are available at 
present regarding HLA gene loss or altered expression in oral cancers, 
this work is currently being carried out. It would be interesting to 
compare host immune status in papillomavirus-positive and negative 
oral carcinomas. This may give an indication of whether HPV 
infection is likely to be involved in malignant transformation of oral 
epithelial cells, or is merely an opportunistic infection secondary to 
tumour development.
A further reason why papillomavirus DNA has not been reported in 
one hundred per cent of oral cancers might be that the oral cavity is 
serving solely as a reservoir for these viruses, which are not involved in 
development of malignancy but are able to infect epithelial cells at 
other body sites. This might explain why similar HPV types are found 
in both the oral cavity and the genital tract, with transmission between 
the two sites occurring during oro-genital contact. If the frequency of 
papillomavirus infection was the same in both normal and malignant 
oral epithelium, as reported by Maitland et al (1987), it would be 
tempting to speculate that the oral cavity was merely acting as a 
reservoir for HPVs. However the incidence of papillomavirus DNA in 
normal mucosa from cancer-free individuals in this study was much 
lower than that found in either frank cancers or in clinically normal
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tissues from cancer patients (eight per cent compared to forty nine per 
cent) and does not support this hypothesis.
5.3. HPV-18 DNA in Oral Samples.
Southern blot analysis revealed HPV-18 DNA to be present in one 
oral carcinoma at high copy number, not an unexpected finding in 
view of its potential oncogenicity, its association with cancers at other 
sites and its propensity to infect the epithelium of mucous membranes, 
similar to HPV-16. When the polymerase chain reaction was used to 
increase the sensitivity of detection, HPV-18 DNA was found to be 
present in around twenty per cent of oral cancer biopsies and adjacent 
normal tissues from patients in this study; this is a similar incidence to 
that quoted previously for HPV-18 in cervical carcinomas (zur 
Hausen, 1988). This suggests that HPV-18 may be involved to an 
equal extent in both oral and cervical carcinogenesis, although one 
can not rule out the possibility of the oral cavity acting as a reservoir 
of HPVs.
The HPV-18 detected in carcinoma Cl showed aberrant restriction 
digestion patterns for both PstI and Hpall, but in the form of 
additional sites for these enzymes in the E l ORF instead of absence 
of restriction fragments as was the case for HPV-16 DNA described 
above. A different polymorphism of PstI restriction sites of HPV-18 
DNA in genital lesions in the west of Scotland has been reported by 
other workers (Millan et a l , 1986), suggesting that a degree of 
heterogeneity of this viral type exists in the area. HPV-18 DNA has 
only been described in association with oral malignancy in one
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previous study (Syrjanen et al, 1988). In that case, though, detection 
was by in situ hybridisation and therefore no detail of restriction 
digestion patterns was available.
An interesting finding was the detection of HPV-18 DNA in two 
samples of normal oral epithelium from cancer-free individuals. 
Maitland and co-workers (1987) previously reported HPV-16 DNA 
in biopsies of normal oral tissues, but this is the first demonstration of 
HPV-18 in a similar situation. Overall, this study found a much lower 
level of papillomavirus DNA in normal oral epithelium (8% of 
samples) than these authors (42%), probably reflecting different levels 
of exposure of each population to HPV infection, as discussed 
previously. The type of viral DNA found also differs between these 
two studies; exclusively HPV-16 DNA was detected in the south of 
England population, whereas this study found only HPV-18 
sequences. This result reflects the viral types found in oral carcinomas 
in both studies, and mirrors the incidence of HPV-16 and HPV-18 
DNA in cervical lesions in different parts of the UK (Millan et al,
1986).
The significance of finding HPV-18 DNA in histologically normal 
oral mucosa obtained from cancer-free subjects in at present unclear. 
This may represent a latent infection of oral mucosa with this viral 
type, with the viral life cycle being suppressed by normal cellular 
control mechanisms. In a recent study on control of HPV-16 gene 
expression in cultured human foreskin or cervical epithelial cells 
immortalised with HPV-16, Woodworth et al (1990) demonstrated 
that transcription of early viral genes was modulated by the action of 
the growth factors TGF-/31 and 2, although cell growth was not
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reduced. This may be a means by which the host is able to down- 
regulate the transforming genes of papillomaviruses in normal, non­
transformed keratinocytes.
Alternatively, the cells containing viral DNA may be initiated while 
still exhibiting a normal phenotype. These may remain dormant for a 
considerable time, during which they might be subject to the action of 
other carcinogenic agents, such as several constituents of tobacco 
smoke, eventually resulting in a fully malignant phenotype.
In order to compare oral isolates of HPV-18 with the original genital 
isolate, nucleotide sequencing of HPV-18 E6 PCR products 
amplified from one carcinoma and two normal samples was carried 
out. This did not reveal any alterations in base composition over the 
region of DNA amplified from oral tissues which was sequenced 
compared to that of wild-type HPV-18. This is not surprising, 
considering that the E6 and E7 ORFs are retained intact in cervical 
carcinoma tissues and cell lines (Seedorf et a l , 1987; Smotkin and 
Wettstein, 1987) and are required for viral transformation functions in 
vitro (Bedell et al, 1989). In view of the altered restriction pattern of 
the HPV-18 DNA in carcinoma Cl, it would be interesting to amplify 
and sequence the E l ORFs of these oral isolates to discover if there is 
a consistent difference in nucleotide sequence resulting in the creation 
of additional restriction sites in this region, and allowing identification 
of a specific geographical variant.
Transformation of cells by HPV-18 DNA has been shown to occur 
with around a ten-fold higher efficiency than transformation by 
HPV-16 DNA (Barbosa and Schlegel, 1989). This difference has now
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been mapped to the viral LCR-E6-E7 region (Villa and Schlegel, 
1991), who also demonstrated that the difference was consistent 
between separate isolates of HPV-18 and HPV-16 from cervical, 
vulvar and penile epithelium. Thus it is likely that similar differences 
in transformation efficiency between virus types will be inherent in 
HPV-18 and HPV-16 isolated from oral epithelium. As Villa and 
Schlegel (1991) rightly note, the presence of HPV-18 DNA rather 
than HPV-16 sequences in carcinomas may give more cause for 
concern, in view of the former viral type being associated with a more 
aggressive tumour phenotype. Comparison of survival rates for oral 
cancer patients with HPV-18 and HPV-16 positive lesions might 
help to substantiate this theory.
Foreskin keratinocytes immortalised in vitro by HPV-18 DNA have 
recently been shown to progress to a fully malignant phenotype with 
continued passaging in culture (Hurlin et al., 1991). No alteration in 
expression of E6 or E7 genes was noted in tumorigenic compared with 
non-tumorigenic cells; however a deletion of a region of the long arm 
of chromosome 5 was consistently noted. It is likely that this 
chromosome encodes a tumour suppressor element, in view of the 
finding that complementation of colon carcinoma cells with a normal 
chromosome 5 results in loss of tumorigenic activity (Tanaka et a l, 
1991). Thus the initial step in HPV-18-induced oral or cervical 
epithelial carcinogenesis might involve the E6 and E7 oncoproteins 
acting on cellular p53 and p l0 5 ^ , with additional genetic events 
further reducing cellular control.
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5.4. HPV-4 DNA in Oral Lesions.
An unusual finding was the presence of HPV-4 DNA in one oral 
cancer sample (C4). This viral type was originally isolated from a 
benign skin lesion (Heilman et a l, 1980) and is not generally 
considered to have a high oncogenic potential or to be associated with 
mucosal epithelium. Although one previous study has described 
HPV-4 DNA in benign oral warts (Adler-Storthz et a l, 1986a), the 
present work is the first demonstration of this viral type in a malignant 
lesion at any site. In order to facilitate comparison of the oral isolate 
of HPV-4 with the prototype from epidermis, viral DNA was 
molecularly cloned from cancer C4. Two inserts positive for HPV-4 
sequences were obtained; the 8kb insert co-electrophoresed with the 
prototype HPV-4 DNA and represents the full-length viral genome. 
Comparative restriction enzymes analysis of both viral DNAs revealed 
no differences between the two isolates at this level, but nucleotide 
changes which do not create or delete a restriction site for one of the 
enzymes used would not be apparent.
Further analysis by sequencing a region of both HPV-4 clones again 
failed to show any differences over the three hundred and eighty 
nucleotides sequenced. Again, this does not prove identity between 
the clones; it is possible that the sequenced region is one of functional 
significance, and is therefore conserved. Homology comparison of the 
available HPV-4 sequence with those of other papillomaviruses 
revealed only poor homology with the HPV genomes sequenced to 
date at the nucleotide level. This reflects and confirms the isolated
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position of HPV-4 in the phylogenetic tree of papillomaviruses 
(Pfister, 1984).
Using the TRANSLATE programme contained in the UWGCG 
sequence analysis software package, a region coding for a putative 
protein greater than seventy seven amino acids in length was 
identified, starting upsteam to nucleotide 1 of the sequence and 
reading through to a TAA termination codon at nt 232-234. Protein 
homology comparison of the potential coding region was performed 
with the previously identified proteins of HPV-6b, HPV-16 and 
HPV-18 using the programme BESTFIT. From the data obtained, it 
is likely that the region sequenced is the 3’ portion of the HPV-4 E2 
ORF. Further sequencing and homology comparison will confirm this.
To exclude the possibility that the region sequenced was the LCR, the 
nucleotide sequence was searched for potential regulatory elements 
present in other papillomavirus control regions. Using BESTFIT, no 
binding sites were identified for the papillomavirus E2 protein, the 
API complex, or NF1. In view of the lack of regulatory sites and the 
potential to code for a protein, it is unlikely that the region of HPV-4 
sequence obtained is the LCR.
From the limited restriction analysis carried out on the shorter 6kb 
fragment, cloned at the same time as the full-length HPV-4, it 
would appear that approximately 2kb of sequence upstream of the 
BamHI site of the prototype virus (Heilman et a l , 1980) is absent. 
Nucleotide sequencing of a region of the 6kb DNA 3’ to the cloning 
site using the same sequencing primer as for the 8kb DNA revealed 
identity with the previously obtained sequences of both full-length
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HPV-4 genomes over the 150 bases sequenced. It is likely that this 
shorter clone is an artefact of the cloning procedure, either by the 
creation of an additional BamHI site internally in the HPV-4 
molecule or by an illegitimate recombination between vector and viral 
sequences. The possibility exists that the 6kb fragment represents a 
second HPV-4 genome present in the cancer and which harboured 
an internal deletion, or one containing an additional BamHI site. This 
is unlikely as there was no evidence of a second HPV-4 genome in 
the carcinoma from which the clone was derived by Southern blot 
analysis, although it might have been present at a very low level 
undetectable by this method. Comparison of the complete nucleotide 
sequences of the 8.0kb and 6.0kb DNAs would resolve this point.
The HPV-4 DNAs described above may be worthy of a more 
detailed analysis than was performed here, such as co-transformation 
experiments similar to those carried out for HPV-6, 11, 16 and 18 
(Storey et a l , 1988; Storey et a l , 1990). The DNAs of HPV-6 and 
HPV-11, commonly found in benign genital mucosal lesions, have 
low transformation efficiencies in vitro (Storey et a l , 1990) when used 
in a co-transformation assays together with an activated Ha-ras 
oncogene, but the cells transformed by these viral DNAs are 
extremely tumorigenic when transplanted into immunocompetent 
animals. These authors, were also able to show that the ability of 
HPV-11 DNA to transactivate a viral promoter was similar to that of 
HPV-16 DNA. If HPV-4 possessed similar transactivating potential, 
it might be able to upregulate transcription of other cellular genes 
involved in growth regulation.
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To strengthen the case for a transforming role for HPV-4 in the oral 
carcinoma described in this study, other reports exist of papillomavirus 
genomes generally associated with benign lesions being isolated from 
frank cancers in vivo. HPV-6vc and HPV-6b DNA have been cloned 
from invasive vulvar carcinomas (Rando et al., 1986; Kasher and 
Roman, 1988) and shown to harbour nucleotide sequence alterations 
in the viral LCR. It is feasible that HPV-4 DNA may have a similarly 
low efficiency of transformation of primary cells, and analysis of the 
viral DNA function in a co-transformation assay would confirm or 
deny this. Additionally, nucleotide sequence comparison of the LCRs 
of the prototype HPV-4 DNA, isolated from a benign lesion, and the 
oral virus described here might reveal some rearrangement or 
enhanced activity which could have a bearing on the transforming 
potential of HPV-4 and help to explain its presence in a malignant 
oral tumour.
5.5. HPV-16 Sequences in Oral Tissue Biopsies.
One cancer positive for viral sequences by Southern blot analysis 
contained the DNA of HPV-16, frequently found to be associated 
with genital carcinomas (Durst et al., 1983) and cell lines derived from 
such lesions (Yee et al., 1985), and capable of transforming primary 
cells in vitro together with co-factors (Storey et al., 1988). The 
presence of this viral type in oral carcinomas in the current series was 
not surprising, in view of the oncogenic potential of HPV-16 and the 
similarity of oral and genital mucosa. Indeed, of the 46% of oral
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cancers found to contain viral DNA by Maitland et al (1987), 
HPV-16 sequences were found exclusively. This was also the case in 
the study of Chang and co-workers (1989), and de Villiers et al 
(1985) found HPV-16 DNA in two out of three tongue carcinomas.
One of these groups (Maitland et a l , 1987) reported that the HPV-16 
sequences present in oral carcinoma DNAs differed from the 
prototype genital isolate in the PstI digestion pattern, with the 
expected 1.55kb ’C’ fragment being absent. The PstI digestion pattern 
of the HPV-16 DNA detected in this study showed a similar feature, 
and digestion with a second restriction enzyme confirmed that a 
deletion or rearrangement event had occurred in the oral variant virus 
compared to the original HPV-16. As this alteration in viral DNA 
structure involves the late region open reading frames (which encode 
the viral capsid proteins) it is debatable whether this variant of 
HPV-16 would be able to complete the viral life cycle and form 
progeny virus, if indeed a large proportion of the L2 and LI genes 
were lost. Alternatively, new sequences might be present which lack 
any cross-reactivity with the genital viral DNA, thus remaining 
undetectable with the probe used.
When the PCR data are taken into account, the overall incidence of 
HPV-16 DNA in oral cancers in this study is approximately half that 
reported for similar lesions of genital mucosa (zur Hausen, 1988). This 
most likely reflects a geographic variation in the incidence of 
HPV-16 as discussed previously, as other workers studying oral 
tissues have reported up to seventy six per cent of oral carcinomas to 
harbour HPV-16 sequences (Chang et a l , 1989). Other as yet 
unidentified HPVs may be present in the remaining negative samples
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in this study. It could, however, be a reflection of different 
mechanisms of HPV-16-mediated transformation at these sites. In 
the majority of cervical carcinoma tissues and cell lines analysed so 
far, the viral genome becomes integrated into the host chromosomal 
DNA to a greater or lesser extent, compared to largely episomal HPV 
DNA in normal and premalignant cervical epithelium (Fuchs et a l ,
1988). Furthermore, the viral DNA was shown to persist in lymph 
node metastases derived from the primary tumours. This is consistent 
with data obtained from in vitro transformation experiments using 
prototype HPV-16 cloned from a cervical carcinoma, where 
continued expression of the E7 protein was found to be necessary for 
maintenance of the transformed state of the cells (Crook et a l , 1989a). 
In contrast, the level of viral DNA detected in nine of the ten oral 
cancers positive for HPV-16 in this study is more consistent with the 
maintenance role being assumed by cellular genes rather than 
papillomavirus proteins. It may be another example of a 
"hit-and-run" mechanism for viral transformation of cells, similar to 
that observed with BPV-4 in bovine alimentary tract epithelium 
(Campo et a l , 1985) and C127 fibroblasts (Smith and Campo, 1988), 
or HSV-2 in cervical carcinomas (reviewed by Galloway and 
McDougall, 1984). Further evidence for this might be gained by 
studying papillomavirus presence and expression in premalignant oral 
lesions such as some leukoplakias, erythroplakias and 
carcinomas-in-situ.
The lack of the prototype PstI ’C’ fragment from the HPV-16 
genome found in sample C2 by Southern blot analysis was interesting, 
if not totally unexpected; a similar phenomenon has previously been 
documented in oral samples containing HPV-16 DNA (Maitland et
183
al, 1987). Hpall digestion confirmed that the L2-L1 region of this 
viral genome was altered in some way, as only the 3’ 0.8kb of the 
expected 2.6kb Hpall fragment could be detected by hybridisation to a 
prototype HPV-16 probe.
Although no DNA from this sample remained from which to clone the 
viral DNA, a PCR-based strategy using HPV-16 oligonucleotide 
primers situated on either side of the putative deletion or 
rearrangement enabled detection of aberrant sized amplification 
products in two further samples, C3 and C5, which had been shown to 
contain HPV-16 early region sequences by PCR. In both cases the 
amplified fragment was shorter than that amplified from a control of 
religated HPV-16 DNA by approximately 0.8kb. It is unlikely that 
these amplification products are artefacts of the polymerase chain 
reaction caused by random priming by the oligonucleotides in the 
cellular DNA, as the amplification was specific for these two samples, 
was not detected in the DNAs of other samples, and was reproducible.
Use of these amplified fragments as hybridisation probes revealed 
hybridisation with specific regions of the prototype HPV-16 genome 
at high stringency, namely the 1.78kb PstI fragment, which is situated 
3’ to the 1.55kb fragment absent in sample Cl, and the 1.81kb 
BamHI-Hpall band, which runs from position 6150 to 57 of the 
HPV-16 genome and encompasses the 3’ end of the 1.55kb PstI 
fragment. Experiments performed at reduced stringency did not reveal 
additional hybridising bands; attempts to map the hybridising regions 
more finely by probing the 2.6kb Hpall band after more extensive 
restriction enzyme digestion did not provide any further information. 
These data suggest that the 5’ oligonucleotide primer was situated
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close to the area of rearrangement, otherwise hybridisation to the 
0.48kb band would have been observed on Southern blot analysis.
Probing Southern blots of restriction enzyme digested cellular DNAs 
from a variety of oral samples, both normal and malignant, resulted in 
hybridisation to the whole smear of genomic DNA, No reduction in 
intensity of signal was observed when the blots were washed at high 
stringency, and this data suggests that the fragments amplified using 
the HPV-specific primers were hybridising to some highly repetitive 
sequences present in the human genome.
Limited DNA sequence analysis was carried out on the l.Okb PCR 
fragments amplified from C3 and C5. Comparison of the sequences 
with the HPV-16 genome showed poor homology with different areas 
of the L2-L1 region of the viral genome; however if both fragments 
were sequenced completely perhaps more homology to HPV 
sequences would be observed. Unfortunately, technical problems 
prevented this work from being accomplished.
Hybridisation of the amplified fragments from C3 and C5 to both 
papillomavirus and cellular sequences implies that at least one 
recombination event has occurred between viral and host DNA in 
these two carcinomas. However, if the viral episome had become 
integrated into the cellular genome by opening within the region 
spanned by the two primers and then recombining, amplification of 
DNA using the 16La/b primers would not have been possible. For 
PCR amplification to occur following such a scenario, the viral DNA 
would have to excise from the host DNA and religate, thus involving
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two recombination events. The excision of HPV sequences would be 
imprecise, removing some cellular DNA at the same time.
Alternatively, a form of "crossing over" of viral and cellular sequences 
may have occurred, without the actual integration of HPV DNA into 
the host genome. It is possible that such a recombination might form 
the first step of a sequence of events by which the episomal HPV 
genome integrates into the cellular DNA. A primary illegitimate 
recombination would result in incorporation of cellular sequences into 
the viral episome. If these sequences were highly repeated in the 
human genome, or contained specific sequence motifs or recognition 
sequences, a subsequent recombination resulting in integration of the 
viral DNA might occur more readily.
Recombination of DNA tumour virus genomes with host DNA 
sequences has been previously reported. Defective variants of SV40 
have been isolated (Wakamiya et a l , 1979; McCutchan et a l , 1979), 
two of which harboured deletions of regions of the wild-type SV40 
genome adjacent to the sites of recombination with cellular sequences, 
inversions within the remaining DNA, and incorporation of highly 
repeated monkey a-sequences as well as sequences present in the 
monkey genome at much lower frequency. These authors noted that 
the monkey DNA sequences present in the recombinant viruses bore 
no significant homology to the viral sequences that had been lost 
during recombination. At the sites involved in the deletion and 
inversion of wild-type viral sequences, again no good regions of 
homology were present. In both variant genomes described by these 
authors the low reiteration frequency host DNA is very A-T rich, 
although different in each case. The host-viral joins in the SV40
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variants were also rich in A-T base pairs, and McCutchan et al. 
(1979) speculated that such regions of DNA duplex instability might 
facilitate recombination, without the need for long regions of 
sequence homology, although short tetra-, hexa- and heptanucleotide 
homologies were observed adjacent to the sequence joints. With 
regard to recombination of HPV-16 DNA with cellular sequences in 
samples C3 and C5 in this study, no sequences involved in the 
recombination mechanism can as yet be identified, although the 
regions of nucleotide sequence determined to date are indeed rich in 
A-T base pairs. This would require the entire DNA sequence of both 
PCR fragments to be determined, and the human DNA sequence 
involved to be cloned and sequenced. Both of these aims must be 
regarded as high priority.
This is not the first association of papillomavirus sequences with 
repetitive human DNA, Schneider-Gadicke and Schwarz (1986) 
reported HPV-16 DNA integrated adjacent to cellular sequences 
which showed homology to the Alu family of repeats. However 
screening of the available sequences from C3 and C5 against Alu 
sequences present in the Genbank and EMBL databases did not 
reveal any homology, and the repeated sequences remain to be 
characterised.
Recently, Choo et al. (1990) analysed the site of integration of 
HPV-16 DNA in a primary cervical carcinoma, where the viral DNA 
had undergone sequence duplication and internal deletion events 
(Choo et al., 1988). Nucleotide sequencing of the upstream viral- 
cellular integration junction enabled identification of two regions of 
homology between the HPV-16 and host cell DNAs, one of which
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\was situated in an A-T rich region of the viral genome. This 
information enabled the authors to propose a model for the 
integration mechanism at the 5’ junction involving these short 
homologies in an illegitimate recombination, while analysis of the viral 
and cellular sequences present at the other junction suggested that 
after the initial integration occured a secondary event took place 
resulting in deletion of both viral and cellular sequences. It is possible, 
though speculative, that the PCR products amplified from samples C3 
and C5 reflect products of illegitimate recombination between 
HPV-16 and cellular DNA, involving an A-T rich region.
5.6. Oral Keratinocvte Cultures Harbour HPV 
Sequences.
PCR analysis of DNA from the T45 oral keratinocyte cell line enabled 
detection of HPV-16 E6-E7 sequences in low amounts, which were 
not apparent by conventional Southern blot hybridisation. This 
suggests that not all of the cells contain HPV sequences, as the cell 
population is not clonal. No late region amplification products were 
observed using the 16La/b primer pair, implying that this region has 
been deleted, or become rearranged such that the primers used were 
unable to anneal to the DNA template, perhaps in a way similar to 
that observed for HPV-16 DNA in sample C2. Attempted 
amplification of HPV-16 late genes in oral keratinocyte cultures 
derived from squamous cell carcinomas has previously been 
unsuccessful (Maitland et al., 1989), although, as seen in this case, the
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E6-E7 genes were retained. This may reflect a function of the 
products of these genes in cell immortalisation.
Other workers studying oral keratinocyte cultures have observed loss 
of viral sequences with increased passage of cells (N. Maitland, 
personal communication). Whether this is due to loss of HPV DNA 
from individual cells as a result of redundancy following establishment 
in culture or to selective pressure against cells harbouring 
papillomavirus sequences is at present unclear. Examination of the 
mechanism by which this phenomenon occurs would then allow 
possible reasons for the loss of viral DNA to be elucidated. The T45 
cell culture described here would be a reasonable starting point for 
such studies, as HPV sequences are present in only a few cells. Single 
cell cloning performed on T45 cells would allow establishment of cell 
lines which were positive or negative for viral sequences. The 
behaviour of these clonal populations in culture could then be 
examined, and changes in viral DNA content, growth characteristics 
and in vivo tumorigenicity monitored.
The availability of clonal oral carcinoma cell lines containing HPV 
genomes would also be conducive to the study of viral transcription 
and regulation in oral tissues. No data concerning these aspects of 
HPV infection of oral epithelium have so far been documented; this 
would help to clarify the role of such viruses in oral carcinogenesis.
The interaction of viral gene products with host proteins and the 
effects of such on the phenotype of the cell could also be examined. 
For example, nothing is known about possible modulation of normal 
cellular tumour suppressor function in oral keratinocytes or
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transactivation of cellular genes by viral proteins, both of which could 
be important for malignant progression.
If recombination between viral and cellular sequences does occur, as 
the data presented here suggests, HPV-containing cell lines derived 
from the oral keratinocyte culture described would provide a good 
model for the study of such events. Integration or recombination 
events could be monitored as the time in culture increased and any 
genotypic changes noted, such as amplification of specific cellular 
sequences similar to those described by Smith and Campo in BPV-4 
transformed fibroblasts (1989), or induction of cellular regulators of 
transcription. Such events could then be related to changes in the 
phenotype of the cells, in particular their tumorigenicity in vivo and 
their ability to differentiate.
The T45 cell culture derived in the course of this work has several 
advantages over other available in vitro systems.The majority of 
cervical carcinoma cell lines which have been used previously to study 
the biology of HPV-16 and HPV-18 and their role in epithelial 
carcinogenesis, such as C-41, SiHa, CaSki and HeLa, have been in 
culture for many years (HeLa since 1951). During their considerable 
in vitro lifespans, these cell lines will most likely have lost many of the 
properties of the cervical epithelial cells from which they originated, 
due to selective pressure on cells in culture. For instance, they may 
have undergone mutational events or chromosome loss, if these would 
impart a growth advantage to the cells. The use of a newly-explanted 
cell line largely overcomes such difficulties, being temporally closer to 
the original tissue phenotype and being a more representative system
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for studying malignant progression of epithelial cells and the 
involvement of papillomavirus genomes.
A further advantage of the T45 keratinocytes described here is their 
apparent lack of in vivo tumorigenicity, despite the source being a 
malignant oral tumour. As reviewed in sections 1 and 2, the 
development of oral squamous cell carcinoma is undoubtedly a 
multistage process involving several genetic events. The availability of 
an immortal, though non-tumorigenic, oral epithelial cell line 
provides a suitable in vitro system for investigating the multifactorial 
nature of oral cancer by using, for example, cloned viral and cellular 
oncogenes and tumour suppressor genes in transfection experiments 
to progress immortal cells to overt malignancy, and to regress 
malignant cells to a non-tumorigenic phenotype. This could be 
performed in parallel with experiments to study the response of cells 
to growth factor-mediated regulation of proliferation, the factors 
important for production of distinct in vitro phenotypes identified, and 
correlation made with gene mutations and altered expression in vivo.
1 9 1
5.7. Conclusions.
This study has succeeded in identifying human papillomavirus 
sequences in both normal and malignant tissues from patients 
suffering from oral squamous cell carcinoma in around fifty per cent 
of cases. This was six times greater than the frequency of HPV 
infection in an age-matched control population of cancer-free 
patients, and is suggestive of an aetiological role for certain HPV 
types in at least some oral carcinomas. In view of the low levels of 
viral DNA present, it is unlikely that viral sequences are required for 
maintaining the transformed state of the oral epithelium. 
Alternatively, the oral cancer patients may be more susceptible to 
HPV infection due to reduced immune function, although the two are 
not necessarily mutually exclusive. Analysis of premalignant oral 
lesions for viral DNA and gene expression may shed further light on 
the importance of papillomaviruses in the aetiology of oral cancer.
The failure to identify HPV DNA in the remaining fifty per cent of 
oral cancer cases may reflect the multifactorial nature of the disease, 
with additional agents playing an aetiological role. It should be 
stressed that, when using the most sensitive procedure available, only 
three HPV types were screened for. Use of specific oligonucleotide 
primers for other HPVs, or degenerative primers at reduced 
stringency, may reveal viral DNA to be present in further samples, or 
indeed allow the isolation of new viral types from oral mucosa.
During the course of this work, HPV-4 DNA was found in one oral 
cancer, the first report of this papillomavirus, normally associated
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with benign lesions, in a malignancy. Its role in the aetiology of oral 
cancer is, at present, unclear. Transfection experiments using the 
cloned viral DNA to assess its transforming potential, together with 
sequencing of prototype and oral isolates may provide an answer to 
this question.
In two cancer cases containing HPV-16 DNA the evidence suggests 
that recombination has occurred between viral and cellular sequences. 
Although this has previously been demonstrated in mammalian cells 
infected with a DNA tumour virus, the significance is unclear. 
Molecular cloning and nucleotide sequence analysis of the viral DNA 
and the associated repetitive human sequences may provide clues to 
the mechanism of recombination and perhaps the significance of such 
events.
Finally, a keratinocyte population has been derived from malignant 
oral epithelium which will provide an excellent system for the study of 
the factors involved in malignant progression of oral epithelium, 
including the role of papillomavirus sequences together with cellular 
oncogenes and tumour suppressors.
The information gained from such studies will help to shed some light 
on the involvement of human papillomavirus genomes and their 
interaction with cellular factors in the development of oral squamous 
cell carcinoma.
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